Georgia State University

ScholarWorks @ Georgia State University
Biology Dissertations

Department of Biology

8-6-2007

KIR Channels in CO2 Central Chemoreception: Analysis with a
Functional Genomics Approach
Asheebo Rojas

Follow this and additional works at: https://scholarworks.gsu.edu/biology_diss
Part of the Biology Commons

Recommended Citation
Rojas, Asheebo, "KIR Channels in CO2 Central Chemoreception: Analysis with a Functional Genomics
Approach." Dissertation, Georgia State University, 2007.
doi: https://doi.org/10.57709/1063856

This Dissertation is brought to you for free and open access by the Department of Biology at ScholarWorks @
Georgia State University. It has been accepted for inclusion in Biology Dissertations by an authorized administrator
of ScholarWorks @ Georgia State University. For more information, please contact scholarworks@gsu.edu.

KIR CHANNELS IN CO2 CENTRAL CHEMORECEPTION:
ANALYSIS WITH A FUNCTIONAL GENOMICS APPROACH
by
ASHEEBO ROJAS
Under the Direction of Chun Jiang

ABSTRACT
The process of respiration is a pattern of spontaneity and automatic motor control
that originate in the brainstem. The mechanism by which the brainstem detects CO2 is
termed central CO2 chemoreception (CCR). Since the early 1960’s there have been
tremendous efforts placed on identification of central CO2 chemoreceptors (molecules
that detect CO2). Even with these efforts, what a central CO2 chemoreceptor looks like
remain unknown. To test the hypothesis that inward rectifier K+ (Kir) channels are CO2
sensing molecules in CCR, a series of experiments were carried out. 1) The first
question asked was whether the Kir4.1-Kir5.1 channel is expressed in brainstem
chemosensitive nuclei. Immunocytochemistry was performed on transverse medullary
and pontine sections using antibodies raised against Kir4.1 and Kir5.1. Positive
immunoassays for both Kir4.1 and Kir5.1 subunits were found in CO2 chemosensitive
neurons. In the LC the Kir4.1 and Kir5.1 were co-expressed with the neurokinin-1
receptor that is the natural receptor for substance P. 2) The second question asked was
whether the Kir4.1-Kir5.1 channel is subject to modulation by neurotransmitters critical
for respiratory control. My studies demonstrated that indeed the Kir4.1-Kir5.1 channel is

subject to modulation by substance P, serotonin and thyrotropin releasing hormone. 3) I
performed studies to demonstrate the intracellular signaling system underlying the
Kir4.1-Kir5.1 channel modulation by these neurotransmitters. The modulation by all
three neurotransmitters was dependent upon the activation of protein kinase C (PKC).
The Kir4.1-Kir5.1 but not the Kir4.1 channel was modulated by PKC. Both the Kir4.1
and Kir5.1 subunits can be phosphorylated by PKC in vitro. However, systematic
mutational analysis failed to reveal the phosphorylation site. 4) The fourth question
asked was whether Kir channels share a common pH gating mechanism that can be
identified. Experiments were performed to understand the gating of the Kir6.2+SUR1
channel as specific sites for ligand binding and gating have been demonstrated. I
identified a functional gate that was shared by multiple ligands that is Phe168 in the
Kir6.2. Other Kir channels appear to share a similar gating mechanism. Taken together,
these studies demonstrate the modulation of Kir channels in central CO2 chemoreception.
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F. SPECIFIC AIMS AND HYPOTHESES
Central chemoreception, defined as the physiological response of the central
nervous system to chemical stimuli (CO2 and H+) has been a puzzling area of medical
science for the past 40-50 years. Although new information is constantly being produced
in the literature about this topic, what a central chemoreceptor looks like remains elusive.
Recent studies indicate that there are specific neurons in the brainstem that are CO2
chemosensitive (Ballantyne & Scheid, 2001; Feldman et al., 2003; Nattie & Li, 2002;
Paterson et al., 2006; Richerson et al., 2001). However, because of the diversity of cell
types in the brainstem, the difficulty for finding the central chemoreceptor molecule has
proven to be rather difficult. One approach to overcome this difficulty is to find
molecules instead of cells, which are responsible for CO2 sensing, as proposed in our
laboratory. Based on the criteria established recently by Jiang et al., 2001, a number of
ion channels qualify as potential CO2/pH sensing candidates, i.e., various inward rectifier
K+ channels (KIR), twik-related acid-sensitive K+ channels (TASK), and non selective
cation channels such as transient receptor potential channels (TRP) and cyclic nucleotide
gated channels (CNG). Immunocytochemistry and in situ hybridization studies have
proposed the existence of members of these channel families in brainstem neurons. The
brainstem neuronal expression of these channels may implicate an involvement in central
CO2 chemoreception. In addition to brainstem expression these potential candidates
satisfy other properties that are required of central CO2 chemoreceptors such as a high
sensitivity to CO2/pH and an ability to detect both alkaline and acidic pH levels.
Although many of these channels meet the criteria, the inward rectifier K+ (Kir) channels
1

are leading candidates because there is evidence showing that certain intrinsic Kir
channel properties are detected in known chemosensitive neurons during changes in CO2
(Kawai et al., 2006; Pineda & Aghajanian, 1997; Schultz et al., 2003). One major finding
from studies involving these Kir channels is that they have the ability to change cellular
excitability (Cui et al., 2001; Isomoto et al., 1997; Nichols & Lopatin, 1997). This is
important because central CO2 chemoreception involves a change in neuronal excitability,
such as a depolarization of brainstem chemosensitive neurons resulting in an increase in
the firing rate of these neurons when challenged with acidosis. Over the past decade a
number of Kir channels suggested to play a role in central CO2 chemoreception have
declined because they fail to satisfy most or all of the requirements of a central CO2
chemoreceptor. The heteromeric Kir4.1-Kir5.1 channel and the KATP channel (composed
of Kir6.2/SUR1) remain strong candidates for a major involvement in central CO2
chemoreception. However, even with extensive in vitro electrophysiological and protein
modification studies carried out on these channels their neuronal specific function has not
been elucidated. Therefore, a neuron-specific functional genomics approach is important
because this may eventually lead to an identification of the long-searched central CO2
chemoreceptors. However, it is not clear whether the Kir4.1-Kir5.1 protein is expressed
in chemosensitive brainstem nuclei; whether the Kir4.1-Kir5.1 channel is modulated by
neurotransmitters critical for respiratory control; what intracellular signaling mechanisms
account for the modulation; and whether Kir6.2 modulation by ATP is important for
central chemoreception. To address the issue of the Kir4.1-Kir5.1 and Kir6.2 channels

2

being central CO2 chemoreceptors, I have designed experiments to target four specific
aims:

A. To demonstrate the expression of the heteromeric Kir4.1-Kir5.1 channel
protein in chemosensitive brainstem nuclei.
B. To

show

the

modulation

of

the

Kir4.1-Kir5.1

channel

by

neurotransmitters critical for respiratory control.
C. To elucidate the molecular basis for the modulation of the Kir4.1-Kir5.1
channel by neurotransmitters.
D. To understand a general gating mechanism shared by the Kir channels
and its effect on CO2 central chemoreception.

The following hypotheses will be tested:

1. The Kir4.1-Kir5.1 channel protein is expressed in the plasma membrane of
chemosensitive neurons in the brainstem where it is co-localized with the
natural receptor for the neurotransmitter Substance-P (NK1R).

2. The Kir4.1-Kir5.1 channel is modulated by the neurotransmitters substanceP, serotonin, and thyrotropin releasing hormone, where channel activity is
reduced by receptor activation via a protein kinase C-dependent mechanism.

3

3. Kir4.1-Kir5.1 channel activity is reduced by PKC activation and channel
phosphorylation and such a regulation requires the presence of the Kir5.1
subunit.

4. Kir6.2+SUR1 channel gating involves a bulky phenylalanine residue located
at the narrowest sector of the ion conductive pore where it allows the
channel to affect cellular excitability.

4

G. BACKGROUND
The ability to respire (breathe) is a basic fundamental function for human
survival. Respiration can simply be defined as the process of gas exchange within the
body. The final goal of respiration is to maintain adequate concentrations of O2, CO2,
and hydrogen ions in the body. It is fortunate therefore, that changes in the levels of these
three molecules or any of the three results in increase respiratory activity to regulate the
changes. When we breathe, we consume O2 during inhalation and liberate CO2 during
exhalation. This exchange of gases is the respiratory system's means of getting O2 to the
blood where it is then delivered to all regions of the body by red blood cells. Unlike O2,
during metabolic processes CO2 is produced by the tissues of the body. It enters the
vascular system where it is transported to the lungs so it can be expired. For this gas
exchange process to be effective and efficient there has to be mechanisms in the body for
the constant detection of the levels of O2 and CO2 that are present. O2 sensing and
detection is carried out mainly by peripheral chemoreceptors, whereas CO2 sensing is
mainly carried out by central CO2 chemoreceptors located within the brainstem (Donnelly
& Carroll, 2005; Lahiri & Forster, 2003; Lahiri et al., 2006; Nattie, 1999; O'Regan &
Majcherczyk, 1982). O2 does not have a significant direct effect on the respiratory center
of the brain. Instead O2 acts on the peripheral chemoreceptors which were found to be
located in the carotid and aortic bodies in the base of the neck (Lahiri et al., 2006). The
effect of O2 on the carotid and aortic bodies is transmitted to the respiratory center in the
brainstem via nerves. The information then travels from the respiratory center to the
respiratory muscles. Changes in CO2 stimulate the respiratory center in the brain directly
5

resulting in increases in both inspiratory and expiratory drive that are transmitted to the
respiratory muscles, thus affecting ventilation. Indirectly, changes in CO2 are also
detected by peripheral chemoreceptors via a change in arterial pH similar to O2 sensing

Fig. G-1. A schematic demonstrating the flow of information in the respiratory system when
ventilation is reduced and CO2 is increased.

6

(Fig. 1).
Although the brainstem contains the respiratory center that is responsible for
generating the involuntary respiratory rhythm, our conscious though processes also affect
respiration. Higher brain centers such as the cerebrum and hypothalamus may send
signals to the respiratory center and alter the activity of the central pattern generator
leading to a change in ventilation. These higher brain centers, although can affect and
modulate respiratory drive are not necessary for respiration as experiments in animals
with severe damage to higher brain areas demonstrate normal breathing. It is also known
that respiration is affected by emotional processes such as fear and excitement. Under
these conditions the neural pathway may bypass the central pattern generator in the
brainstem and go directly to the somatic motor neurons that innervate respiratory
muscles. No matter what information is sent to the respiratory center the chemoreceptor
reflex is still dominant. We cannot override the chemoreceptor reflex although
consciously we can alter our respiratory output. No matter how long we hold our breath
voluntarily the increased PCO2 in our system will activate the chemoreceptor reflex and
we will be forced to breath. Therefore, the strong CO2 stimulus cannot be ignored.

G-1. Central CO2 chemoreception
The process by which the respiratory center in the brainstem detects CO2 is
termed central CO2 chemoreception (CCR). Central CO2 chemoreception is an important
process in the maintenance of brain function. The brain tightly monitors changes in pH in
both acidic and alkaline directions. The presence of the blood-brain barrier does not allow
7

H+ to get from the periphery of the body into the brain. However, CO2 can cross the
blood-brain barrier. Gaseous CO2 is recognized as the molecule that diffuses across the
blood-brain barrier, but pH is the actual stimulus that elicits a response by chemosensing
neurons leading to a change ventilation (Erlichman & leiter, 1997; Feldman et al., 2003;
Jiang et al., 2001; Kawai et al., 2006; Lahiri & Forster, 2003; Lahiri et al., 2006;
Lamanna, 2003; Nattie et al., 2002; Sugama et al., 1997). This leads to the question:
What is the relationship between CO2 and H+? Gaseous CO2 in the presence of the
enzyme carbonic anhydrase is rapidly hydrated by water to form carbonic acid. Carbonic
acid dissociates into a proton and bicarbonate ion. The rate limiting factor in this reaction
is the enzyme carbonic anhydrase. This enzyme allows for the extremely rapid
conversion of gaseous CO2 to carbonic acid.

Fig. G-2. Diagram showing the relationship between CO2 and H+.

Therefore, increases in CO2 (hypercapnia) physiologically result in very rapid increases
in hydrogen ions. The increase in hydrogen ions results in a decrease in pH (acidosis).
Although pH is the accepted stimulus that elicits a ventilatory response, it is still possible
that some central chemoreceptors can detect CO2 directly. This possibility cannot be
completely excluded although there is no evidence supporting this idea.
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G-2. Inability to identify the central CO2 chemoreceptor
Unfamiliarity with the research conducted in the field of central CO2
chemoreception may lead someone to the conclusion that the field is long on problems
and short on solutions. Although this conclusion would be false, it is justified due to the
inability of many researchers over a long period of time to detect and characterize the
central chemoreceptor which is the molecule responsible for detecting changes in CO2
within the brainstem. Although researchers have been unable to find the long searched for
chemoreceptor molecule, many breakthroughs and accomplishments have occurred over
the last 50-60 years within this field. For example, one important finding involving
central chemoreception over the past decade has been the role of the brainstem in CO2
chemoreception (Coates et al., 1993; Feldman et al., 2003; Lamanna et al., 2003; Nattie,
2000;). The discovery that the brainstem is the area of the brain responsible for pH
chemosensitivity is no longer controversial. However, although the location of the
modulation of breathing in the brain is known (respiratory center in the brainstem),
exactly how CO2 and pH can be detected by this area to generate a pattern of breathing
remains elusive and is an area of interest. With the knowledge of the brainstem’s role in
chemoreception researchers tried to detect specific cells in this region of the brain that are
potential candidates for sensing changes in CO2 and pH and coupling this sensing to a
ventilatory response.
G-3. Various CO2 chemosensitive nuclei within the brainstem
The search for chemosensitive neurons within the brainstem has led to the
identification of many CO2 chemosensitive nuclei within the brainstem. These
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chemosensitive nuclei share several common features. For example, the level of C-fos
(the gene that encodes the nuclear protein FOS) increases in these areas when challenged
with CO2 (Anton et al., 1991; Haxhiu et al., 1996; Ribas-Salgueiro et al., 2006; Sato et
al., 1992). Also, individual neurons in these nuclei exhibit CO2 chemosensitivity in vitro
as measured by their firing activity (Dean et al., 1989; Dean et al., 1990; Guyenet et al.,
2005a; Guyenet et al., 2005b; Li & Nattie, 2006; Richerson et al., 2005; Severson et al.,
2003; Sugama et al., 1997). And, focal acidification of these chemosensitive nuclei
stimulates breathing in vivo (Budzinska et al., 1985; Hodges et al., 2004a; Hodges et al.,
2004b; Li & Nattie, 1997; Li et al, 2006; Nattie et al., 1991; Nattie & Li, 1994; Nattie &
Li, 2002a; Nattie & Li, 2002b; Taylor et al., 2005; Wenninger et al., 2004). In addition to
this, neurons in some chemosensitive nuclei have been shown to detect changes in
intracellular CO2 and pH resulting in changes in membrane excitability (Kawai et al.,
2006; Lahiri & Forster, 2003; Nattie, et al., 2002; Sugama et al., 1997).
For much of the history of CCR it was believed that the central chemoreceptors
were located on the ventral surface of the medulla in an area known as the ventral lateral
medulla (VLM). The VLM is now believed to be the area where the central pattern
generators for respiration are located (Solomon, 2003a; Solomon, 2003b; Wu et al, 2005;
Guyenet et al., 2005). In addition to the VLM we now know that there are chemosensitive
sites located throughout the brainstem. Such nuclei as the nucleus tractus solatarius
(NTS), the retrotrapezoid nucleus (RTN), nucleus paragigantocellularis, midline raphé
nuclei in the medulla and midbrain, ventral respiratory column, area postrema, nucleus
ambiguous, etc, have all been demonstrated to be CO2 chemosensitive nuclei (Dean et al.,
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1989; Dean et al., 1990; Guyenet et al., 2005a, Guyenet et al., 2005b; Hodges et al.,
2004a; Hodges et al., 2004b; Li & Nattie, 1997; Li et al., 2006; Miura et al., 1998; Nattie
et al., 1991; Nattie et al., 1994; Nattie & Li, 2002). There are even CO2 chemosensitive
nuclei within the dorsal pons such as the locus coeruleus (LC) nucleus and the Kolliker
Fuse nucleus (Li & Nattie, 2006; Mizusawa et al., 1995; Pineda & Aghajanian, 1997). All
of these chemosensitive nuclei have been classified into three groups that are the ventral
respiratory group (VRG), the dorsal respiratory group (DRG), and the pontine respiratory
group (PRG) (Fig. 3). The identification of these multiple chemosensitive nuclei located
throughout the brainstem has raised the question; why are there so many CO2
chemosensitive sites within the brainstem? One potential explanation is perhaps these
chemosensitive sites are communicating with each other allowing for fine tuning of the
respiratory system. Or, maybe these various sites allow for integration between the
respiratory system and other neuronal systems. These multiple CO2 chemosensitive sites
may be involved in the control of breathing, cardiovascular regulation, and other
sympathetic functions such as hypercapnia-induced arousal, anxiety and aggression. The
exact reason there are so many chemosensitive sites within the brainstem is not known.
However, all of these CO2 chemosensitive nuclei appear to be important for the whole
body response to changes in CO2 as ablation of these sites individually results in impaired
respiration in animals.
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Fig. G-3. Brainstem anatomy demonstrating the location of the various respiratory groups. A.
Ventral view of the brainstem. B. Dorsal view of the brainstem. C, D, E. Representative
transverse sections taken at different locations of the respiratory groups. PRG=pontine
respiratory group, DRG=dorsal respiratory group (medulla), VRG=ventral respiratory group
(medulla). (Nattie, 1999)

G-4. The involvement of neurotransmitter systems in central CO2 chemoreception
Recently, the importance of neurotransmitter systems in central CO2
chemoreception has been under intense investigation. One reason for this is that there
must be amplification of the stimulus during central CO2 chemoreception. There is a
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significant discrepancy in central CO2 chemoreception. This discrepancy stems from
results obtained from experiments conducted in vitro versus those that were conducted in
vivo. Based on the results from in vivo experiments none of the potential chemoreceptor
candidates studied thus far demonstrates a CO2/pH sensitivity that is required of a central
CO2 chemoreceptor molecule in vivo. The central CO2 chemoreceptor molecule should
possess the capability to detect very minute changes in CO2. A change in pCO2 as low
1mm Hg is sufficient enough to produce a 20-30% change in ventilation (Nattie, 1999;
Putnam et al., 2004). No molecule identified to date demonstrates such sensitivity to
CO2/pH. Therefore, perhaps there is amplification of the signal in central CO2
chemoreception. The involvement of neurotransmitter systems in this process may allow
for amplification of the signal. Indeed, several neurotransmitters have been shown to be
important for respiratory control. Different approaches have been used to demonstrate the
importance of neurotransmitters in the control of respiration. The neurotransmitters
substance P (SP), serotonin (5-HT), thyrotropin releasing hormone (TRH), GABA, and
glutamate have all been shown to be important for respiratory control (Bonham, 1995;
Chen et al., 1990; Nattie & Li, 2002; Nink et al., 1991a; Nink et al., 1991b; Severson et
al., 2003; Taylor et al., 2005; Vonhof et al., 1991). Site-specific injections of these
neurotransmitters in chemosensitive nuclei potently augment or suppress ventilation
frequency (Chen et al., 1990; Li et al., 2006; Messier et al., 2002; Nink et al., 1991a;
Nink et al., 1991b). Researchers have also site-specifically killed neurons containing
receptors for some of these neurotransmitters and assayed to determine whether the
animal’s ventilatory response to CO2 was the same or compromised (Hodges et al., 2004;
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Nattie et al., 1991; Nattie & Li, 1994; Nattie & Li, 2002). Site specific lesions of neurons
containing the neurokinin-1 receptor (NK1R), the natural receptor for SP, using a
saporin-SP conjugate (SAP-SP) compromised the ventilatory response in rats challenged
with CO2 (Hodges et al., 2004; Nattie & Li, 2002; Wenninger et al., 2004). In these
experiments SP guides the toxin saporin to neurokinin receptor positive neurons. Once
substance P binds to the receptor the SAP-SP is internalized and the toxin kills the
neurons. The technique has been shown to be very effective for site-specific lesioning of
nuclei within the brainstem. Experiments have also been carried out to show the
importance of neurons that produce the neurotransmitter serotonin in central CO2
chemoreception (Hodges et al., 2004; Richerson et al., 2005; Severson et al., 2003;
Taylor et al., 2005). The finding that neurotransmitters such as serotonin, substance-P and
thyrotropin releasing hormone are involved in and are critical for the control of
respiration suggests that they may play a role in the amplification of the CO2/pH signal.
This idea is further strengthened by the demonstration that the receptors for the
neurotransmitters, SP, 5-HT, and TRH are G-protein coupled receptors (GPCR). Ligand
binding to these receptors activates a guanine nucleotide binding protein (G-protein)
which in turn leads to the activation of multiple second messenger cascades. One such
activation cascade involves activation of phospholipase-C β that cleaves
phosphatidylinositol bisphosphate (PIP2) into inositol triphosphate (IP3) and
diacylglycerol (DAG). The PIP2 derivative, DAG, activates protein kinase C (PKC) and
IP3 increases intracellular calcium which is also often necessary for PKC activation. The
G-protein involved in this activation cascade is Gαq. Interestingly, there are receptor
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subtypes for SP, 5-HT, and TRH that are coupled to Gαq. This Gαq signaling cascade may
lead to the amplification of the signal as many intracellular messengers are activated
following ligand binding to Gαq coupled receptors.
G-5. Potential chemoreceptor candidates
According to Jiang et al., 2001 there are at least four requirements for a molecule
to be considered a possible central CO2 chemoreceptor. Based on experimental
observations the central CO2 chemoreceptor molecule should: 1) be highly sensitive to
CO2/pH changes within the physiological range; 2) it should be able to detect CO2/pH
changes in both acidic and alkaline (hypercapnic or hypocapnic) directions; 3) it should
be able to couple the variation in CO2/pH to a change in neuronal membrane excitability
(depolarization or hyperpolarization); and 4) it should be expressed in CO2
chemosensitive sites within the brainstem. Of these four requirements the last one is
arguably the most important for limiting the number of potential chemoreceptor
candidates. However, based on the criteria above a number of molecules can be
considered possible CO2 chemoreceptors. Amongst the different membrane proteins ion
channels receive the most consideration as central CO2 chemoreceptors because, ion
channels posess qualities necessary for central CO2 chemoreception that are lacking in
other membrane proteins, such as an ability to rapidly change cellular excitability. The
list of ion channels considered potential chemoreceptor molecules include inward
rectifier K+ (Kir) channels, twik-related acid-sensitive K+ (TASK) channels, gap junction
channels, voltage activated K+ channels, and several non-selective cation channels such
as cyclic nucleotide gated (CNG) channels and transient receptor potential (TRP)
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channels. Some of these channel families contain several potential candidates, making
this list very long. None of the ion channels studied thus far have been shown to be the
central CO2 chemoreceptor. These channels however are all still candidates for different
reasons. For example, some ion channels such as TASK channels are sensitive to
CO2/pH, but these channels are expressed abundantly throughout the brain suggesting a
more universal role in neuronal functional than a specific role in central CO2
chemoreception. The finding that a large number of ion channels can detect CO2/pH has
raised the question: Why are there so many potential CO2/pH sensing molecules?
Perhaps, there is more that one central CO2 chemoreceptor molecule and potentially they
work together to detect changes in CO2. Indeed, we know that in addition to the
requirement for high CO2 sensitivity discussed in the previous section, the central
chemoreceptor molecule should be able to detect a wide range of CO2 changes. In
humans the partial pressure of CO2 (PCO2) can range from ~40 mmHg to ~80 mmHg. To
date no known molecule possess the ability to cover such a wide range of CO2 changes.
The use of multiple molecules to detect a wide range of stimuli can be found in other
homeostatic systems. For example, temperature sensing and transduction has been shown
to be carried out by multiple molecules many of which are transient receptor potential
channels (Caterina et al., 1999; Jiang et al., 2005; Story et al., 2003; Watanabe et al.,
2002; Xu et al, 2002). Perhaps, central CO2 chemoreception has adopted a similar
mechanism. This idea is becoming more and more popular with researchers in the field
of central CO2 chemoreception.
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G-6. Kir channels as potential chemoreceptor molecules
Inward rectifier K+ channels are key players in the maintenance of membrane
excitability and the control of intracellular as well as extracellular K+ homeostasis
(Baukrowitz et al., 1999; Jan & Jan, 1997; Nichols & Lopatin, 1997; Oliver et al., 2000;
Reimann & Ashcroft, 1999). In addition to satisfying criteria necessary for a central CO2
chemoreceptor, the Kir channels demonstrate an additional characteristic that makes them
strong candidates as sensing molecules, which is their involvement in setting the resting
membrane potential (Baukrowitz et al., 1999; Nichols & Lopatin, 1997; Oliver et al.,
2000). This characteristic allows these channels to directly alter cellular excitability.
Unlike other K+ channels, Kir channels conduct inward currents more readily than
outward currents through a process known as “rectification”. The property of inward
rectification makes these Kir channels unique potassium channels (Fig. 4A). The K+
channel family is one of the largest ion channel family. Within this super-family there are
several sub-families. Currently, there are more than 70 cloned mammalian K+ channels.
Amongst the numerous K+ channel sub-families the Kir channel family is the largest,
containing the most members. In the Kir channel family there are seven sub-families,
i.e., Kir1 (ROMK), Kir2 (IRK), Kir3 (GIRK), Kir4, Kir5, Kir6 and Kir7 (Fig. 4B).
Totally, there are more than 15 functional Kir channels.
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Fig. G-4. Diagram showing rectification in Kir channels and the Kir channel family tree. A.
Current-voltage relationship observed in Kir channels. These are representative currents recorded
from Kir channels in a high extracellular potassium environment. The red trace represents
currents from a strong rectifier and the blue represents currents from a weak rectifier. Note that at
positive membrane voltages the current changes direction (rectification). B. Phyllogenetic tree of
Kir channels. The channels highlighted in blue are the channels discussed in this thesis. (Nichols
& Lopatin, 1997)
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Kir channels have a unique architecture. Each channel is composed of four
subunits arranged in a tetrameric fashion (Fig. 5A, B). Each subunit is composed of two
transmembrane spanning domains (TMD1, TMD2) that are joined by a pore loop and
selectivity filter (H5) with intracellular N and C termini (Fig. 5C). The H5 (pore) contains
a “TIGYG” motif that determines the selectivity for K+. The N-termini in Kir channels
are shorter (consisting of ~80 residues) than the C-termini (consisting of ~200 residues).
Both termini have been shown to contain ligand binding and gating sites.

Fig. G-5. Kir channel structure. A, B. Structural representation of a typical Kir channel viewing
from outside-in and from inside-out, respectively in a tetrameric arrangement. C. Diagram
showing the architecture of one Kir channel subunit cross-sectioned through the plasma
membrane. (Doyle et al., 1998)
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Kir channels are functional in a number of specialized tissues such as the heart,
brain, pancreas, skeletal muscle, testis, and kidney (Cuevas et al., 1991; Doi et al., 1996;
Donley et al., 2005; Doring et al., 1998; Haller et al., 2001; Jiang et al., 2001; Karschin et
al., 1998; Karschin & Karschin, 1997; Karschin et al., 1997; Lagrutta et al., 1996; Quayle
et al., 1997; Salvatore et al., 1999; Vivaudou & Forestier, 1995; Wu et al., 2004).
Although some Kir channels such as the Kir6.2 can be found in a variety of tissues,
others such as the Kir1.1 and Kir7.1 are more localized to specific areas. The various Kir
channels are regulated by a number of intracellular ligands such as ATP, PIP2, proton, Gproteins, etc (Baukrowitz et al., 1999; Baukrowitz & Fakler, 2000; Cui et al., 2001; Doi
et al., 1996; Jan & Jan, 1997; Matsuo et al., 2005; Nichols & Lopatin, 1997; Oliver et al.,
2000; Quayle et al., 1997; Reimann & Ashcroft, 1999; Takano & Kuratomi, 2003). The
ligand modulation of each Kir channel is specific for that channel. For example, only the
Kir6 channels are sensitive to intracellular ATP. This property allows these Kir6x
channels to couple the cellular metabolism to cellular excitability. The Kir6 family
members are also the only Kir channels that associate with the sulphonylurea receptor
(SUR) to form fully functional channels that are sensitive to ATP and ADP (Baukrowitz
& Fakler 2000; Karschin et al., 1998; Karschin et al., 1997; Matsuo et al., 2005;
Mikhailov et al., 2000; Moreau et al., 2005). Together the Kir6 and the SUR families
form the KATP channel whose arrangement is based on a tetrameric structure with a 1:1
ratio of Kir to SUR. In the KATP channels the Kir6 subunits forms the center of the
channel (pore) and the SUR subunits are regulatory subunits that surround the Kir6
subunits.
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In addition to the homomeric channels, there are also several heteromeric Kir
channels that exist as well. The heteromeric combinations increase the number of
members in the Kir channel sub-family. One such interesting heteromeric channel is the
Kir4.1-Kir5.1 channel. This channel is a unique Kir channel for several reasons. The
Kir4.1-Kir5.1 channel is formed by the heteromultimerization of two inter-subfamily
members (Kir4.1 and Kir5.1). In this channel there are two Kir4.1 subunits and two
Kir5.1 subunits arranged in a “trans” configuration. The heteromultimerization of
different proteins typically generates a new protein with unique properties and a
specialized function. Indeed, this has been found to be the case for the Kir4.1-Kir5.1
channel. Although the Kir4.1 channel functions homomerically and exist in nature, its
properties are very different than those of the heteromeric Kir4.1-Kir5.1. On the other
hand, the Kir5.1 channel is the only Kir channel cloned with no identified homomeric
function. The Kir5.1 is believed to only exist as a heteromer with members in the Kir4
sub-family. This is puzzling to researchers because as previously mentioned the Kir4.1Kir5.1 heteromer has several different characteristics than the Kir4.1 suggesting that two
Kir5.1 subunits are enough to function, however, four is not. This has led to intense
investigation into the function of the Kir5.1 protein. Many researchers have tried to
express this protein in vitro using heterologous systems. Unfortunately, detectable Kir
currents are never identified although protein expression experiments show the presence
of the Kir5.1 protein in the cells. Therefore, it is currently believed that this channel can
only function as a heteromer with Kir4.1 or Kir4.2.
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The heteromeric interaction of Kir4.1 and Kir5.1 produces a channel with distinct
properties. The Kir4.1-Kir5.1 channel has increased pH sensitivity with a pKa at 7.35
(Yang et al., 2000). The channel also has distinct biophysical properties such as
conductance, Popen, sensitivity to barium, and activation kinetics (Yang et al., 2000). The
Kir4.1-Kir5.1 is considered a strong candidate sensing molecule for central CO2
chemoreception because of its ability to satisfy the requirements of a central CO2
chemoreceptor in addition to its fine tuned pH sensitivity (Cui et al., 2001; Xu et al.,
2000; Yang et al., 2000). This channel is able to detect both hypocapnia and hypercapnia
and couple this sensing to a change in membrane excitability (Cui et al., 2001). The role
of the Kir4.1-Kir5.1 in central CO2 chemoreception may be to detect changes in CO2/pH
and change the firing rate of respiratory neurons via membrane excitability. An increase
in the firing rate of respiratory neurons from baseline is generated by a depolarization that
causes the neurons to fire more action potentials, whereas a decrease in the firing rate of
respiratory neurons is typically generated by hyperpolarization that can cause neurons to
become silent firing fewer action potentials. Figure 6 show that the Kir4.1-Kir5.1 channel
has a sigmoid response to pHi with a pKa at 7.35. This allows the channel to detect both
acidic and alkaline pH levels with acidic pH levels inhibiting the channel and alkaline pH
levels stimulating the channel, as such, the channel may be involved in both the
augmentation and supression in the firing rate of respiratory neurons. Inhibition of the
Kir4.1-Kir5.1 channel by slight acidosis may lead to augmentation of the firing frequency
whereas stimulation of the channel by slight alkalization may lead to reduction of the
firing frequency of respiratory neurons. Although previous in vitro studies with the
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Kir4.1-Kir5.1 demonstrated its potential as a CO2 chemoreceptor molecule, it’s identity
as a central CO2 chemoreceptor molecule remains to be proven. This is mostly due to the
lack of information regarding the expression level of this channel in the chemosensitive
sites within the brainstem. Evidence for the expression of the heteromeric Kir4.1-Kir5.1
channel in brainstem neurons will strengthen its candidacy as a chemoreceptor molecule.
However, a clear demonstration of the role played by this channel in central CO2
chemoreception is necessary for the identification of this channel as one of the long
searched for chemoreceptor molecules.
The Kir6.2 channel expressed with the SUR1 receptor has been shown to be
expressed in several tissues including the brain. This KATP channel has been shown to
be present in brainstem neurons at mRNA and protein levels (Haller et al., 2001;
Karschin et al., 1998; Karschin et al., 1997). These important findings suggest that this
channel may function in these neurons as the level of expression is not low. Several
reports have suggested that during the process of central CO2 chemoreception
intracellular ATP levels decrease and appear to regulate an ATP sensitive K+ channel
(Gourine et al., 2003; Gourine, 2005; Haller et al., 2001). The level of intracellular ATP
is critical for the regulation of the Kir6.2/SUR1 channel. An increase in intracellular ATP
inhibits this channel whereas a decrease in ATP stimulates the channel activity. This
channel contains ATP binding sites in the Kir6.2 and ATP/ADP binding sites in the
SUR1 subunits. In the Kir6.2 the ATP binding sites are located in the N and C-termini
where they form a three dimensional pocket for the binding of ATP (Cukras et al., 2002;
Drain et al., 1998; Wu et al., 2002). Experiments performed on the Kir6.2 channel (in the
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absence of the SUR1) demonstrated that the Kir6.2 channel is inhibited by high
concentrations of ATP whereas the SUR1 is regulated by ATP and ADP.
Unlike the other Kir channels the Kir6.2 channel is activated by intracellular
acidosis. When the channel current is plotted as a function of intracellular pH the channel
shows a bell shaped response curve to acidosis (Fig. 6). Slight acidification activates the
channel whereas strong acidification leads to channel inhibition. Alkalization also
inhibits this channel. Independent of changes in intracellular ATP, acidification of a
respiratory neuron may activate the Kir6.2 channel leading to a hyperpolarization of the
cell. Although depolarization is seen in many chemosensitive neurons in response to
acidosis, hyperpolarization of an inhibitory presynaptic motor neuron may release this
neuron’s inhibition and allow firing of the postsynaptic cell. However, when considering
the function of the KATP channel the regulation by ATP has to be considered as ATP is a
major modulator of the channel. In the situation where there is a change in intracellular
ATP during acidosis, the pH sensitivity of the channel may be changed. Indeed, it has
been shown that ATP and H+ have allosteric effects on the Kir6.2/SUR1 channel. This
characteristic gives this channel an advantage over other potential central CO2
chemoreceptor molecules as the concentrations of ATP and H+ that change during central
CO2 chemoreception may convert on the same molecule. However, the identification of
this Kir6.2/SUR1 channel as a chemoreceptor molecule remains to be proven. Therefore,
a clear demonstration of the role played by this channel is also necessary for the
identification of this channel as one of the long searched chemoreceptor molecules.
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B

Fig. G-6. pH sensitivity of the various Kir channels. A. The channel current (I) is plotted as a
function of intracellular pH. Most Kir channels are inhibited by intracellular acidosis. B. The
Kir6.2 channel shows a bi-phasic response to intracellular acidification. The asterisks show the
shift in the pH sensitivity of the Kir4.1 versus the Kir4.1-Kir5.1 channel. The blue bar represents
an intracellular pH of 7.4 that is close to neutral. (Jiang et al., 2001; Xu et al., 2001)
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G-7. The molecular basis for CO2/pH sensing
The ability to detect pH is carried out by the titration of amino acids in the
primary sequence of the proteins. There are only a few amino acids that are titratable (i.e.
histidine, lysine, apartate, etc). Among the titratable amino acids only histidine is
titratable at or near physiological levels. Although lysine has been demonstrated as a
titratable residue in some pH sensing proteins, the titration of histidine appears to be
much more common. The detection of elevated levels of protons resulting in the titration
of amino acids is not sufficient for central CO2 chemoreception. As discussed earlier, the
central CO2 chemoreceptor molecule has to have the ability to change cellular
excitability. Therefore, following titration of the amino acid histidine, there has to be a
coupling between the sensing and the effect. In ion channels this is done through a
mechanism called “channel gating”.
Gating refers to the opening and closure of ion channels. The mechanism for
channel gating is poorly understood. The gating mechanism of a channel would allow for
or reduce the flow of ions through the channel resulting in a change in cellular
excitability. Ligand binding in ion channels leads to a change in the gating conformation
of the channel through a “binding-gating” coupling mechanism. Therefore, the
demonstration of the gating mechanism of a potential chemoreceptor candidate channel
may lead to an understanding of the role played by this channel in central CO2
chemoreception and how this molecule may lead to a change in cellular excitability.
Clearly, in order to demonstrate that a molecule is a central CO2 chemoreceptor,
experiments should be performed indicating that the whole body response to changes in
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CO2/pH is compromised in the absence of this molecule and is restored in its presence.
This is usually done by the genetic manipulation of the gene of interest. However, before
experiments can be performed involving genetic manipulations of a gene, there should be
a clear demonstration of the basic properties of the gene product. In this way the removal
of the gene and its by-product can be analyzed thoroughly. Therefore, the identification
of Kir channels in chemosensitive brainstem neurons in addition to a demonstration of
the modulation by neurotransmitters and CO2 combined with an identification of the
channel gating mechanism may correlate a particular protein such as a Kir channel with
central CO2 chemoreception and help to solidify the identification of the long sought after
CO2 chemoreceptor molecule.

27

H. SIGNIFICANCE
H-1. The problem and its clinical relevance
Since the early 1960’s there have been tremendous efforts placed on identification
of central CO2 chemoreceptors. The widespread interests can be attributed to several
medical complications associated with CO2 detection. The ability to sense and regulate
CO2/pH has been found to be linked to diseases such as sleep apnea as well as sudden
infant death syndrome (SIDS). Another specific disease that is caused by the central
chemoreceptors inability to sense changes in CO2 is Central Congenital Hypoventilation
Syndrome (CCHS). CCHS is a human condition recognized within the first year of life in
which central chemoreceptors are absent or malfunctional. These children breathe
normally during the day. The problem arises at night when they are asleep. In order to
survive during the night some sort of ventilation support is needed. Although there is a
change in the response to hypoxia, the most dramatic and consistent abnormalities are the
result of the loss of CO2 chemosensitivity. There is a high incidence of death amongst
children diagnosed with CCHS. In the normal population the increased respiratory drive
response to the build up of CO2 during a stoppage of ventilation of blockage of the lung
airways is still poorly understood.

The molecular mechanism for the detection of

CO2/pH under normal and pathophysiological conditions remains elusive. Therefore it is
imperative to understand the molecular basis of central CO2 chemoreception.
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H-2. Why study the Kir4.1-Kir5.1 and Kir6.2+SUR1 channels?
While several Kir channels are recognized as potential chemoreceptors, the
Kir4.1-Kir5.1 and Kir6.2+SUR1 channels are arguably the strongest candidates for
central chemoreception. The Kir4.1-Kir5.1 is probably the strongest candidate amongst
the Kir channels. This is mostly attributed to the fact that the Kir4.1-Kir5.1 channel
satisfies the criteria required for a central CO2 chemoreceptor molecule. The Kir4.1Kir5.1, unlike any other Kir channels, has a pKa at 7.35 that allows it to detect both
alkaline and acidic pH levels within the physiological range (Cui et al., 2001; Yang et al.,
2000). This property is a result of the heteromultimerization of these two Kir channel
subfamily members (Kir4.1, Kir5.1). However, the candidacy of the Kir4.1-Kir5.1
channel is weakened by the lack of information regarding its expression in
chemosensitive brainstem nuclei. A demonstration of neuronal brainstem expression of
the heteromeric Kir4.1-Kir5.1 channel may solidify a role of this channel in central CO2
chemoreception.
Most of the focus placed on Kir6.2+SUR1 has been to understand its role in
insulin secretion. However, immunocytochemistry and in situ hybridization studies have
revealed high levels of expression of Kir6.2 and SUR1 in the brainstem (Haller et al.,
2001; Karschin et al., 1998; Karschin et al., 1997). In addition to its expression in the
brainstem, it is suggested that during the process of central CO2 chemoreception
intracellular ATP levels change and this change may regulate an ATP sensitive potassium
channel (Gourine et al., 2003; Gourine, 2005).
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Since both the Kir4.1-Kir5.1 and the Kir6.2+SUR1 channels are strong CO2/pH
chemoreceptor candidates, a clear demonstration of their function may answer questions
lurking in the field of central CO2 chemoreception and respiratory control. Although
genetic manipulation will eventually solidify these channels as CO2 chemoreceptors,
prior experiments are necessary to strengthen their candidacy. In this thesis, a series of
experiments was proposed to elucidate the role played by Kir channels (Kir4.1-Kir5.1,
Kir6.2/SUR1) in central CO2 chemoreception using a combined electrophysiological and
molecular biological approach.
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I. MATERIALS AND METHODS
I-1. Xenopus Oocyte Preparation and Injection
All experimental procedures were carried out in accordance with the Guidelines
for the Care and Use of Laboratory Animals by the NIH and the Animal Welfare
Assurance of Georgia State University (#A97008). Oocytes from female Xenopus laevis
frogs (Xenopus One, Inc, Dexter, MI) were used in the present studies. Frogs were
anesthetized by bathing them in 0.3% 3-aminobenzoic acid ethyl ester. After a few lobes
of ovaries were removed through a small abdominal incision (~5 mm), the frog was
allowed to recover from the anesthesia. The Xenopus oocytes were treated with 1 mg/ml
of collagenase (Type IA, Sigma Chemicals, St. Louis, MO) in the OR2 solution
containing (in mM): NaCl 82, KCl 2, MgCl2 1 and HEPES 5 (pH 7.4) for 60 min at room
temperature. After five washes (10 min each) of the oocytes with the OR2 solution,
cDNAs (25–50 ng or 5-10 femtomoles in 50 nl DD water) were injected into the oocytes.
The oocytes were then incubated at 18 °C in the ND-96 solution containing (in mM):
NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5, and sodium pyruvate 2.5 with 100 mg/l
G418 sulfate (Medlatech, INC, Herndon, VA) and 50 mg/l tetracycline (Sigma
Chemicals) added (pH 7.4).
I-2. Molecular Biology
Standard molecular biology techniques were used including site-directed
mutagenesis, polymerase chain reaction (PCR), gene expression, and DNA sequencing.
Rat Kir4.1 cDNA (GenBank #X83585) and rat Kir5.1 cDNA (GenBank #AF249676) are
gifts from Dr. John Adelman at Oregon Health and Science University, Portland, OR. For
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co-expression of Kir4.1 and Kir5.1, a tandem dimer of these two cDNAs was constructed
using the overlapping extension technique, in which full length Kir4.1 and Kir5.1
sequences were obtained using Pfu DNA polymerase (Stratagene, La Jolla, CA) chain
reaction (PCR). The PCR products were joined to each other at the 3’ end of Kir4.1 and
5’ end of Kir5.1. Mouse Kir6.2 (GenBank #D50581) was generously provided by Dr.
S. Seino at Kobe University Graduate School of Medicine, Kobe, Japan. The Kir6.2 with
a truncation of 36 AAs at the C-terminus end (Kir6.2∆C36) expresses functional currents
without the SUR subunit and retains ATP and pH sensitivities (Tucker et al., 1997; Xu et
al., 2001). Rat Kir1.1 (GenBank #X72341) (from Dr. Steven Hebert, Yale University)
and Mouse Kir2.1 (GenBank #X73052) (from Dr. Lily Jan, University of California at
San Francisco) were also used in the present studies. Hamster SUR1 (GenBank#L40623)
was a gift from Dr. L. Bryan at Baylor College of Medicine, Houston, TX. All of the
above mentioned cDNAs were sub-cloned into the eukaryotic expression vector
pcDNA3.1 (Invitrogen, Carlsbad, CA) and used for Xenopus oocyte expression without
cRNA synthesis.
Rat neurokinin-1 receptor (NK1R) cDNA (Genbank #J05097) was generously
provided by Dr. Shigetada Nakanishi at Kyoto University Faculty of medicine, Kyoto,
Japan. Rat serotonin 2A receptor (5-HT2A) cDNA (Genbank #M30705) was generously
provided by Dr. David Julius at the University of California at San Francisco, San
Francisco, CA. Mouse thyrotropin-releasing hormone receptors R1 (mTRH-R1)
(Genbank #M59811) and R2 (mTRH-R2) (Genbank #NM_133202) were generously
provided by Dr. Marvin Gershengorn at the National Institutes of Health, Bethesda, MD.
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Rat mu-opioid receptor cDNA (MOR) (Genbank #L22455) was generously provided by
Dr. Stanley Watson at the University of Michigan, Ann Arbor, MI. All receptor cDNAs
were sub-cloned into the eukaryotic expression vector pcDNA3.1 (Invitrogen, Carlsbad,
CA) and used for Xenopus oocyte expression without cRNA synthesis.
Dynamin II (aa) wild-type and Dynamin II (aa) K44A are gifts from Dr. Mark
McNiven at the Mayo Clinic. These two cDNAs were subcloned into the eukaryotic
expression vector pEGFP-N1 creating an N-terminal GFP-Dynamin fusion and used
directly for expression in Xenopus oocytes.
Site-specific mutations were made using a pfu DNA polymerase-based sitedirected mutagenesis kit (Quickchange, Stratagene, La Jolla, CA). Orientation of the
correct mutations and constructions were confirmed with DNA sequencing.
I-3. Expression and purification of MBP and C-terminal-MBP fusion proteins
The membrane and C-terminal cytoplasmic junction for the Kir4.1 (GenBank
#X83585) and Kir5.1 (GenBank #X83581) was determined by ScanProsite. The Cterminal fragments were amplified by PCR and inserted into the pMALc2x vector (New
England Biolabs) using EcoRI and XbaI. The PCR fragments contained these restriction
enzyme sites as well as a stop codon to terminate transcription after the C-terminus. To
express the maltose binding protein (MBP) alone a stop codon was introduced to prevent
expression of part of the LacZ gene present in the pMALc2x vector. Correct
constructions were confirmed with DNA sequencing.
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Expression and purification of the fusion proteins were carried out in Eschericia
coli BL21 competent cells. The cells were grown overnight at 37 ºC. The next morning
the cultures were diluted in LB broth medium and grown to an A600 ~1 at 37 ºC. Protein
induction was achieved by the addition of 1 mM isopropylthiogalactoside (IPTG) to the
cultures which were then incubated at 25 ºC for 2 hours. The cells were harvested by
centrifugation (4,000 x g, 15 min, 4 ºC). The bacterial pellet was washed with STE (150
mM NaCl; 10 mM Tris, pH 8.0; 1 mM EDTA) plus protease inhibitors (EDTA-free)
(Roche Molecular Biochemicals) once and then resuspended in the same buffer. The cell
membranes were lysed by the addition of lysozyme (100 µg/ml) added immediately
following resuspension. The samples were incubated on ice for 15 min. Dithiothreitol
(DTT) (5 mM) was added to the samples and the cell membranes were further lysed by
sonication (4 x 20 s) followed by centrifugation (4,000 x g, 15 min, 4 ºC). The resulting
supernatant was collected and Triton X-100 was added to a final concentration of 1%.
The supernatant was then loaded onto amylose resin (New England Biolabs) preequilibrated with protein elution buffer (PEB) (50 mM Tris, pH 8.0; 1 mM EDTA) and
incubated on ice for 45 minutes. The amylose resin was centrifuged and the supernatant
was discarded. The resin was washed 7 times with 2 volumes of PEB. Elution of the
maltose binding protein (MBP) and MBP fusion proteins was achieved by incubating the
amylose resin with 1 volume of PEB containing 10 mM maltose. All fractions containing
the fusion proteins were pooled and concentrated using centricon YM-10 centrifugal
units (Millipore, Bedford, MA).

Protein purity was determined by sodium dodecyl

sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10%) and subsequent
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coomassie blue staining.

The protein concentration was determined using a UV

spectrophotometer at A280.
I-4. In vitro kinase assay
One µg of purified proteins (Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-MBP,
MBP, Histone III-S) was added to a reaction mixture consisting of the catalytically active
PKC subunit (20 ng) (BioMol, Plymouth Meeting, PA) 10 µCi of
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P-γ-ATP (Perkin

Elmer, Waltham, MA), Magnesium/ATP cocktail (75 mM MgCl2 and 500 µM ATP in 20
mM MOPS, pH 7.2, 25 mM β-glycerol phosphate, 5 mM EGTA, 1 mM sodium
orthovanadate and 1 mM dithiothreitol) and 5x reaction buffer (containing: 125 mM TrisHCl, pH 7.5 and 0.1 mM EGTA) in a total volume of 25 µl. The samples were incubated
at 30 ºC for 1 hour and 5x loading buffer was added to stop the reaction. The samples
were then analyzed by running a symmetric 10% SDS-PAGE gel. The gel was cut down
the middle and one half was stained with Coomassie brilliant blue solution and destained
and the other half was dried and subjected to autoradiography. The autoradiograph was
taken using the Fujifilm BAS 2500 phosphor imager and analyzed with the Multigauge
software.
I-5. Transfection of HEK293 Cells
Human Embryonic Kidney cells (HEK293, CRL-1573, Batch #2187595, ATCC,
Rockville, MD) were chosen to express the Kir4.1-Kir5.1, Kir1.1, and Kir2.1 channels.
HEK293 Cells were cultured as a monolayer in MEM-E medium with 10% fetal bovine
serum and penicillin/streptomycin added. The cells were incubated at 37 °C in the
presence of 5% atmospheric CO2 and split twice weekly.
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The cells were transfected using Lipofectamine2000 (Invitrogen, Carlsbad, CA)
with 5 µg wild-type Kir cDNA per petri dish (35 mm). To facilitate the identification of
positively transfected cells, 0.5 µg of green fluorescent protein (GFP) cDNA (pEGFPN2, Clontech, Palo Alto, CA) was added to the cDNA mixture. Cells were disassociated
from the monolayer using 0.01% trypsin 24 hours post-transfection. A few drops of the
cell suspension were added to a new petri dish. The cells were then incubated at 37 °C for
48 hrs before experiments.
I-6. Primary culture of brainstem neurons
The medulla oblongata and pons of fetal (P16-20) sprague dawley rat embryos
were surgically removed and rapidly placed in ice cold Earle’s Balanced Salt Solution
(EBSS). The tissue was dissociated by treatment using a papain preparation kit
(Worthington, Lakewood, NJ). The neurons were then plated on a polyethyleneimine,
polyornithine, and laminin coated MEA dish which has 64 planar microelectrodes (ALA
Scientific, Westbury, NY) containing dulbecco's modified minimum essential medium
(Invitrogen-Gibco, Carlsbad, CA), with 5% horse serum (Invitrogen-Gibco), and 5% fetal
calf serum (Invitrogen-Gibco) added. Two-thirds of the culture medium was replaced
twice weekly. The neurons showed a similar morphology as in regular cell culture plates.
The dissociated neurons were cultured at 37 oC in 5% CO2/95% air at saturating humidity
(Su & Jiang, 2006; Su et al., 2007).
I-7. Electrophysiology
Two-electrode voltage clamp (TEVC) was used to record whole-cell currents were
studied on oocytes 2–4 days post cDNA injection using an amplifier (Geneclamp 500, Axon
36

Instruments Inc., Foster City, CA) at room temperature (~24 °C). The extracellular solution
contained (in mM): KCl 90, MgCl2 3, and HEPES 5 (pH 7.4). The cells were impaled with
recording pipettes filled with 3 M KCl. The potential leakage of KCl from the recording
electrodes was not corrected because of the large volume of oocytes. One of the
electrodes (1.0-3.0 MΩ) served as the voltage recording which was connected to the HS2 x1L headstage (input resistance=1011 Ω), and the other (0.3-0.6 MΩ) was used for
current recording connected to the HS-2 x10MG headstage (maximum current=130 µA).
Oocytes were accepted for further experiments if they did not show evident leakage in
membrane currents. Current records were low-pass filtered (Bessel, 4-pole filter, 3 dB at
5 kHz), digitized at 5 kHz (12-bit resolution) and stored on a computer disk for later
analysis (pClamp6.0.3, Axon Instruments).
Patch clamp experiments for Kir4.1-Kir5.1 were performed at room temperature (~
25 °C) using the Axo-patch 200B amplifier (Axon Instruments). In brief, the vitelline
membranes were mechanically removed after exposing the oocytes to a hypertonic solution
(400 mOsm). The stripped oocytes were placed in a petri dish containing the regular bath
solution (see below). Fire-polished patch pipettes (2-4 MΩ) were made of 1.2 mm
borosilicate glass capillaries (Sutter Instruments, Novato, CA). The pipette tip was ~2 μm.
The bath solution (FVPP) contained (in mM): 40 KCl, 75 potassium gluconate, 5 potassium
fluoride, 0.1 sodium vanadate, 10 potassium pyrophosphate, 1 ethylene glycol-bis-βaminoethylether-N,N,N’,N’-tetraacetic acid (EGTA), 0.2 adenosine diphosphate (ADP),
10 piperazine-N,N’-bis-2-ethanesulfonic acid (PIPES), 10 glucose, and 0.1 spermine
(pH=7.4). The pipette was filled with the same FVPP solution used in the bath or a solution
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containing: 40 KCl, 110 potassium gluconate, 0.2 ADP, 1 EGTA, 10 N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES), 10 glucose, 2 MgCl2 (pH 7.4). Single
channel currents were recorded from cell-attached patches. Current records were low-pass
filtered (2,000 Hz, Bessel, 4-pole filter, -3 dB), digitized (10 kHz, 12-bit resolution), and
stored on computer disk for later analysis using the pClamp 9 software. Junction potentials
between bath and pipette solutions were appropriately nulled before seal formation. The
open-state probability (NPo) was calculated by first measuring the time, tj, spent at current
levels corresponding to j=0, 1, 2,...N channels open. The Popen was then obtained as Popen =
(∑Nj=1 tj j)/TN, where N is the number of channels active in the patch and T is the duration
of recordings. Popen values were calculated from one or a few stretches of data having a
duration of 20 s each.
Single-electrode whole-cell voltage-clamp was performed using the HEK293 cell
line (American Type Culture Collection, Manassas, VA) at room temperature as described
previously (Li et al., 2004; Wu et al., 2002a; Zhu et al., 1998). In brief, fire-polished
patch pipettes were made from 1.2 mm borosilicate capillary glass (Sutter Instruments,
Novato, CA). Tight seals (>1 gigaohm before breaking into the whole-cell mode) were
obtained with the transfected cells. The patch electrodes had an open tip resistance of 0.51.0 MΩ. The series resistance during recording varied from 5 to 10 MΩ and was not
compensated. Recordings were terminated whenever significant increase (>20%) in series
resistance occurred. Current records were low-pass filtered (2 kHz, Bessel, 4-pole filter, -3
dB), digitized (20 kHz, 16-bit resolution), and stored on computer disk for later analysis
using the pCLAMP 9 software (Axon Instruments Inc, Foster City, CA). Recordings were
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performed using solutions containing equal concentrations of K+ applied to the bath and
recording pipettes. This solution contained (in mM): KCl 40, potassium gluconate 110,
ADP 0.2, EGTA 1, Hepes 10, glucose 10 and MgCl2 2 (pH 7.4). 100 nM thymeleatoxin
dissolved in DMSO and the same concentration of DMSO alone was applied to the bath
solution.
Patch clamp experiments for Kir6.2 were performed at room temperature (about
25 °C) as described previously (Xu et al., 2001; Wu et al., 2002a; Wu et al., 2002b). In
brief, fire-polished patch pipettes were made from 1.2 mm borosilicate glass capillaries
using a Sutter P-97 puller (Sutter Instrument, Novato, CA). Giant inside-out patches were
employed to study macroscopic currents in a cell-free condition using recording pipettes
of 0.5–1.0MΩ and an Axo-patch 200B amplifier (Axon Instruments, Foster City, CA).
The current records were low-pass filtered (Bessel, 4-pole filter, -3 dB at 2 kHz),
digitized with pClamp 9 software (Axon Instruments), and stored on computer disk for
later data analysis. Patch clamp recording solutions contained equal concentrations of K+
applied to the bath and recording pipettes. The solution contained (in mM): 10 KCl, 105
potassium gluconate, 5 KF, 5 potassium pyrophosphate, 0.1 sodium vanadate, 5 EGTA, 5
glucose, and 10 HEPES (pH = 7.4) (Xu et al., 2001; Wu et al., 2002a; Wu et al., 2002b).
Pyrophosphate and vanadate are known to alleviate channel rundown in the Kir6.2. In
several control experiments, we did not find any evident difference in current profile and
channel responses to pH and ATP from those recorded in the absence of pyrophosphate
and vanadate. The open-state probability (Po) was calculated by measuring the time, tj,
spent at current levels corresponding to j = 0,1,2,······N channels open, based on all
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evident openings during the entire period of record (Wu et al., 2002b). The Po was then
obtained as Po = (∑Nj=1 tj j)/TN, where N is the number of channels active in the patch and
T is the duration of recordings. Open and closed times were measured from records in
which only a single channel was active. In the some patches, the second active channel
appeared during recording. The data from such patches were used for the open-time and
closed-time analysis only if the Po for the second openings was not larger than 0.002. The
open-time and closed-time distributions were fitted using the Marquardt-LSQ method in
the Pstat6 software (Axon Instruments Inc.) (Wu et al., 2002b). Open/closed events <
200µs were ignored.
A parallel perfusion system was used to deliver perfusates with different
concentrations of ATP (K+ Salt) at a rate of ~1 ml/min with no dead space (Xu et al.,
2001; Wu et al., 2002a). All solutions with ATP were prepared immediately before
experiments and were used for less than 4 hours. The ATP-current relationship was
expressed with the Hill equation: y = 1 / (1 + ([ATP] / IC50)h), where [ATP] = ATP
concentration, and IC50 = the [ATP] at midpoint channel inhibition.
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Our data was fitted to the kinetic scheme 1 in which O is the open state, C1
represents the short-lived closure, and C2 refers to the long-lived closed state in the
absence of ATP. A third long-lived close state (C3) appears in the presence of ATP for
the Kir6.2∆C36. In the scheme the bold arrows indicate the transitions that are more
favored and the dashed arrow refers to transitions that are lessened. The rate constants for
Kir6.2∆C36 were calculated from our single channel data based on the following
equations (equations 1-6) (Colquhoun & Hawkes, 1990; Trapp et al., 1998):
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where τc1 is the time constant for short closures, τc2 for long closures, τc3 for the
additional long closures in the presence of ATP, and τo is the time constant for openings.
POB is the open state probability in the absence of ATP. In the F168G mutant, an
additional closed state appeared in the absence of ATP. Thus, additional equations
(equations 7-10) were used to calculate the rate constant kinetics (Colquhoun & Hawkes,
1990; Trapp et al., 1998). Under this condition τc3 is the additional long closed time
constant, Nc3 and Nc1 are the number of C3 and C1 events. Notice that the equations
used to calculate the F168G mutant are very similar to those used to calculate the kinetics
of Kir6.2∆C36. The difference is that the k3 and k-3 in the F168G mutant represents the
rate constant kinetics of the closed time in the baseline level (in the absence of ATP),
which requires additional calculations.
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I-8. Recording of Neuronal Activity Using Multi-Electrode Arrays
Extracellular recordings were carried out in the DMEM medium using a
preamplifier (MCS MEA1060, Reutingen, Germany) 10-60 days post culture at 37 ºC.
The spikes were digitized at 40 kHz with a 64-channel A-D converter and the MEA
workstation software (Plexon inc. Dallas, TX). Single units were identified using the
Offline Sorter software (Plexon Inc.) based on the Principal Component Analysis method
(Horn & Friedman, 2003), with which the likelihood to achieve pure single unit recording
is greatly improved over the traditional window discriminators. Single-unit recordings
were also determined by the absence of action potentials in the initial period (5-100ms) of
the inter-spike histogram.
I-9. CO2 Exposure
For acidification experiments with CO2, the oocytes were placed in a semi-closed
recording chamber (BSC-HT, Medical System, Greenvale, NY, USA), on a supporting
nylon mesh, where perfusion solution 90 K+ (90mM NaCl, 3mM MgCl2, and HEPES (pH
7.4) bathed both the top and bottom surfaces of the oocytes. The perfusate and
superfusion gas (15% CO2) entered the chamber from the inlet at one end and flowed out
through the other end. At the top of the chamber, enough space was provided for the
gases to escape and also for the recording microelectrodes to be injected into the oocytes.
During baseline-control recording, the chamber was ventilated with atmospheric air.
Exposure of the oocytes to CO2 was carried out by exposing the oocytes to a gas mixture
containing CO2 at 15% balanced with 21% O2 and N2. The oocytes were exposed to this
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mixture for ~4-8 minutes or until the current reached a steady state. The high solubility of
CO2 resulted in very rapid changes in intracellular and extracellular pH levels. The pH
level was stabilized within 4 min (Xu et al., 2001; Yang et al., 2000; Zhu et al., 2000).
Intracellular acidification alone of oocytes was carried out by using 90mM
KHCO3 to replace all KCl (90 mM) in the extracellular solution, so that the K+
concentration remained the same in these experiments. This solution was titrated to pH
7.4 immediately before use to selectively acidify the cytosol of the oocytes to pH 6.6.
I-10. Chemical Administration and Exposure
4-α-Phorbol 12-myristate 13-acetate (PMA) and 4α-phorbol-12,13-didecanoate
(4α-PDD) were purchased from Calbiochem (La Jolla, CA). 1-Oleoyl-2-acetyl-snglycerol (OAG), thymeleatoxin, chelerythrine chloride and calphostin-C were purchased
from Sigma (St Louis, MO). Genistein and wortmannin were purchased from Tocris
(Ellisville, MO). Substance-P (SP) (acetate salt), Spantide I, L-703,606, 4-Iodo-2, 5dimethoxyamphetamine (DOI), serotonin (5-HT), thyrotropin releasing hormone (TRH),
and [D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin (DAMGO) were also purchased from
sigma. Spiperone and Ketanserin Tartate were purchased from Tocris (Ellisville, MO).
PMA, OAG, thymeleatoxin, genistein, wortmannin, chelerythrine, calphostin-C,
spiperone and 4α-PDD were dissolved in dimethylsulfoxide (DMSO) as stocks and
mixed with a recording solution reaching a final concentration as indicated in the results.
The final DMSO concentration was ≤0.1%. Other chemicals were dissolved in doubledistilled water or experimental solutions. Exposures to these chemicals were done after
baseline currents were stabilized.
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I-11. Data Analysis
Data are presented as means ± S.E. (standard error). Student t test or single-factor
ANOVA was used. Differences of chemical effects before versus during chemical
exposures were considered to be statistically significant if P ≤ 0.05.
I-12. HEK293 Cell Culture Immunocytochemistry
For single-label immunohistochemistry of Kir4.1 and Kir5.1 the cultured
HEK293 cells transfected 3 days prior with Kir4.1-Kir5.1 dimer cDNA were fixed with
4% paraformaldehyde in Phosphate Buffered Saline (PBS) (0.01 M, pH 7.4) for 30 min.
The cells were washed three times with PBS and then blocked for 30 min in PBS
containing: 1% bovine serum albumin (BSA), 10% normal serum (NS), and 0.3% Triton
X-100. The cultures were then incubated overnight at 4 °C in primary antibodies of rabbit
anti-Kir4.1 (1:400) (Alomone Labs, Jerusalem, Israel) or goat anti-Kir5.1 (1:400) (Santa
Cruz Biotechnology, Santa Cruz, CA), diluted in Antibody Dilution Solution (ADS),
containing: 0.1% gelatin, 0.1% NaN3, and 0.3% Triton X-100 in PBS. Both antibodies
were used to detect antigen of human, rat, and mouse origin. After washing three times
with ADS, the cultured cells were then incubated with biotinylated goat anti-rabbit IgG
(Kir4.1) or biotinylated donkey anti-goat (Kir5.1) (Jackson Immuno Research, West
Grove, PA) diluted to 1:1000 in ADS for 2 hr at 25 °C. The cells were rinsed with ADS
and then incubated at 25 °C with a 546 fluorophore conjugated streptavidin (Molecular
Probes, Eugene, OR) diluted to 1:1000. The fluorescence reaction was visualized using a
Zeiss axioscope 200 fluorescence microscope (Zeiss, Oberkochen, Germany). Pictures
were taken using the software AxioVision AC 4.1 (Zeiss, Oberkochen, Germany).
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Subsequently, fluorescence imaging was performed with a confocal microscope (LSM
510) (Zeiss, Jena, Germany). The confocal images were taken using a 40x oil immersion
objective lens.
I-13. Brainstem Neuron Culture Immunocytochemistry
Brainstem neurons were fixed with 4% paraformaldehyde in phosphate buffered
saline (PBS, 0.1 M, pH 7.4) for 30 min. The cells were washed three times with PBS and
then blocked for 30 min in PBS containing 1% bovine serum albumin (BSA), 10%
normal donkey serum (NDS) or 10% normal goat serum (NGS), and 0.3% Triton X-100.
The cells were then incubated overnight with the primary antibodies: rabbit polyclonal antiKir4.1 (1:1000) (Alomone Lab, Israel), goat polyclonal anti-Kir5.1 (1:500), (Santa Cruz
Biotech, Santa Cruz, CA), and mouse monoclonal anti-MAP2 (1:400, Sigma, St. Louis,
MO) diluted in antibody dilution solution (ADS), containing 0.1% gelatin, 0.1% NaN3,
and 0.3% Triton X-100 in PBS. After washing five times with ADS (5 min each), the
cultured cells were incubated at 25 °C with the secondary antibodies for 2 hrs:
AlexaFluor488-conjugated donkey anti-rabbit IgG for demonstration of Kir4.1 (1:1000)
(Molecular Probes, Eugene, OR), AlexaFluor594-conjugated donkey anti-goat IgG for
Kir5.1

(1:1000)

(Molecular

Probes,

Eugene,

OR),

and

AMCA

(7-amino-4-

methylcoumarin-3-acetic acid) conjugated donkey anti-mouse IgG (1:100, Jackson
ImmunoRes, West Grove, PA) for MAP2. In control experiments, the primary antibodies
were omitted for Kir5.1 and MAP2 or pre-absorbed with a 3-fold excess of the epitope for
Kir4.1 (Alomone Lab). All of these control experiments showed negative stainings. The
fluorescence reaction was first visualized using a Zeiss axioscope 200 fluorescence
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microscope (Zeiss, Oberkochen, Germany). Subsequently, fluorescence imaging was
performed with a confocal microscope (LSM 510) (Zeiss, Jena, Germany). The confocal
images were taken using a 20x and 40x objective lenses.
I-14. Brainstem Tissue Slice Immunocytochemistry
All experimental procedures were carried out in accordance with the Guidelines
for the Care and Use of Laboratory Animals by the NIH and Georgia State University.
Male Sprague-Dawley rats (200-250 g) were deeply anesthetized by inhalation with
halothane and perfused transcardially with 0.9% saline followed by 4% (wt/vol)
paraformaldehyde in 0.1 M PBS (pH 7.4).The brains were rapidly dissected, post-fixed in
the same solution at 4 °C for 3 hrs, and transferred to 30% (wt/vol) sucrose in PB at 4 °C
overnight. The brains were then mounted onto a tissue cutting block and frozen in
optimum cutting temperature (OCT) compound (VWR, West Chester, PA). Transverse
sections (10 µm, 20 µm and 40 µm) were cut on a cryostat (Leica, Wetzlar, Germany)
and placed in PBS (free-floating for 40 µm sections) or mounted on a slide (fixed for 10
µm, 20 µm sections). The sections were washed five times with PBS for 5 min each and
pre-treated with PBS containing: 1% bovine serum albumin (BSA), 10% normal serum
(NS), and 0.3% Triton X-100 at 25 °C for 30 min to reduce nonspecific immunostaining.
The sections were then incubated in the primary antibodies [Kir4.1 (1:400) (Alomone
Labs, Jerusalem, Israel); Kir5.1(1:200) (Santa Cruz Biotechnology, Santa Cruz, CA);
Tyrosine Hydroxylase (TH) (1:5000) (Sigma-Aldrich, St. Louis, MO); NK1R (1:3000)
(Sigma-Aldrich, St. Louis, MO); and 5-HT2AR (1:500) (Immunostar Inc, Hudson, WI)]
diluted with ADS at 4 °C for 48 hrs. The sections were then washed five times with ADS
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at 25 °C for 5 min each and incubated with the corresponding secondary antibody
(Jackson Immuno Research, West Grove, PA) diluted to 1:1000 in ADS for 2 hrs at 25
°C. In the case where ABC was used the sections were subsequently rinsed with ADS
and then incubated at 25 °C with a 546 fluorophore conjugated streptavidin (Molecular
Probes, Eugene, OR) diluted to 1:1000. The fluorescence reaction was visualized using a
Zeiss axioscope 200 fluorescence microscope (Zeiss, Oberkochen, Germany). Pictures
were taken using the software AxioVision AC 4.1 (Zeiss, Oberkochen, Germany).
Confocal images were obtained with a LSM510 confocal imaging system (Zeiss,
Oberkochen, Germany) and manipulated with Adobe Photoshop 5.5 software (Adobe
Systems, Mountain View, CA).
Diaminobenzidine (DAB) with enhanced nickel staining was used to increase
the sensitivity of the antibody staining. Ni-DAB immunocytochemistry was performed on
free-floating and fixed sections similarly as described above. Briefly, sections were
washed 3 times with 0.05 M Tris Buffered Saline (TBS) and then exposed to 0.5% H2O2
for 30 min. The sections were then washed 3 times again with 0.05 M TBS and pre
incubated for 30 min at 25 °C in the corresponding blocking solution (see above section).
Following blocking the sections were incubated for 48 hours at 4 °C with specific
primary antibodies against (Kir4.1, Kir5.1, and TH) diluted in ADS made with TBS. The
sections were washed five times with ADS for 5 min each and subsequently exposed to
ADS containing the horse radish peroxidase (HRP) conjugated secondary antibody at 25
°C overnight. The sections were washed again 5 times for 5 min each and then soaked in
ADS containing an HRP-conjugated streptavidin for 4 hours at 25 °C. The sections were
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washed with TBS and exposed to DAB and nickel ammonium sulfate in the presence of
glucose oxidase. The floating sections were subsequently mounted onto clean slides and
allowed to dry. After drying the sections were dehydrated by exposure to increasing
concentrations of ethanol. The sections were made transparent with Xylene and then
cover slipped in the presence permount. The Ni-DAB reaction was visualized using a
Zeiss axioscope 200 microscope as well as a bright-field microscope and digit-imaged.
Protein expression was judged according to the relative optical intensity of the stain.
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J. EXPERIMENTAL DESIGN AND RESULTS

I.

IDENTIFICATION OF THE HETEROMERIC KIR4.1-KIR5.1 CHANNEL
IN BRAINSTEM NEURONS*

Manuscript in preparation:
Asheebo Rojas, Junda Su, Xiaoli Zhang, Ming Lee, Morium Chowdhury & Chun Jiang.
Identification of the Heteromeric Kir4.1-Kir5.1 channel in brainstem neurons.
*In this part, Dr. Junda Su and Ms. Xiaoli Zhang helped me to perform
immunocytochemistry on brainstem sections. Dr. Junda su performed 20 % of the DAB
immunocytochemistry on sections taken from the LC and the ventralateral medulla. Ms.
Xiaoli Zhang performed 10 % of the fluorescence immunocytochemistry on sections
taken from the LC. Mr. Ming Lee helped me by obtaining and preparing the 10 µM
adjacent sections from the LC. All of the adjacent sections were obtained by Mr. Ming
Lee. Ms. Morium Chowdhury assisted me with 40 % of the animal perfusions and she
prepared solutions in addition to mounting the brainstem sections onto the slides. All of
their help is greatly appreciated.
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Ia. INTRODUCTION
The candidacy of the Kir4.1-Kir5.1 channel as a central CO2 chemoreceptor
molecule is strengthened by demonstrating expression of the channel in brainstem
chemosensitive neurons where it is co-expressed with receptors for neurotransmitters that
are critical for respiratory control. Recently, a study using in situ hybridization
demonstrated the presence of mRNAs of both Kir4.1 and Kir5.1 in chemosensitive
neurons of the brainstem (Wu et al., 2004). However, in situ hybridization results
showing the presence of mRNAs are suggestive. Although mRNAs are present in
neurons, the channel may not exist at the protein level. Therefore, we have conducted the
present study to demonstrate the presence of the Kir4.1-Kir5.1 channel in brainstem
neurons. The locus coeruleus (LC) nucleus is chosen as the primary site of interest as
this nucleus is highly sensitive to changes in pH/CO2, it is easy to identify, and also
mRNAs for both Kir4.1 and Kir5.1 are found in LC neurons. We also conducted
experiments to demonstrate that the Kir4.1-Kir5.1 channel is co-expressed with the NK1
recepter, the natural receptor for SP. Here we present evidence showing expression of
the Kir4.1, Kir5.1, and NK1R subunits in the locus coeruleus, and the Kir4.1 and Kir5.1
in the hypoglossal and trigeminal motor nuclei.
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Ib. RESULTS
Ib-1. Specificity of the Kir4.1 and Kir5.1 antibodies
The Kir4.1 and Kir5.1 antibodies are both commercially available. We first
performed control experiments to demonstrate the specificity and efficiency of these
antibodies in our system. The specificity of the Kir4.1 and Kir5.1 antibodies was
demonstrated using HEK293 cells. HEK293 cells were transfected with the Kir4.1Kir5.1 dimer cDNA along with GFP cDNA as described in the methods
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Fig I-1. Specificity and efficiency of the Kir4.1 and Kir5.1 antibodies. A. The Kir4.1 and Kir5.1
antibodies are highly effective. HEK293 cells were transfected with the Kir4.1-Kir5.1 cDNA
along with the GFP cDNA. Immunocytochemistry was performed on these cells. Strong
labellings were seen when cells expressing the Kir4.1-Kir5.1 were stained with the anti-Kir4.1
(A) and anti-Kir5.1 (C). No labellings were seen when cells expressing the Kir1.1 (B) and Kir2.1
(D) were stained with the anti-Kir4.1 and anti-Kir5.1, respectively. GFP was used as an indicator
of transfection efficiency. The arrows represent typical and healthy HEK293 cells. Bar=50 µm.
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sections. GFP was used as an indicator of transfection efficiency. Positive
immunoassays were identified for both Kir4.1 and Kir5.1 when the HEK293 cells were
incubated with the Kir4.1 and Kir5.1 antibodies as described in the methods section,
suggesting that the antibodies can efficiently label the Kir4.1 and Kir5.1 proteins (Fig. 1
A, C). Similar experiments were repeated using two other Kir channels that share high
homology to Kir4.1 and Kir5.1 to demonstrate the specificity of the antibodies. The
Kir1.1 was used to demonstrate the specificity of the Kir4.1 antibody as the Kir1.1 shares
the highest homology to Kir4.1. The Kir1.1 also shares the highest identity with the
Kir4.1 in the epitope region that was used to generate the Kir4.1 antibody used here.
When cells transfected with Kir1.1 were exposed to the Kir4.1 antibody no positive
immunostains were detected although the GFP fluorescence suggests that the Kir1.1
channel was expressed (Fig. 1B). The same experiment was carried out using Kir2.1 to
demonstrate specificity of the Kir5.1 antibody. The Kir2.1 channel shows the highest
homology to the Kir5.1 and the highest idenitity in the epitope region of Kir5.1 used to
generate the antibody. Cells transfected the Kir2.1 cDNA failed to reveal positive
immunostains after incubation with the Kir5.1 antibody although GFP fluorescence
indicated that the Kir2.1 channel was expressed (Fig. 1D). Experiments were also
conducted with the homomeric Kir4.1 and Kir5.1 and positive immunostains were also
detected (data not shown). Taken together, these results suggests that the Kir4.1 and
Kir5.1 antibodies are specific and can be used to detect the presence of the Kir4.1 and
Kir5.1 subunits in the heteromeric Kir4.1-Kir5.1 channel.
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Ib-2. Expression of Kir4.1 and Kir5.1 in hypoglossal and trigeminal motor neurons
Recently, tremendous efforts have been placed on detecting the tissue specific
expression of various Kir channels. Although these efforts have led to the identification
of many Kir channels in various tissues, there still remains debate as to the cellular
expression of certain Kir channels. For example, the Kir4.1 and Kir5.1 has been shown
to be highly expressed in brain tissue (Hibino et al., 2004; Ma et al., 1998;
Poopalasundaram et al., 2000), however, it is not known whether these channels are
expressed in neurons, in glia, or in both. There is overwhelming evidence showing that
the Kir4.1 and Kir5.1 channels are expressed in glial cells within various regions of the
brain (Hibino et al., 2004; Higashi et al., 2001; Horio 2001), suggesting that these
channels may not function in neurons. However, recently a study using in situ
hybridization demonstrated the presence of mRNA for both Kir4.1 and Kir5.1 in many
brainstem neurons, suggesting that these channels may be expressed in neurons in
addition to glial cells (Wu et al., 2004). To strengthen this conclusion we used
immunocytochemistry to detect the Kir4.1 and Kir5.1 proteins in brainstem motor
neurons, which are large and easily identifiable. Also, motor neuron clusters are not
easily contaminated by neurons from adjacent nuclei. DAB immunocytochemistry was
performed on brainstem sections as indicated in the methods section. Positive
immunostains were detected for both Kir4.1 and Kir5.1 in hypoglossal motor neurons at
the level of the medulla (Fig. 2).
Immunoassay experiments were also performed to detect Kir4.1-Kir5.1
expression in motor neurons at the level of the pons. Using DAB immunocytochemistry,
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positive immunostains were detected for both Kir4.1 and Kir5.1 in trigeminal motor
neurons (Fig. 3). These results suggest that the Kir4.1 and Kir5.1 channels are not only
localized to glia, but are also expressed in neurons.
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Fig I-2. Detection of Kir4.1 and Kir5.1 in hypoglossal motor neurons. DAB
immunocytochemistry was performed on medullary sections (40 µm) obtained from rats. Strong
staining was seen in the hypoglossal motor neurons for Kir4.1 (B1) and Kir5.1 (D1) at 10x
magnification. Higher magnification (20x) revealed expression of both Kir4.1 (B2) and Kir5.1
(D2). For the controls the medullary sections were treated in a similar manner as the
experimental sections except the control sections were not exposed to the primary antibody. In
both cases no DAB staining was detected in the absence of the primary antibody at low and high
magnifications (A1, A2, C1, C2). The horizontal arrow in A1-D1 represents the central canal.
Vertical arrows in B2 and D2 represent typical hypoglossal motor neurons expressing Kir4.1 and
Kir5.1. Bar=100 µm.
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Fig I-3. Expression of Kir4.1 and Kir5.1 in trigeminal motor neurons. Labelling of Kir4.1 and
Kir5.1 proteins in trigeminal motor neurons of rats. DAB immunocytochemistry was performed
on brainstem (pons) sections (40 µm) at the area of the trigeminal motor neurons. At 10x these
neurons were differentially stained with some showing strong labelling for Kir4.1 (B1) and
Kir5.1 (D1). Higher magnification (20x) revealed expression of both Kir4.1 (B2) and Kir5.1
(D2). For the controls the pontine sections were treated in a similar manner as the experimental
sections except the control sections were not exposed to the primary antibody. In both cases no
DAB staining was detected in the absence of the primary antibody at low and high magnifications
(A1, A2, C1, C2). The horizontal arrow in A1-D1 represents the 4th ventricle. Vertical arrows in
B2 and D2 represent typical trigeminal motor neurons expressing Kir channels. Bar=100 µm.
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Ib-3. Co-expression of Kir4.1 and Kir5.1 in Locus Coeruleus neurons of rats
There are several primary chemosensitive sites within the brainstem. We focused
our attention on the locus coeruleus (LC), because it is known to be highly
chemosensitive (Elam et al., 1981; Haxhiu et al., 1996; Oyamada et al., 1998; Oyamada
et al., 1999; Pineda & Aghajanian, 1997). The ventilatory response to CO2 was
significantly reduced in rats that had specific lesioning of LC neurons (Li & Nattie,
2006). According to the study carried out by Wu et al., Kir4.1 and Kir5.1 mRNA is
highly abundant in the LC. In addition to this, the LC is an easily identifiable nucleus in
the brainstem with nearby markers such as the fourth ventricle and the trigeminal motor
nucleus. The neurons of the LC are densely packed and they are almost uniform in size.
Since the LC is the major norepinephrine producing site in the brain, the presence of
enzymes necessary for the production of NE is a useful tool used to identify the locus
coeruleus.
We performed DAB immunocytochemistry on 40 µm brainstem sections taken at
the level of the pons as described in the materials and methods section. Positive
immunostains were identified for both Kir4.1 and Kir5.1 in the area of the LC (Fig. 4).
As a positive control we assayed for expression of both channels in the trigeminal motor
neurons in the same animals, as these motor neurons contain both Kir4.1 and Kir5.1 as
previously mentioned. Negative staining in the areas ventrolateral and dorsolateral to the
trigeminal motor neurons again demonstrated the specificity of the antibodies (Fig. 4).
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Fig I-4. The Kir4.1 and Kir5.1 expression in LC area. DAB immunocytochemistry was
performed on pontine sections (20 µm) at the region of the LC. At 10x strong staining was seen
in the LC nucleus for Kir4.1 (B1) and Kir5.1 (D1). The staining was more apparent at a higher
magnification (20x) for Kir4.1 (B2) and Kir5.1 (D2). For the controls the pontine sections were
treated in a similar manner as the experimental sections except the control sections were not
exposed to the primary antibody. In both cases no DAB staining was detected in the absence of
the primary antibody at low and high magnifications (A1, A2, C1, C2). The horizontal arrows in
A1-D1 represent the 4th ventricle. The arrow heads in B1 and D1represent trigeminal motor
neurons expressing Kir4.1 and Kir5.1. The horizontal arrows in B2 and D2 represent typical
neurons expressing Kir channels. Bar=100 µm.
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We took advantage of the fact that LC neurons, that have a diameter ranging from 15-25
µM, produce norepinephrine to demonstrate the expression of the Kir4.1 and Kir5.1
subunits in the same individual LC neurons. The enzyme tyrosine hydroxylase (TH) is
the rate limiting enzyme for the production of the catecholamines dopamine and
norepinephrine. Therefore, immunoassaying for TH would allow for the identification of
LC neurons. Brainstem sections were obtained at the level of the LC in the pons. Groups
of adjacent 10 µm sections were obtained using a cryostat. Each group consisted of three
consecutive sections that were used to stain for the presence of Kir4.1, Kir5.1 and TH.
Using the DAB procedure described in the methods section we identified positive
immunostains for Kir4.1, Kir5.1, and TH in the LC (Fig. 5). Such a high magnification
allowed for the positive detection of individual neurons identified by the presence of TH
co-expressing the Kir4.1 and Kir5.1 (Fig. 5).
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Fig I-5. Expression of Kir4.1 and Kir5.1 in individual LC neurons. DAB immunocytochemistry
was performed on three adjacent pontine sections (10 µm) at the region of the LC. At 20x strong
staining was seen in the LC nucleus for Kir4.1 (A1), Kir5.1 (B1), and TH (C1). The staining was
more apparent at a higher magnification (40x) (A2-C2). For the controls the pontine sections
were treated in a similar manner as the experimental sections except the control sections were not
exposed to the primary antibody. In each case no DAB staining was detected in the absence of
the primary antibody at a high magnification (A3-C3). The red horizontal arrows represent the
same LC neurons with positive labelling for Kir4.1, Kir5.1, and TH. The blue horizontal arrows
represent the same LC neurons with positive labelling for Kir4.1 and Kir5.1. Bar=50 µm.
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To confirm the co-existence of the Kir4.1 and Kir5.1 in LC neurons we decided to use
triple fluorescence immunocytochemistry. Brainstem sections (20 µm) were obtained at
the level of the LC in the pons and fixed on glass slides. These sections were incubated
with anti-Kir4.1, anti-Kir5.1 and anti-TH. To simplify the antibody staining and reduce
the amount of background signal we decided to use fluorescent conjugated secondary IgG
antibodies for detection instead of the ABC method. Kir4.1 was labeled with a 488-IgG
fluorophore (green) (Fig. 6A); Kir5.1 with a 594-IgG fluorophore (red) (Fig. 6B); and TH
with an AMCA-IgG (blue) (Fig. 6C). Using these three fluorophores we assayed for
positive immunostains for all three antigens in the same neurons. Indeed, all three
proteins were identified in the LC (Fig 6). High magnification confocal images allowed
us to view the expression at the single cell level. When viewed at a higher magnification
(40x) we were able to identify co-existence of both Kir4.1 and Kir5.1 in the same TH
positive neurons (Fig. 6). Taken together, these results suggest that the Kir4.1 and Kir5.1
proteins co-exist in locus coeruleus neurons and the heteromeric channel may also exist
here.
Ib-4. Detection of the NK1R in the LC of Rats
The neuromodulators substance-P (SP) and serotonin (5-HT) have been shown to
regulate the control of respiration (Moss et al., 1986; Nattie et al., 2004). The receptors
for these neurotransmitters are G protein coupled receptors (GPCRs). Chemosensitive
neurons co-expressing these receptors and the Kir4.1-Kir5.1 channel may be modulated
by these neurotransmitters. Therefore, we immunoassayed for the presence of the
neurokinin-1 receptor (NK1R) and the serotonin 2A receptor subtypes (5-HT2AR) in the
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LC of rats. Using double fluorescence immunocytochemistry against TH (used to
identify the LC) and the NK1R, we detected positive expression of the NK1R in a
positive TH cluster of cells (Fig. 7A), suggesting that there may be a coupling of function
between the Kir4.1-Kir5.1 channel and the NK1R as has been demonstrated
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Fig I-6. Triple labelling of Kir4.1, Kir5.1 and TH in LC neurons. Fluorescence
immunocytochemistry was performed on brainstem sections (20 µm) at the region of the LC.
Strong staining was seen in LC neurons for Kir4.1 (A2), Kir5.1 (B2), and TH (C2) at 20x
magnification using a confocal microscope. Higher magnification (40x) revealed expression of
Kir4.1 (A3) and Kir5.1 (B3) and TH (C3) in the LC. Panels D1-D3 show the overlay of A, B, and
C. The overlay shows the co-localization of Kir4.1, Kir5.1 and TH in the same individual LC
neurons. For the controls the pontine sections were treated in a similar manner as the
experimental sections except the control sections were not exposed to the primary antibody. In
each case no fluorescence staining was detected in the absence of the primary antibody at a high
magnification (A1, B1, C1).The box represents the area that was magnified to 40x. Bar=40 µm.
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Fig I-7. Expression of the NK1R in the LC. Fluorescence immunocytochemistry was performed
ponto-medullary sections (20 µm) at the region of the LC. Strong staining was seen in LC
neurons for TH (A1) and the NK1R (A2) at 20x magnification using a confocal microscope. The
overlay shows that the NK1R is expressed in the same TH positive neurons (A3). A4 shows the
phase contrast. The same experiment was repeated for the 5-HT2A receptor. Although there were
positive labellings for TH (LC neurons) (B1), no labellings were seen for the 5-HT2A (B2). The
overlay shows that the 5-HT2A is not expressed in the same TH positive neurons (B3). B4 shows
the phase contrast. For the controls the pontine sections were treated in a similar manner as the
experimental sections except the control sections were not exposed to the primary antibody. In
each case no fluorescence staining was detected in the absence of the primary antibody at a high
magnification (C1-C3). Bar=40 µm.
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for G-protein coupled inward rectifier K+ (GIRK) channels. The same experiment was
carried out for the 5-HT2A receptor. Unfortunately we failed to detect positive
immunostains for the 5-HT2A in the LC of rats (Fig. 7B).
Ib-5. Expression of Kir4.1, Kir5.1 and NK1R in the LC of mice
All of the previous experiments were carried out using Sprague Dawley rats. We
recently obtained a strain of transgenic mice that expresses GFP in the 98 % of LC
neurons (van den Pol et al., 2002). Therefore, we decided to take advantage of these
transgenic (GFP expressing) LC mice to immunoassay for the co-existence of the Kir4.1
and Kir5.1 proteins in the locus coeruleus. In this way we could assay for expression of
Kir4.1 and Kir5.1 without having to perform triple labelling. This also made
identification of the LC easier. Single staining fluorescence immunocytochemistry
showed the presence of the Kir4.1 and Kir5.1 in LC neurons of the GFP-transgenic mice
(Fig. 8D-I). We immunoassayed for the neurokinin-1 receptor (NK1R) in these mice and
similar to the results obtained with rats we also found expression of this receptor in the
LC of mice (Fig. 8J-L).
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Fig I-8. Expression of the Kir4.1, Kir5.1 and NK1R in the LC of mice. Fluorescence
immunocytochemistry was performed on brainstem sections (20 µm) at the region of the LC.
These mice express GFP in LC neurons as shown by panels B, E, H, and K. Strong staining was
seen in LC neurons of these mice for Kir4.1 (D) Kir5.1 (G) and the NK1R (J) at 20x
magnification using a confocal microscope. The overlay shows that the Kir4.1, Kir5.1 and NK1R
are expressed in GFP positive LC neurons (F, I, L). For the controls the pontine sections were
treated in a similar manner as the experimental sections except the control sections were not
exposed to the primary antibody. In each case no fluorescence staining was detected in the
absence of the primary antibody at a high magnification (A1). Note that the trigeminal motor
neurons were positively labeled for Kir4.1 and Kir5.1 as previously mentioned. Bar=40 µm.
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I-c. DISCUSSION
In the present study we have presented evidence for the expression of the Kir4.1
and Kir5.1 proteins in neurons. Our results show that hypoglossal motor neurons and
trigeminal motor neurons contain both Kir4.1 and Kir5.1 subunits. There appeared to be a
difference in the expression pattern of these two subunits. The Kir4.1 subunit appeared
to express predominantly on the surface of these motor neurons, whereas the Kir5.1
channel was express throughout the cell. However, both subunits were detected on the
surface of several motor neurons suggesting that the heteromeric Kir4.1-Kir5.1 channel
may be expressed there. The expression of the heteromeric channel on the surface of
these motor neurons may be important physiologically. Both hypoglossal motor neurons
and trigeminal motor neurons are chemosensitive (Komai et al., 1993; Necakov et al.,
2002). Perhaps, the Kir4.1-Kir5.1 channel plays a role in the CO2 chemoreception of
these motor neurons.
We also showed evidence for the detection of both the Kir4.1 and Kir5.1 subunits
in the same TH positive neurons using two different methods (DAB staining in adjacent
sections and triple fluorescence immunoassaying in the same sections). Although the
DAB method is more sensitive than fluorescence we were able to detect significant levels
of expression using triple labelling with fluorescence suggesting that the heteromeric
Kir4.1-Kir5.1 channel may function in these LC neurons.
This demonstration of the presence of the heteromeric Kir4.1-Kir5.1 channel in
chemosensitive brainstem nuclei strengthens the candidacy of this channel as a central
CO2 chemoreceptor molecule.

However, further functional studies with the Kir4.171

Kir5.1 in brainstem chemosensitive nuclei must be performed to solidify the roles of this
channel in central CO2 chemoreception. Now that we know the channel is expressed in
brainstem neurons the next step is to demonstrate the role played by the channel in these
brainstem neurons during central CO2 chemoreception. Ultimately, the aim is to prove
that the heteromeric Kir4.1-Kir5.1 channel is one of the central CO2 chemoreceptor
molecules that have eluded researchers for more than 50 years.
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I-d. SUMMARY AND CONCLUSION
Using immunocytochemistry we present evidence for the co-expression of the
Kir4.1 and Kir5.1 proteins in the hypoglossal nucleus, the trigeminal motor nucleus, and
the locus coeruleus (LC). Both Kir4.1 and Kir5.1 subunits were present in these nuclei,
suggesting that the heteromeric channel may be expressed in these cells. We also show
that the Kir4.1 and Kir5.1 subunits are located in the same tyrosine hydroxylase
containing cells suggesting expression of the Kir4.1-Kir5.1 channel in the LC. The
Kir4.1-Kir5.1 channel along with the NK1 receptor was also detected in LC neurons.
Unfortunately, we were unable to obtain positive immunoassays for the 5-HT2A receptor
in the LC. Taken together these results suggest that the Kir4.1-Kir5.1 channel is indeed
expressed in chemosensitive neurons and the channel may be regulated by
neurotransmitters involved in the control of respiration.
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II.

MODULATION OF THE HETEROMERIC KIR4.1-KIR5.1 CHANNEL BY
MULTIPLE NEUROTRANSMITTERS VIA Gαq-COUPLED
RECEPTORS*

Manuscript in press:
Asheebo Rojas, Junda Su, Liang Yang, Ming Lee, Ningren Cui, Xiaoli Zhang, Dyanna
Fountain & Chun Jiang. Modulation of the Heteromeric Kir4.1-Kir5.1 Channel by
Multiple Neurotransmitters via Gαq-coupled Receptors. J Cell Physiol (2007).
*In this part, Dr. Junda Su prepared 80 % of the neuronal cultures for MEA recording and
together Dr. Junda Su and I recorded the neuronal activity from the dishes. Dr. Liang
Yang performed all of the offline data analysis for the MEA experiments. Dr. Ningren
Cui taught me to do whole cell recording and performed 20 % of all cDNA injections and
recordings. Mr. Ming Lee and Ms. Xiaoli Zhang performed 20 % of the
immunocytochemistry on the cultured neurons. Ms. Dyanna Fountain constructed 30 %
of the mutations on the Kir4.1-Kir5.1 channel and prepared cDNAs for injection. I
greatly appreciate all of their help.
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IIa. INTRODUCTION
It is known that the brainstem control of respiration relies on several
neurotransmitters including serotonin (5-HT), substance-P (SP) and thyrotropin releasing
hormone (TRH) (Cream et al., 1997; Dekin et al., 1985; Moss et al., 1986; Mutolo et al.,
1999; Nattie et al., 2004; Nink et al., 1991; Pete et al., 2002; Richerson, 2004; Richerson
et al., 2005; Schulz et al., 1996; Severson et al., 2003; Taylor et al., 2005; Wang et al.,
2001). Site-specific injections of these neurotransmitters can potently stimulate
ventilation. Systemic CO2 response is reduced by selective disruption of serotonergic
neurons and neurons expressing the neurokinin-1 receptor (NK1R) (Hodges et al., 2004;
Nattie & Li, 2002; Wenninger et al., 2004a; Wenninger et al., 2004b). Receptors for these
neurotransmitters have been identified in the ventral and dorsal respiratory groups (VRG,
DRG). Midline raphe neurons that are known to be CO2 chemosensitive and project to
the DRG and VRG also contain these neurotransmitters, suggesting that they may
modulate the neuronal response to hypercapnia (Richerson, 2004; Richerson et al., 2005;
Severson et al., 2003). Therefore, we tested whether the Kir4.1-Kir5.1 channel is a
downstream target of these neurotransmitters as this channel is expressed CO2
chemosensitive neurons.
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IIb. RESULTS
IIb-1. Inhibition of the Kir4.1-Kir5.1 channel by SP, 5-HT, and TRH
The NK1 receptor cDNA was co-injected into Xenopus oocytes together with the
Kir4.1-Kir5.1 tandem dimer cDNA. Inward rectifying currents were recorded from the
oocytes 2-3 days post injection using two-electrode voltage clamp with the bath solution
containing 90 mM K+. Typical Kir4.1-Kir5.1 currents were revealed: small outward
currents and large inward currents with slow activation at highly negative membrane
potentials (Fig. 1A, B, C). Following stabilization of the baseline, the Kir4.1-Kir5.1
currents were inhibited by an exposure to 1 μM SP applied to the bath (Fig. 1A). Similar
experiments were done by expressing the Kir4.1-Kir5.1 with the 5-HT2A or mTRH-R1
receptor. The currents were inhibited by 40 μM 5-HT and 100 μM TRH, respectively
(Fig. 1B, C).
The current-voltage (I-V) relationship was examined for the neurotransmitter
effects. Currents were recorded at baseline as well as at the peak plateau effect after
exposure to 1 μM SP, 40 μM 5-HT, and 100 μM TRH, respectively. Both currents were
then normalized to -160 mV and plotted against the membrane potential. The I-V plot
indicated that current inhibition occurred at all negative membrane potentials and did not
show evident voltage-dependence (Fig. 1D, E, F). Recordings using a ramp protocol
showed that the Kir4.1-Kir5.1 channel was inhibited by SP, 5-HT, and TRH in both
negative and positive membrane potentials without a change in rectification (Fig. 1G, H,
I).
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Fig II-1. Kir4.1-Kir5.1 channel is inhibited by SP, 5-HT, and TRH. A, B, C. Using TEVC wholecell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1Kir5.1 dimer cDNA along with the NK1R, 5-HT2A, and mTRH-R1 receptor cDNAs. With 90
mM K+ in the extracellular solution inward rectifying currents were recorded at baseline.
Membrane potential (Vm) was held at 0 mV. A series of command pulse potentials from –160 mV
to 140 mV with a 20-mV increment was applied to the cell. Note that in highly negative
membrane potentials, there was slow activation of the currents. Exposure by bath application to 1
µM SP, 40 µM 5-HT, and 100 µM TRH inhibited the currents by 36, 34, and 30%, respectively.
D, E, F. When baseline and peak PMA affected currents were scaled to the same magnitude at 160 mV, the I/V relationship of the currents recorded under these two conditions were
superimposed, suggesting that the effects were voltage-independent. G, H, I. Using TEVC wholecell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1Kir5.1 dimer cDNA along with the NK1R, 5-HT2A, and mTRH-R1 receptor cDNAs. With 90
mM K+ in the extracellular solution inward rectifying currents were recorded at baseline.
Membrane potential (Vm) was held at 0 mV with -100 mV and 100 mV applied to the cell using a
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ramp protocol. Exposure to 1 µM SP, 40 µM 5-HT, and 100 µM TRH inhibited the currents in a
similar manner as in A, B, C.
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The response to SP, DOI (a potent 5-HT2A agonist), and TRH showed clear dose
dependence. The maximum inhibition by SP (44.6±4.6% (n=9) occurred with 50 μM SP
(Fig. 2A). Channel inhibition (8.7±1.2%, n=4) was seen with SP concentrations as low as
1 nM. Similarly, 160 μM DOI produced the maximum inhibition of the Kir4.1-Kir5.1
currents by 56.1±6.8% (n=4), while significant channel inhibition was seen with 10 μM
DOI (21.9±7.5%, n=7) (Fig. 2B). Dose-dependent inhibition was also observed with TRH
(Fig. 2C). The concentrations represented by the gray bars in Figure 2 were used in
subsequent experiments as these concentrations are within the physiological range and
have been used before (Bajic et al., 2002; Cream et al., 1997; Koike-Tani et al., 2005; Lei
et al., 2001; Mao et al., 2004; Mutolo et al., 1999).
Specificity of the neurotransmitter effects was examined using specific
antagonists. Pre-incubation of oocytes expressing the Kir4.1-Kir5.1+NK1R with 10 μM
spantide I, a competitive peptide antagonist for SP, markedly attenuated the effect of 1
μM SP (Fig. 2D). Higher concentrations of spantide I (30 μM) more potently attenuated
the effect of 1 μM SP by over 60% (15.9±4.6% inhibition, n=4) (Fig. 2D). Similar
attenuation was seen with 10 μM L-703,606, a non-competitive receptor blocker
(23.7±3.0%, n=4) (Fig. 2D). Pre-incubation of oocytes expressing the Kir4.1-Kir5.1+5HT2A with 40 μM ketanserin or 40 μM spiperone, two 5-HT2A receptor antagonists,
almost completely abolished the effect of 40 μM DOI that inhibited the currents by
5.3±4.5% (n=6) and 8.9±3.1% (n=5), respectively (Fig. 2E). Since there is no
commercially available antagonist for the mTRH-R1 receptor, we used the mTRH-R2
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receptor to demonstrate the specificity as it is less sensitive to TRH than the mTRH-R1
receptor. Indeed,
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Fig II-2. Specificity and concentration-dependence of the neurotransmitter effect. A, B, C. The
effect of SP, DOI, and TRH on the Kir4.1-Kir5.1 channel was clearly concentration-dependent
(n≥4). The Kir4.1-Kir5.1 channel was inhibited by low concentrations of each agonist. Exposure
to higher concentrations of the agonists resulted in greater channel inhibition. The gray bars
represent the concentrations used for further experiments. The concentrations in A and B are µM.
The concentrations in C are mM. D, E, F. Specificity for the receptor-mediated channel
inhibition was studied. The channel inhibition was attenuated in the presence of specific
antagonists of the neurotransmitters or receptors. The Kir4.1-Kir5.1 channel expressed without
receptors failed to be inhibited by the neurotransmitters. Also, SP, DOI, and TRH failed to inhibit
the homomeric Kir4.1 channel expressed with the respective receptors. n≥4 for each experiment.
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100 μM TRH inhibited the Kir4.1-Kir5.1+mTRH-R1 to a greater degree than the Kir4.1Kir5.1+mTRH-R2 (Fig. 2F).
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Injection of the Kir4.1 cDNA along with the NK1R, 5-HT2A, or mTRH-R1
expressed typical Kir4.1 currents. Strikingly, the homomeric Kir4.1 channel was not
capable of being inhibited by SP, DOI, or TRH (Fig. 2D, E, F). Furthermore, the Kir4.1Kir5.1 channel expressed without exogenous receptors failed to be inhibited by SP, DOI
and TRH (Fig. 2D, E, F). Taken together these results strongly suggest that inhibition of
Kir4.1-Kir5.1 currents by SP, DOI, and TRH is specific depending on their receptors and
requiring the expression of both Kir4.1 and Kir5.1 subunits.
Although the exposure was carried out by application of the neurotransmitters to
the bath solution, the time-dependent inhibition occurred rapidly. The inhibition started
within the first minute and reached a maximal effect in ~15 min (Fig. 3A, B). At the
maximal effect, 37.8% of the inward rectifying currents were inhibited by 1 μM SP. The
effect of DOI on the Kir4.1-Kir5.1 currents was also time dependent. The inhibition
occurred rapidly, starting within the first minute after exposure to the chemicals and
reaching a maximal effect in ~10 min (Fig. 3C, D). In the presence of 100 μM TRH the
Kir4.1-Kir5.1 currents were inhibited by 29% with a rapid onset and reaching a maximal
effect in ~10 min (Fig. 3E, F). Thereafter, all neurotransmitter experiments were done
with a 10-20 min exposure.
The Kir4.1-Kir5.1 co-expressed with the mu-opioid receptor (MOR) failed to be
regulated by 1 μM DAMGO, an enkephalin analog and potent activator of the MOR (Fig.
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3G, H). Since the MOR is also a GPCR, this result suggests that the Kir4.1-Kir5.1
channel may not interact with G-proteins directly.
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Fig II-3. Time-dependent effects. A. Using TEVC whole-cell Kir4.1-Kir5.1 currents were
recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1 dimer cDNA along with the
NK1R receptor cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents
were recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command
pulse potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell.
Exposure to 1µM SP inhibited the channel currents by ~36%. B. The time profile showed that the
current amplitude decreased rapidly when SP was present in the bath solution, and reached
maximum inhibition in ~15 min. C. Whole cell currents were recorded from an oocytes 3 days
post injection of the Kir4.1-Kir5.1 tandem-dimer along with the 5-HT2A as described in A. D.
The time profile shows that DOI decreased the current amplitude rapidly when applied to the bath
solution. The maximum inhibition was reached in ~10 min. E. Whole cell currents were recorded
from an oocytes 3 days post injection of the Kir4.1-Kir5.1 tandem-dimer along with the mTRHR1 as described in A. F. The time profile shows that TRH decreased the current amplitude rapidly
when applied to the bath solution. The maximum inhibition was reached in ~10 min. G. Using
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of
the Kir4.1-Kir5.1 dimer cDNA along with the mu-opioid receptor (MOR) cDNA as described in
A. Exposure to 1 µM DAMGO failed to affect the channel currents H. The time profile shows
that the current amplitude did not change when DAMGO was present in the bath solution.
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IIb-2. PKC involvement in the modulation of the Kir4.1-Kir5.1 channel by the
neurotransmitters
The NK1, 5-HT2A, and TRH-R1 are G-protein coupled receptors (GPCRs).
These receptors share a common cascade following ligand binding involving activations
of Gαq, phospholipase C and protein kinase C (PKC). The latter has been shown to
phosphorylate several Kir channels and regulate their activity (Fakler et al., 1994; Henry
et al., 1996; Light et al., 2000; Zhu et al., 1999). For instance, we have previously shown
that protein kinase C (PKC) phosphorylation underscores the inhibition of GIRK
channels by SP (Mao et al., 2004). Therefore, we conducted experiments to determine
whether PKC was involved in the Kir4.1-Kir5.1 channel inhibition by SP, DOI, and TRH
as both the Kir4.1 and Kir5.1 subunits contain putative PKC phosphorylation sites. Preincubation of oocytes expressing Kir4.1-Kir5.1+NK1R, Kir4.1-Kir5.1+5-HT2A, or
Kir4.1-Kir5.1+mTRH-R1 with the specific PKC inhibitor chelerythrine showed a clear
attenuation of the SP, DOI, and TRH effects (Fig. 4A, B, C). Calphostin-C, another
specific and potent PKC inhibitor, showed strong attenuations of the channel inhibition to
6.7±2.8% (n=6), 3.4±10.8% (n=6), and 11±4.0% (n=8) by SP, DOI, and TRH,
respectively (Fig. 4A, B, C).
Exposure of oocytes expressing Kir4.1-Kir5.1+NK1R to 15 nM PMA, a specific
and potent PKC activator, inhibited Kir4.1-Kir5.1 currents by 39.8±5.5% (n=5). The
same degree of inhibition was also seen in the absence of the NK1R suggesting that the
effect is not mediated by receptor phosphorylation (data not shown). The inhibition by 1
μM SP was significantly lessened when the oocytes were prior exposed to PMA (Fig.
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4D). Similar effects were observed for DOI and TRH (Fig. 4E, F). The attenuation of
PKC activation was also observed when the order of the neurotransmitter and PMA
exposure was reversed, suggesting that the effects of the neurotransmitters and PMA are
mediated via a common mechanism (Fig. 4G, H, I).

87

Fig II-4. Involvement of PKC in the Kir4.1-Kir5.1 inhibition by SP, DOI and TRH. A, B, C.
Currents were recorded from an oocyte in the same condition as in Figure 1A. Prior to exposure
to SP, DOI or TRH the cells were incubated with PKC inhibitors. Pre-incubation of oocytes with
specific PKC inhibitors (50 μM chelerythrine or 3 μM calphostin-C) strongly attenuated the effect
of SP, DOI, and TRH (n≥4). D, E, F. Currents were recorded from an oocyte in the same
condition as in Figure 1A. Following exposure to 15 nM PMA for ~30 minutes the cells were
subsequently treated with 1 µM SP or 40 µM DOI. Prior exposure to PMA resulted in a much
lower channel response to the neurotransmitters. Instead of 36% current inhibition for SP and
43% current inhibition for DOI, the Kir4.1-Kir5.1 currents were barely inhibited (>10%).G, H, I.
Currents were recorded from an oocyte in the same condition as in Figure 1A. Following
exposure to SP, DOI or TRH the cells were subsequently treated with 15 nM PMA. Prior
exposure to the neurotransmitters resulted in a reduced response to PMA. Instead of 40% current
inhibition as indicated by the dashed lines, the Kir4.1-Kir5.1 currents were inhibited by 0~20%.
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IIb-3. Effects of SP on single-channel properties
To identify the exact channel mechanism leading to a decrease in the whole cell
currents, the effect of SP on the single-channel biophysical properties was studied in cellattached patches with 145 mM K+ applied to the extracellular solution at a membrane
potential of -80 mV. Inward rectifying currents with a single-channel conductance of ~40
pS (Pessia et al., 1996; Tanemoto et al., 2000; Tanemoto et al., 2004) showing longlasting openings and closures were recorded from oocytes expressing the Kir4.1Kir5.1+NK1R (Fig. 5). These currents were inhibited with an exposure to 1 μM SP (Fig.
5A, B). Macroscopic currents also showed a clear inhibition by application of SP to the
bath solution (Fig. 5C). The current inhibition was mainly produced by a suppression of
the channel open-state probability (NPo). Plotting the baseline NPo versus SP NPo shows
a clear reduction in the NPo (0.43±0.11 at baseline vs. 0.06±0.01 with SP, n=7), while the
single-channel conductance did not show any significant changes (Fig. 5D).
IIb-4. Relationship with CO2/pH Sensitivity
We have previously shown that the Kir4.1-Kir5.1 channel is strongly inhibited by
intracellular acidosis (Cui et al., 2001; Xu et al., 2000a; Yang et al., 2000). To understand
whether the neural modulation affects the channel sensitivity to pH, the Kir4.1-Kir5.1
channel was co-expressed in Xenopus oocytes with the NK1R or 5-HT2A. Following
stabilization the cells were perfused with 1 μM SP or 40 μM DOI until the plateau effect
was reached. Subsequently, the cells were exposed to 90 mM KHCO3 that has been
shown to reduce intracellular pH (pHi) to ~6.6. Intracellular acidosis inhibited the Kir4.1Kir5.1 channel expressed without receptors by 58.2±2.4% (n=8), by 60.8±1.5% (n=9) in
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the presence of the NK1R and by 55.0±3.7% (n=5) with the 5-HT2A receptor,
respectively. No significant difference was found, suggesting that the presence of the
receptors do not interfere with the channel sensitivity to CO2. Following SP and DOI

Fig II-5. Effects of SP on the single channel activity of Kir4.1-Kir5.1. A. Single Kir4.1-Kir5.1
currents were recorded from an oocyte in a cell-attached patch configuration with 145 mM K+ in
the patch pipette. At Vm of -80 mV, two active channels are seen at pH 7.4. B. Following
stabilization, exposure to 1 µM SP reduced the channel activity mainly by a decrease in the NPo.
Labels on the left: c, closure; 1, the first opening; 2, the second opening; etc. Labels on the top
represent NPo at baseline and NPo at SP exposure level. C. Reduction of the macroscopic inward
currents can be seen in the cell-attached patch configuration. D. Bargraph showing that 1 µM SP
drastically reduced the NPo, but only slightly affected the single-channel conductance (n≥6).
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exposure all of the oocytes tested were further inhibited by intracellular acidosis in the
presence of the neurotransmitters (Fig. 6A, D), and recovered with washout. The time
course showed that following SP and DOI inhibition, the channel was rapidly inhibited
by intracellular acidosis to the same degree as in the absence of the neurotransmitters
(Fig. 6B, E), suggesting that the neurotransmitters and CO2 inhibit the channel through
independent mechanisms. Also both CO2 and neurotransmitters have a partial additive
effect leading to a stronger channel inhibition when both are present (P<0.05, n≥4; Fig.
6C, F). The same experiments were repeated with 15% CO2 and similar results were
obtained (Fig. 6C, F).

91

Fig II-6. Independent regulation of the Kir4.1-Kir5.1 channel by neurotransmitters and pHi. A, B.
Using TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days postinjection of the Kir4.1-Kir5.1 dimer cDNA along with the NK1R. With 90 mM K+ in the
extracellular solution inward rectifying currents were recorded at baseline. Membrane potential
(Vm) was held at 0 mV. A series of command pulse potentials from –160 mV to 140 mV with a
20-mV increment was applied to the cell. Following exposure to 1 µM SP, the cells were
perfused with 90 mM KHCO3 (pHi≈6.6). Such an exposure resulted in a further inhibition of the
Kir4.1-Kir5.1 currents to the degree identical to that of KHCO3 exposure alone, suggesting that
the two channel inhibitors are independent of each other. Washout allowed the currents to recover
to the level prior to KHCO3 exposure. C. The percent effect shows that exposure to SP/KHCO3
gives a larger inhibition of the Kir4.1-Kir5.1 currents than either modulator alone. D, E. Using
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of
the Kir4.1-Kir5.1 dimer cDNA along with the 5-HT2A in a similar manner as in A. Following
exposure to 40 µM DOI, the cells were perfused with 90 mM KHCO3 (pHi≈6.6). Such an
exposure resulted in a further inhibition of the Kir4.1-Kir5.1 currents. Washout allowed the
currents to recover to the level prior to KHCO3 exposure. F. The percent effect shows that
exposure to DOI/KHCO3 gives a larger inhibition of the Kir4.1-Kir5.1 currents than either
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modulator alone. Both sets of experiments were repeated with 15% CO2 represented by the gray
bars. n≥4 for each experiment. The SP and DOI effects are relatively slow and long-lasting, while
the effect of 90 mM KHCO3 is rapid and fully reversible. The asterisk represents the comparable
difference between KHCO3 and neurotransmitter+KHCO3 as well as the comparible difference
between 15% CO2 and the neurotransmitter+15% CO2. Differences were considered to be
statistically significant if P ≤ 0.05. The arrows in B and E represent the time points shown in panels
A and D.
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IIb-5. Modulation of brainstem neurons by neurotransmitters
To demonstrate the modulation of brainstem neurons by the neurotransmitters SP
and 5-HT we took advantage of multi-electrode array (MEA) technology. Neurons were
isolated from the brainstem of fetal rats and cultured on MEA dishes as detailed in the
methods section (Su & Jiang, 2006; Su et al., 2007). Extracellular recordings were carried
out in the DMEM medium at 37 ºC. Single-unit recordings were identified using the
Offline Sorter software based on the principal component analysis methods (Horn &
Friedman, 2003). Single-unit recordings were also determined by the absence of action
potentials in the initial period (5-100ms) of the inter-spike histogram. Most spikes
showed a negative-positive waveform with a duration > 1 ms, suggesting that they were
recorded from the soma (Gustafsson & Jankowska, 1976; Jiang & Lipski, 1990).
Neuronal responses to CO2, SP and DOI were studied. Changes in neuronal firing rate
were determined with a change in CO2 from 5% (basal level) to 9.2% (hypercapnia). The
CO2-augmented units whose firing rate increased during acidosis (Fig. 7A, E) were
chosen for further study, although neurons that were inhibited by CO2 or showed no
response were also observed (Su and Jiang, 2006; Su et al., 2007). Following washout of
the CO2, the cells were exposed to SP and DOI that augmented reversibly the firing
frequency of a group of neurons (Fig. 7B, C, F, G). To determine whether PKC played a
role, 100 nM calphostin-C was applied to the MEA dish for 1 hour prior to application of
SP and DOI. Action potentials were recorded before and after application of calphostinC. In the presence of calphostin-C, SP and DOI only modestly augmented the firing rate
(Fig. 7D, H). Statistical analysis showed that the difference in the effects of SP and DOI
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before versus after calphostin C treatment was significantly different (P<0.01 for both SP
and DOI) (Fig. 7D, H).
Immunocytochemistry showed that both Kir4.1 and Kir5.1 subunits were colocalized in cultured brainstem neurons that also displayed positive immunoreactivity of
the microtubule-associate protein 2 (MAP2) (Fig. 8). Control experiments were
performed with HEK293 cells, demonstrating the specificity of the anti-Kir4.1 and antiKir5.1 antibodies (shown in prior part).
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Fig II-7. Modulation of brainstem neurons by neurotransmitters. A. A single unit was recorded
from a 14-day brainstem neuronal culture using the multiple electrode arrays technique in 5%
CO2. The spikes had a negative-positive waveform with a duration >1 ms, and the 2D cluster plot
and the interspike interval (ISI) histogram indicated single-unit recording. Increasing CO2 to
9.2% augmented the firing frequency shown in a period of 5 min. B. The same unit recorded in A
was stimulated during exposure to 1 μM SP. C. The effect of SP on the average firing frequency
from a 5 min recording. SP1=the first recording taken following SP application. SP2=the second
recording taken following SP application. Nine units were stimulated during SP exposure.
Washout led to complete recovery. D. Following pre-incubation with 100 nM calphostin-C (cal-
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C) for 1 hour the stimulatory effect of SP was greatly reduced. E. A single unit was recorded from
a 14-day brainstem neuronal culture using the multiple electrode arrays technique in 5% CO2.
The spikes had a negative-positive waveform with a duration >1 ms, and the 2D cluster plot and
the interspike interval (ISI) histogram indicated single-unit recording. Increasing CO2 to 9.2%
augmented the firing frequency shown in a period of 5 min. F. The same unit recorded in E was
strongly stimulated during exposure to 40 μM DOI. G. The effect of DOI on the average firing
frequency from a 5 min recording. Ten units were stimulated during DOI exposure. Washout led
to complete recovery. DOI1=the first recording taken following DOI application. DOI2=the
second recording taken following DOI application. H. Following pre-incubation with 100 nM
calphostin-C for 1 hour the stimulatory effect of DOI was greatly reduced. CTL=control,
SP=substance P, DOI=4-Iodo-2, 5-dimethoxyamphetamine, WS=washout.
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Fig II-8. Expression of Kir4.1-Kir5.1 in brainstem neurons. A. Immunocytochemistry was
performed on cultured brainstem neurons. A. Shows positive immunoassaying for Kir4.1. B.
Shows positive immunoassaying for Kir5.1. C. Blue fluorescence indicates the presence of the
neuronal marker microtubule associated protein 2 (MAP2). D. Overlay of A, B, C. The horizontal
arrows represent typical neurons expressing the Kir4.1 and Kir5.1 subunits. Vertical arrows
represent typical glia cells expressing Kir4.1 and Kir5.1. Horizontal arrowheads indicate neurons
void of Kir4.1 and Kir5.1. The vertical arrowheads indicate glia void of Kir4.1 and Kir5.1. E.
Shows the phase contrast (note that majority of cells are neurons). Bar=20 µm.
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IIb-6. Amplification of CO2 chemosensitivity by synaptic transmission
The high sensitivity of central chemoreceptors may be attributed to a potential
amplification mechanism in the neuronal network. If this is the case, blockade of
presynaptic input should reduce neuronal CO2 chemosensitivity. We thereby performed
studies to test this hypothesis. Since several groups of serotonin producing neurons in the
brainstem are CO2 chemosensitive (Wang et al. 1998; Severson et al. 2003), we used 20
μM ketanserin to block 5-HT2A receptors known to play an important role in respiratory
control (Richerson 2004; Tryba et al. 2006). Ketanserin markedly diminished neuronal
responses to hypercapnia from 4.88 ± 0.84 Hz to 3.07 ± 0.69 Hz (P<0.001, n=28, paired t
test) (Fig. 9, Fig. 10A). Amongst 29 CO2-stimulated units in 3 MEA dishes, only 2 cells
lost their CO2 sensitivity completely. The CO2 chemosensitivity of such a small number
of cells was interpreted to be derived solely from presynaptic input. The other 27 units
remained to be stimulated by hypercapnia to various degrees. Of these 27 units, 20
showed significant reduction in their CO2 sensitivity, suggesting that the CO2
chemosensitivity of most neurons is determined by both pre- and postsynaptic
mechanisms. The CO2 chemosensitivity of the remaining 7 units was either retained
(n=2) or slightly enhanced (n=5) with ketanserin, suggesting that their CO2
chemosensitivity is independent of serotonergic input or slightly inhibited by serotonergic
input.
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Fig II-9. Neuronal FR before, during and after ketanserin during CO2 exposure. Neuronal FR
was studied before, during and after ketanserin (20µM) exposure in two MEA dishes. Neuronal
FR was normalized to the peak frequency, and plotted against PCO2 levels. Ketanserin drastically
attenuated neuronal response to hypercapnia (0.62 ± 0.06 to 0.79 ± 0.04, P<0.05, n=28,
ANOVA). C is the slope of the bold black line and it represents the sensitivity index that was
determined: ΔFR / ΔPCO2, where ΔFR is the percentage change in the firing rate and ΔPCO2 is the
change in PCO2 (mm Hg). The value C = 0.0067 corresponds to a 0.67% change in FR per mm Hg
PCO2.
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Another group of candidate CO2 chemoreceptors are glutamatergic neurons,
especially those in the retrotrapezoid nucleus that are activated by glutamate (Mulkey et
al. 2004). We found that neuronal CO2 sensitivity was significantly inhibited from 2.41 ±
0.57 Hz to 1.40 ± 0.44 Hz (P<0.001, n=28, paired t test) in the presence of 10μM CNQX,
a non-NMDA receptor antagonist (23 reduced, 2 enhanced, and 4 lost response out of 29
units in 4 MEAs) (Fig. 10B). Similar effect was found with blockade of NK1 receptors
(from 1.57 ± 0.40 Hz to 0.85 ± 0.25 Hz; P<0.01, n=21, paired t test) in the presence of
100μM spantide (of 22 units in 3 MEAs, CO2 sensitivity was reduced in 17 units,
enhanced in 3, and lost in 2) (Fig. 10C). In contrast, blockade of purinergic P2x receptors
that have been suggested to be involved in CO2 chemosensitivity (Thomas et al. 1999;
Gourine et al. 2005) with 10μM PPADS did not show any significant effect (from 2.24 ±
0.79 Hz to 2.66 ± 0.92 Hz; P>0.05, n=36) (Fig. 10D), suggesting that the enhancement of
CO2 chemosensitivity is rather specific to certain synaptic connections.
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Fig II-10. A. Average FR with and without ketanserin during CO2 exposure. When the average
FR was compared with and without ketanserin, significant reductions in the FR were seen during
CO2 (70 mm Hg) exposure (P<0.001, n=28 from 3 MEAs, paired t test). B,C. Similar attenuations
of the hypercapnic response were observed with CNQX (P<0.001, n=28 from 4 MEAs, paired t
test) and spantide (P<0.01, n=21 from 3 MEAs, paired t test). D. PPADS, a P2x receptor blocker,
did not have significant effect (P>0.05, n=36 from 3 MEAs, paired t test). Note that the units
studied did not show significant differences in their baseline FR with and without the blockers
(A-D).
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IIc. DISCUSSION
In the present study, we have demonstrated a novel property of the Kir4.1-Kir5.1
channel but not the Kir4.1, i.e., the capability to be modulated by several
neurotransmitters. This finding provides more evidence for the functional significance of
the heteromultimerization.
The Kir4.1 and Kir5.1 subunits are expressed in brainstem neurons. The mRNAs
of both Kir subunits have been detected in various nuclei within the brainstem (Wu et al.,
2004). Several studies have demonstrated specific expression of Kir4.1 and Kir5.1 at the
protein and mRNA level in oligodendrocytes and astrocytes in the CNS (Hibino et al.,
1999; Hibino et al., 2004; Higashi et al., 2001). Here, we have shown expression of both
the Kir4.1 and Kir5.1 proteins in cultured brainstem neurons. Although direct evidence
demonstrating the involvement of this channel in central CO2 chemoreception is lacking
the co-expression of the Kir4.1 and Kir5.1 subunits in the same neurons strongly suggests
that the heteromeric Kir4.1-Kir5.1 channel may form in brainstem neurons.
Several neurotransmitters are particularly important for the brainstem control of
respiration including substance-P, serotonin, and thyrotropin releasing hormone. These
neuromodulators have been shown to regulate central respiratory activity in vitro and in
vivo (Cream et al., 1997; Dekin et al., 1995; Hodges et al., 2004; Moss et al., 1986;
Mutolo et al., 1997; Nattie & Li, 2002; Nattie et al., 2004; Nink et al., 1991; Pete et al.,
2002; Richerson, 2004; Richerson et al., 2005; Schulz et al., 1996; Severson et al., 2003;
Taylor et al., 2005; Wang et al., 2001; Wenninger et al., 2004a; Wenninger et al., 2004b).
In the present study, we have shown evidence for the inhibition of the heteromeric
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Kir4.1-Kir5.1 channel by these neurotransmitters. Exposures to SP, 5-HT, and TRH
resulted in inhibition of the Kir4.1-Kir5.1 channel currents when the channel was
expressed with the corresponding receptors in Xenopus oocytes. The neurotransmitter
effects were reversible, specific and dependent on ligand concentrations. The current
inhibition is voltage-independent and is mediated by selective inhibition of Po with no
effect on single-channel conductance.
We previously showed that PKC underscored the inhibition of GIRK channels by
substance-P (Mao et al., 2004). Therefore, we assayed for the involvement of PKC in the
inhibition of the heteromeric Kir4.1-Kir5.1 channel by SP, DOI and TRH. Our results
suggest that PKC activation also underscores the inhibition of the Kir4.1-Kir5.1 channel
by these neurotransmitters. In cultured brainstem neurons, inhibition of PKC led to a
dramatic attenuation of the augmentation of the firing frequency in neurons by SP and
DOI, suggesting that PKC activation also underscores the SP and DOI dependent
increase in the firing rate of the cultured brainstem neurons.
The modulation of the Kir4.1-Kir5.1 channel by SP, 5-HT, and TRH does not
compromise the channel sensitivity to pH, as we have shown that the application of both
modulators combined had a greater inhibitory effect on the channel than either modulator
alone. This is important physiologically as we know that during central CO2
chemoreception, there is an amplification of the CO2 signal.
The neural modulation described in the present study seems to enable the Kir4.1Kir5.1 channel to function as a distinct member in the Kir channel family. It is known
that GIRK channels play a role in neurotransmission (Jan & Jan, 1997; Luscher et al.,
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1997; Yamada et al., 1998). A common characteristic of these channels is that their
activity is controlled by neurotransmitters and hormones. Clearly such a property is
shared by the Kir4.1-Kir5.1 channel, as shown in our current studies.
The neural modulation shown in the present study does not occur in the
homomeric Kir4.1 channel and relies on the Kir5.1 that is known to form heteromeric
channels only with Kir4x (Casamassima et al., 2003; Konstas et al., 2003; Pessia et al.,
2001; Tanemoto et al., 2000). Thus, the expression of the Kir4.1 in cells allows two
functional properties that both can control membrane potential and cellular excitability
with one of them regulated by extracellular messengers. All of these functional properties
therefore allow diverse cellular responses that appear to fit well to the diverse cellular
functions in the brainstem and other systems.
Previous studies have demonstrated the presence of CO2 chemosensitivity in both
pre- and postsynaptic neurons (Kawai et al 1996; Kawai et al., 2006; Richerson 1995;
Stunden et al 2001; Takakura 2006), which we inferred may allow an amplification of
PCO2 signals detected by each cell. Consistent with this scenario, our results indicate that
CO2 chemosensitivity is significantly reduced when 5-HT2A, NK1 or non-NMDA
receptors are blocked, all of which are receptors for neurotransmitters that play an
important role in the modulation of central respiratory activity and CO2 chemosensitivity
(Feldman et al, 2003; Richerson 2004; Guyenet 2005). Blockade of the P2x receptor,
however, did not produce evident attenuation of the CO2 chemosensitivity, consistent
with two recent studies showing lack of effect on the CO2 chemosensitivity by P2x
receptor blockade (Lorier et al., 2004; Mulkey et al. 2006).
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IId. SUMMARY AND CONCLUSION
The heteromeric Kir4.1-Kir5.1 channel is a candidate sensing molecule for CO2
central chemoreception. Since CO2 central chemoreception is subject to neural
modulations, we performed studies to test the hypothesis that the Kir4.1-Kir5.1 channel is
modulated by the neurotransmitters critical for respiratory control, including serotonin (5HT), substance-P (SP), and thyrotropin releasing hormone (TRH). The heteromeric
Kir4.1-Kir5.1 channel was strongly inhibited by SP, TRH, and 5-HT when expressed in
Xenopus oocytes, whereas these neurotransmitters had no effect on the homomeric Kir4.1
channel. Such an inhibition was dose-dependent and relied on specific Gαq-proteincoupled receptors and protein kinase C (PKC). No direct interaction of the channel with
G-proteins was found. Channel sensitivity to CO2/pH was not compromised with the
inhibition by these neurotransmitters, as the channel remained to be inhibited by acidic
pH following an exposure to the neurotransmitters. The firing rate of CO2-sensitive
brainstem neurons cultured in microelectrode arrays was augmented by SP or a 5-HT2A
receptor agonist, which was blocked by PKC inhibitors suggesting that PKC underscores
the inhibitory effect of SP and 5-HT in cultured brainstem neurons as well. Immunostaining
showed that both Kir4.1 and Kir5.1 proteins were co-localized in the cultured brainstem
neurons. These results therefore indicate that the heteromeric Kir4.1-Kir5.1 channel is
modulated by the neurotransmitters critical for respiratory control, suggesting a novel
neuromodulatory mechanism for the chemosensitivity of brainstem neurons to elevated
PCO2 and acidic pH. The CO2 chemosensitivity was reduced but not eliminated by blockade
of presynaptic input from serotonin, substance P or glutamate neurons, indicating that both
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pre- and postsynaptic neurons contribute to the CO2 chemosensitivity. This strongly
suggests that the high sensitivity may be achieved by cellular mechanisms via synaptic
amplification in cultured brainstem neurons.
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III.

PROTEIN KINASE C DEPENDENT INHIBITION OF THE
HETEROMERIC KIR4.1-KIR5.1 CHANNEL*

Manuscript in press:
Asheebo Rojas, Ningren Cui, Junda Su, Liang Yang, Jean-Pierre Muhumuza, and Chun
Jiang. Protein Kinase C Dependent Inhibition of the Heteromeric Kir4.1-Kir5.1 Channel.
BBA-Biomembranes (2007).
*In this part, Dr. Junda Su performed 20% of the cDNA injections. Dr. Ningren Cui
performed 30 % of the whole cell recordings. Dr. Liang Yang and Mr. Jean-Pierre
Muhumuza (combined) created 40% of the mutations on the Kir4.1-Kir5.1 and did Mini
and Midi preparations. All of their help is greatly appreciated.
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IIIa. INTRODUCTION
It is known that the central CO2 chemoreception and K+ transport in renal
epithelium are regulated by neurotransmitters, hormones and pharmacological agents
through specific intracellular signaling systems (Feldman et al., 2003; Germann &
Stanfield, 2005; Richerson, 2004). Therefore, it is possible that the heteromeric Kir4.1Kir5.1 channel is regulated by certain second messenger systems. Such a modulation may
enable cells expressing the Kir4.1-Kir5.1 channel to respond to PCO2 and pH changes
according to systemic needs. One common intracellular signaling system activated by
neurotransmitter and hormone is mediated by protein kinase C (PKC). Indeed, a number
of consensus sequences of potential PKC phosphorylation sites exist in the Kir4.1 and
Kir5.1 subunits. Supporting the idea of PKC phosphorylation are also previous reports
indicating that other Kir channels such as Kir3.1-Kir3.4, Kir2.2, Kir2.3, and Kir6.2 are
modulated by PKC with several phosphorylation sites identified in these channel proteins
(Fakler et al., 1994; Henry et al., 1996; Light et al., 2000; Lin et al., 2000; Mao et al.,
2004; Stevens et al., 1999; Vorobiov et al., 1998; Zhang et al., 2004; Zhu et al., 1999;
Zitron et al., 2004). Therefore, we performed experiments to test the possibility that PKC
regulates the Kir4.1-Kir5.1 channel. Our results showed that the Kir4.1-Kir5.1 channel
was strongly inhibited by the activation of PKC.
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IIIb. RESULTS
IIIb-1. Inhibition of the Heteromeric Kir4.1-Kir5.1 Channel by PMA
In two-electrode voltage clamp, inward rectifying K+ currents were recorded from
Xenopus oocytes 2-3 days post injection of the Kir4.1-Kir5.1 cDNA using a bath solution
containing 90 mM K+. Typical Kir4.1-Kir5.1 currents were revealed: small outward
currents and large inward currents with slow activation at highly negative membrane
potentials (Fig. 1A). Following stabilization of the baseline currents, PMA, a specific and
potent PKC activator, was added to the bath solution. The PMA exposure resulted in a
strong inhibition of the Kir4.1-Kir5.1 currents. Higher concentrations of PMA resulted in
a more rapid inhibition of the Kir4.1-Kir5.1 currents (Fig. 2E). This inhibition was dosedependent (Fig. 3A, B): Evident channel inhibition was seen with PMA concentrations as
low as 5 nM; maximum effect occurred with 1 µM PMA at which the Kir4.1-Kir5.1
currents were inhibited by 93.3±1.4% (n=4); and 15 nM PMA inhibited the Kir4.1-Kir5.1
currents by 41.4±2.2% (n=13). In comparison, the homomeric Kir4.1 channel showed no
response to 15 nM PMA (Fig. 1B), and was slightly inhibited (8.4±8.6%, n=5) by 100
nM PMA. Numerous attempts were made to express the homomeric Kir5.1 channel.
Unfortunately, we were unable to detect inward rectifying K+ currents that were sensitive
to micromolar concentrations of barium in Xenopus oocytes and HEK293 cells.
Therefore, we were unable to determine the effect of PMA on the Kir5.1 channel.
The voltage dependence was analyzed using the current-voltage (I-V) plot. The
currents recorded at -160 mV were normalized to the same level for both baseline and
PMA treatment. When plotted in the I-V curve, the curve of the PMA treatment
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overlapped that obtained from the baseline suggesting that the inhibition of the Kir4.1Kir5.1 currents by PMA is voltage independent (Fig. 1C). The same analysis on the
Kir4.1 showed an identical effect (Fig. 1D).
When the time course of the Kir4.1-Kir5.1 channel inhibition by 15 nM PMA was
plotted, the inhibition started 2 min after exposure to PMA and reached the maximum in
~30 min (Fig. 1E). Thus, all PMA experiments were done with a PMA exposure of 20-40
min.

111

Kir4.1-Kir5.1
Baseline
15nM PMA

A

Kir4.1
15nM PMA
Baseline

B

3 μA
140

5 μA
140

500 ms

0
-160mV

C

-0.3

-160mV

D

Normalized I (μA)

-0.3

Normalized I (μA)

-0.1

-0.1
-160-140-120-100 -80 -60 -40 -20 0
0.1

500 ms

0

-160-140-120-100 -80 -60 -40 -20 0
0.1

20 40 60 80 100 120 140

20 40 60 80 100 120 140

Vm (mV)

Vm (mV)
0.3

0.3

0.5

0.5

0.7

0.7

0.9

0.9

Baseline
15nM P MA

1.1

Baseline
15nM P MA

1.1

E

Kir4.1-Kir5.1
Kir4.1

Current (µA)

19
18
17
16
7
6
5
4
3
2
1
0

15nM PMA
-6

-2

2

6

10

14

18

22

26

30

34

38

42

Time (min)
Fig III-1. The Kir4.1-Kir5.1 channel but not homomeric Kir4.1 is sensitive to PMA. A. Using
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of
the Kir4.1-Kir5.1 dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying
currents were recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of
command pulse potentials from –160 mV to 140 mV with a 20-mV increment was applied to the
cell. Note that in highly negative membrane potentials, there was slow activation of the currents.
Exposure to 15 nM PMA (a specific and potent PKC activator) inhibited the Kir4.1-Kir5.1
currents by 40%. B. The same experiment was carried out with the homomeric Kir4.1. Exposure
to 15 nM PMA failed to inhibit this channel. C, D. When baseline and peak PMA affected
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currents were scaled to the same magnitude at -160 mV, the I/V relationship of the currents
recorded under these two conditions were superimposed, suggesting that the effects were voltageindependent. E. The time profile showed that the Kir4.1-Kir5.1 current amplitude decreased
rapidly when PMA was present in the bath solution, and reached maximum inhibition in ~35 min.
The Kir4.1 currents remained constant for 30 minutes during exposure to PMA.
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Fig III-2. A. Inhibtion of Kir4.1-Kir5.1 by PMA and not 4α-PDD. Using TEVC whole-cell
Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1
dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents were
recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command pulse
potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell. Exposure to
100 nM PMA strongly inhibited the Kir4.1-Kir5.1 currents. B. The same experiment was carried
out using the 4α-PDD (an inactive analogue of PMA) instead of PMA. Exposure to 20 nM 4αPDD failed to inhibit the Kir4.1-Kir5.1 channel. C, D. Shows the I-V curve relationships for the
experiments carried out in A and B. E. The time profile shows that the Kir4.1-Kir5.1 current
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amplitude decreased rapidly when PMA was present in the bath solution at a high concentration
(100 nM), and reached maximum inhibition in ~25 min.
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Fig III-3. Concentration-dependent response of PMA. A. The effect of PMA on the Kir4.1Kir5.1 channel was clearly concentration-dependent. The Kir4.1-Kir5.1 channel was inhibited by
very low concentrations of PMA. Exposure to 5 nM PMA suppressed Kir4.1-Kir5.1 channels by
16.9±3.8% (n=5). 1 µM PMA maximally inhibited the Kir4.1-Kir5.1 currents by 93.3±1.4%
(n=4). n≥4 for each concentration tested. B. The concentration-dependent response fits a sigmoid
curve. This curve was used to more accurately obtain the IC50 concentration which was 15 nM
PMA.
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IIIb-2. Involvement of PKC
To demonstrate that PKC activation underscores the PMA inhibition of Kir4.1Kir5.1, we took advantage of several other specific kinase activators and inhibitors.
Exposure of the oocytes to phorbol ester (OAG), another PKC activator, resulted in a
similar inhibition as PMA (Fig 4A, F). Thymeleatoxin (100 nM), that selectively
activates the conventional PKC isoforms (α, β, & γ), brought about an inhibition of the
Kir4.1-Kir5.1 channel (47.8±2.5%, n=5) to the same degree as PMA (P>0.05),
suggesting that at least one of the conventional PKC isoforms is involved (Fig. 4B, F). In
contrast, the homomeric Kir4.1 was not inhibited by OAG and thymeleatoxin, consistent
with the results from PMA (Fig. 4D-F). An inactive analogue of PMA (4α-PDD, 15 and
20 nM) failed to inhibit the Kir4.1-Kir5.1 channel (Fig. 4F; Fig. 2B, D, E).
The cAMP dependent protein kinase A (PKA) has been shown to modulate Kir
channels (Light et al., 2000; Lin et al., 2000; Wischmeyer & Karschin, 1996; Zitron et al.,
2004). We therefore used forskolin that activates the enzyme adenylyl cyclase leading to
increases in the cAMP concentration and activation of PKA. With 100 µM forskolin,
oocytes expressing the Kir4.1-Kir5.1 channel showed a modest inhibition of the Kir4.1Kir5.1 currents (10.2±3.3%, n=8; Fig. 4F), suggesting that the PMA-induced channel
inhibition is not a result of PKA activation.
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Fig III-4. PKC activation inhibits the Kir4.1-Kir5.1channel. A. Currents were recorded from an
oocyte in the same condition as in Figure 1A. These currents were strongly inhibited (46.3%) by
exposure to 50 µM OAG (another potent activator of PKC). B. Exposure of an oocyte expressing
the Kir4.1-Kir5.1 channel to 100 nM thymeleatoxin (activator of the conventional PKC isoforms
α, β, γ) resulted in a similar inhibition (48.9%). C. Currents were recorded from an oocyte in the
same condition as in 3B. Prior to application of 100 nM thymeleatoxin the cell was pre-incubated
with 100 µM Genistein (a potent and general tyrosine kinase inhibitor) for 1 hour. Blocking
activation of tyrosine kinases failed to reduce the inhibition by thymeleatoxin. D, E. The same
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experiments in 3A and 3B were carried out on oocytes expressing the homomeric Kir4.1 channel.
This channel was barely inhibited by 50 µM OAG and 100 nM thymeleatoxin 8.9%, 6.8%,
respectively. F. The effect of PMA appears to be via activation of PKC as Forskolin (a PKA
activator) shows very little inhibition. Also, neither DMSO alone nor 4α-PDD (an inactive analog
of PMA) had a significant effect. n≥4 for each experiment.
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Specific PKC inhibitors were studied, in which oocytes were pre-incubated in
chelerythrine or calphostin-C prior to PMA application to the recording solution. The
pre-incubation of cells with 3 μM calphostin-C for 2 hours resulted in a complete
elimination of the PMA-induced inhibition (Fig. 5A, B). A similar effect was seen with
chelerythrine (50 µM for 1 hour), though to a lesser degree (Fig. 5B). Pre-incubation with
genistein, a potent inhibitor of tyrosine kinases did not block the PMA effect (Fig. 4C, F).
These results strongly suggest that the PMA inhibition of the Kir4.1-Kir5.1 channel is
mediated by PKC, but neither by PKA nor by tyrosine kinase activation.
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Fig III-5. PKC is necessary for inhibition of Kir4.1-Kir5.1 by PMA. A. Using TEVC whole-cell
Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1
dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents were
recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command pulse
potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell. Before
exposure to 15 nM PMA the oocyte was pre-incubated with 3 µM Calphostin-C (a potent and
specific inhibitor of PKC) for 2 hours. Inhibition of PKC drastically attenuated the effect of
PMA. PMA exposure after incubation with calphostin-C slightly activated the Kir4.1-Kir5.1
currents by 9.8%. B. Pre-incubation of oocytes with specific PKC inhibitors (50 μM chelerythrine
or 3 μM calphostin-C) strongly attenuated the effect of 15 nM PMA (n≥4). C. Whole-cell currents
were recorded from an oocyte 3 days post injection of the Kir4.1-Kir5.1V211L mutant channel
recorded under the same condition as in A. This mutant is suggested to have increased PIP2
affinity. Exposure of the oocytes to 15 nM PMA inhibited the Kir4.1-Kir5.1V211L currents by
57.6%. D. The converse mutant was created on the Kir4.1 channel (Kir4.1L208V) and tested in
an oocyte under the same experimental conditions as for Figure 4C. Similarly as for the wild-type
channel this mutant failed to be inhibited by 15 nM PMA.
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IIIb-3. Inhibition of the Kir4.1-Kir5.1 Channel by PKC activation in HEK293 cells
The Kir4.1-Kir5.1 channel was transiently expressed in HEK293 cells. Whole-cell
voltage clamp was performed on GFP-positive cells. Both the bath and pipette solutions
contained 145 mM K+. The Kir4.1-Kir5.1 positive transfected cells showed typical
Kir4.1-Kir5.1 currents that were relatively big at the basal level upon the formation of the
whole-cell configuration. Without any treatment the currents remained at this level for
more than 5 min. The cells were held at a membrane potential of 0 mV. Command
pulses of -80 mV were applied to the cell every 3 seconds and the Kir4.1-Kir5.1 currents
were recorded. Application of 15 nM PMA strongly inhibited the Kir4.1-Kir5.1 channel
by 39.3±2.1% (n=10) (Fig. 6A, D).

The inhibition by 15 nM PMA was greatly

diminished [1.40±2.6% (n=6)] in the presence of the PKC inhibitor peptide (10 µM
PKCi) that was added to the pipette solution (Fig. 6B, D). 100 nM thymeleatoxin similar
to 15 nM PMA also inhibited the Kir4.1-Kir5.1 channel [44.7±2.6% (n=10)] expressed in
HEK293 cells. However, an inactive analogue of PMA (4α-PDD) only inhibited the
Kir4.1-Kir5.1 currents in HEK293 cell by 10.7±2.7% (n=9) (Fig. 6D). Taken together,
these results suggest that the Kir4.1-Kir5.1 channel is inhibited by PKC activation in
HEK293 cells in a similar manner as in Xenopus oocytes.
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Fig III-6. PKC activation inhibits the Kir4.1-Kir5.1channel in HEK293 cells. A. Whole-cell
currents were recorded from an HEK293 cell transfected with the Kir4.1-Kir5.1 dimer cDNA
with a holding potential at 0mV and command pulses of –80mV in every 3 seconds. After the
whole-cell configuration was formed, the cell was perfused with the extracellular solution for a 25 min period of baseline recording. The currents were inhibited by exposure to 15nM PMA. The
arrow represents the magnification of the current at the time point and shown on the right. B. In
the presence of the PKC inhibitory peptide (10µM PKCi), 15nM PMA failed to inhibit the
Kir4.1-Kir5.1 channel. C. Inhibition of the Kir4.1-Kir5.1 channel was also seen with exposure to
100nM thymeleatoxin. D. Bargraph showing that PKC activation results in inhibition of the
Kir4.1-Kir5.1 channel. In each experiment n≥6.
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IIIb-4. Single-channel Properties Affected
The effect of PMA on the single-channel biophysical properties was studied in
Xenopus oocytes using cell-attached patches with 145 mM K+ applied to the extracellular
solution at a membrane potential of -80 mV. Only patches containing ≤4 active channels
were considered in the experiment. Inward rectifying currents with single-channel
conductance of ~40 pS were recorded from oocytes that were injected with the Kir4.1Kir5.1 cDNA 2-3 days prior to recordings. These currents were inhibited with an
exposure of the cells to 15 nM PMA (Fig. 7A). The current inhibition was mainly
produced by a suppression of the channel open-state probability (Popen), while the singlechannel conductance was barely effected (Fig. 7).
IIIb-5. Independence of PIP2
A number of Kir channels are regulated by membrane lipids including
phosphatidylinositol bisphosphate (PIP2). The presence of this phospholipid has been
shown to increase Kir channel activity, and consequently depletion of PIP2 leads to
channel inhibition. To test the possibility that the PMA-induced Kir4.1-Kir5.1 channel
inhibition is related to PIP2 depletion, we mutated the potential PIP2 binding sites in the
channel to increase or decrease the channel affinity for the phospholipid based on a
sequence alignment with other Kir channels (Du et al., 2004; Lopes et al., 2002; Mao et
al., 2004). One mutant R178Q, that has previously been reported to increase PIP2 binding
affinity (Yang et al., 2000), was created in the Kir5.1 and expressed with wild-type
Kir4.1. This mutant channel showed a similar PMA sensitivity as the wild-type (Table 1).
Another mutant Kir4.1-Kir5.1V211L, that has also been shown to increase the PIP2
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sensitivity, did not affect the channel inhibition by 15 nM PMA (41.2±5.7%, n=10) (Fig.
5C). A converse mutation, exchanging these residues at a different site on the Kir4.1
(Kir4.1L208V) had no effect (Fig. 5D).
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Fig III-7. Effects of PMA on the single channel properties of the Kir4.1-Kir5.1. A. Single Kir4.1Kir5.1 currents were recorded from an oocyte in a cell-attached patch configuration with 145 mM
K+ in the patch pipette. At Vm of -80 mV, two active channels are seen at pH 7.4. Following
stabilization, exposure to 15 nM PMA reduced the channel activity by a decrease in the NPo.
Labels on the left: c, closure; 1, the first opening; 2, the second opening; etc. B, C. Bargraph
showing that 15 nM PMA drastically reduced the Po, but did not affect the single-channel
conductance (n≥6).
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To further assess the effect of PIP2 depletion in the channel inhibition,
wortmannin that inhibits the phosphoinositide kinase-3 (PI3K) and thus the resynthesis of
PIP2 from PIP3 was used to treat the oocytes prior to PMA exposure. Following
incubation of oocytes with 10 µM wortmannin, PMA continued to inhibit the Kir4.1Kir5.1 channel by 41.4±8.8% (n=5) (Fig. 4F). Taken together these results suggest that
PIP2 depletion does not seem to underlie the PMA-induced Kir4.1-Kir5.1 channel
inhibition.
IIIb-6. Lack of Evidence for Endocytosis
Several recent studies indicate that protein kinase activation can lead to
endocytosis and thus the suppression of surface Kir channel activity (Lin et al., 2002;
Sterling et al., 2002; Wang et al., 2002; Wang et al., 2006; Zeng et al., 2002). To evaluate
the role of endocytosis in the inhibition of the Kir4.1-Kir5.1 channel by PKC activation,
we carried out experiments with dynamin II and its dominant negative mutant where
lysine at position 44 is mutated to alanine (K44A). We reasoned that co-expression of
this dominant-negative dynamin II may abolish the effect of PKC if the Kir4.1-Kir5.1
channel inhibition by PKC results in dynamin dependent endocytosis. The Kir4.1-Kir5.1
channel was co-expressed with the wild-type dynamin II as well as the dynamin II K44A
mutant. Exposure to 15 nM PMA led to inhibition of the currents by 53.2±4.4% (n=4) in
the cells expressing the wild-type dynamin II (Fig. 8A, D) and by 49.5±6.8% (n=5) in
cells expressing the dynamin II K44A mutant (Fig. 8B, D).
Another mechanism of endocytosis involves clathrin-coated pits. Proteins that
undergo clathrin-dependent endocytosis contain an internalization recognition motif in at
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least one of the intracellular domains, usually in the C-terminal (Zeng et al., 2002). This
motif [(Y/F)(D/E)NPXY] shares high homology in many proteins. A primary scan of the
Kir4.1 amino acid sequence failed to show any similar recognition motif. However, a
scan of the Kir5.1 led to the identification of such a motif. The second and third amino
acids of the motif have been found to be critical for endocytosis of Kir1.1 (Zeng et al.,
2002).
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Fig III-8. PKC activation inhibits Kir4.1-Kir5.1 currents independent of endocytosis. A. Wholecell currents were recorded from an oocyte 3 days following injection of the Kir4.1-Kir5.1 +
dynamin II cDNAs (co-injection) under the same conditions as described for Figure 1A. PMA
exposure inhibited the Kir4.1-Kir5.1+ dynamin II currents by 53%. B. Whole-cell Kir4.1-Kir5.1
currents were recorded from an oocyte 3 days following injection of the Kir4.1-Kir5.1 + dynamin
II K44A mutant cDNAs (co-injection) using TEVC. Exposure to 15 nM PMA also inhibited the
Kir4.1-Kir5.1+ dynamin II K44A (-49%). C. Whole-cell currents were recorded from an oocyte 3
days following injection of the Kir4.1-Kir5.1E260A/S261A mutant channel. This mutant has lost
the recognition site for CCV endocytosis. Exposure of the oocyte to 15 nM PMA inhibited the
Kir4.1-Kir5.1E260A/S261A currents by 42%. D. Bargraph summarizing panels A, B, and C.
Note that the Dynamin K44A mutant and the Kir4.1-Kir5.1E260A/S261A mutant showed no
significant difference to the Kir4.1-Kir5.1 in respect to inhibition by PMA. n≥4 for each
experiment.

129

Therefore, we mutated these residues in Kir5.1. Consistent with the dynamin experiment
we found that the Kir4.1-Kir5.1E260A/S261A mutant remained highly sensitive to PMA
(Fig. 8C, D).
To further assess the possibility of channel endocytosis, whole cell currents were
recorded from HEK293 cells before and during a treatment with thymeleatoxin. The
whole cell capacitance (CAP) and series resistance (SR) were measured. If the Kir4.1Kir5.1 channel inhibition by PKC activation was a result of endocytosis, the whole cell
capacitance would decrease following application of thymeleatoxin to the bath solution.
The percent change in the whole cell capacitance of HEK293 cells expressing the Kir4.1Kir5.1 channel exposed to 100 nM thymeleatoxin for 15 min was 5.9±8.2% (n=4). This
change in capacitance did not significantly differ from that of cells exposed to DMSO
only (3.1±9.9%, n=4) (Fig. 9). The series resistance did not show a significant difference
between cells exposed to DMSO versus cells exposed to 100 nM thymeleatoxin (Fig. 9).
We also performed immunocytochemistry to demonstrate membrane expression
of the Kir4.1-Kir5.1 channel. Both the Kir4.1 and Kir5.1 antibodies are commercially
available. By taking advantage of these antibodies and using immunocytochemistry we
decided to look at membrane expression of the Kir4.1-Kir5.1 channel before and after
exposure to PMA. HEK293 cells were transfected with the Kir4.1-Kir5.1 dimer.
Immunocytochemistry was performed as described in the methods section. Prior to PMA
exposure the channel showed membrane surface expression (Fig. 10A1-A3). After
exposure to 15 nM PMA for 25 min the membrane expression was retained (Fig. 10B1-
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B3). Taken together these results suggest that the Kir4.1-Kir5.1 channel inhibition does
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Fig III-9. Endocytosis independent inhibition of Kir4.1-Kir5.1 in HEK293 cells. Whole-cell
currents were recorded from HEK293 cells 3 days post-transfection of the Kir4.1-Kir5.1 cDNA.
Membrane potential (Vm) was held at 0 mV. A series of command pulse potentials from –120 mV
to 80 mV was applied to the cell and the corresponding currents were recorded. Following
stabilization 100 nM thymeleatoxin was applied to the bath solution and inhibited the Kir4.1Kir5.1 currents by 51.4±2.6% (n=4). Application of DMSO alone barely inhibited the Kir4.1Kir5.1 currents. During the experiments with thymeleatoxin and DMSO, the whole cell
capacitance and series resistance were monitored. Neither capacitance nor series resistance
changed significantly upon application of 100 nM thymeleatoxin or DMSO to the bath solution.
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A1

HEK-Kir4.1-Kir5.1+^GFP

A2

HEK-Kir4.1-*Kir5.1
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Overlay
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Fig III-10. Surfacce expression of the Kir4.1-Kir5.1. Immunocytochemistry was performed on
HEK293 cells 48 hours post-transfection of the Kir4.1-Kir5.1dimer cDNA together with the GFP
cDNA. A. Prior to PMA exposure the channel was mainly expressed on the surface of the
HEK293 cells, suggesting membrane expression. B. Following application of 15 nM PMA for 25
minutes the channel maintained expression on the cell surface. ^ Denotes GFP fluorescence
imaging. * Denotes Kir5.1 antibody was used as the primary antibody. GFP was used as an
indicator of transfection efficiency. Note that all HEK293 cells expressing GFP also expressed
the Kir4.1-Kir5.1 channel although the GFP intensity was compromised by the fixation process.
Bar=10 µm.
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IIIb-7. Phosphorylation Sites
To identify the PKC phosphorylation site, a sequence scan of amino acids was
made for both the Kir4.1 and Kir5.1 channels. Numerous putative PKC phosphorylation
sites were found in Kir4.1 and Kir5.1, according to the consensus sequence, i.e., R(K)-X02-T/S-X0-2-R(K).

Four different phosphorylation prediction programs were also used to

predict potential PKC phosphorylation sites (NetPhos, Scansite, ScanProsite,
Phosphobase). We performed systematic screening of these predicted sites according to
the prediction programs in both Kir4.1 and Kir5.1 by single mutation of the serines or
threonines to an alanine residue. The effect of PMA on these mutants was tested
subsequently in Xenopus oocytes. The mutant channels were grouped: the first group of
mutants consisted of the potential phosphorylation sites that were predicted using all
prediction programs and had the highest score for potential phosphorylation by PKC; the
second group consisted of those residues that had a lower phosphorylation prediction
score; and the third group was residues not predicted by the phosphorylation prediction
programs, but was found in a sequence similar to the consensus sequence for PKC. We
tested 30 mutant channels with a single mutation representing each group and 9 channels
with double mutations. All single mutants tested except for Kir4.1-Kir5.1T174D
remained highly sensitive to PMA (Fig. 11A, B, Table 1).

Further analysis of the

Kir4.1-Kir5.1T174 position suggests that it is involved in another channel function as
mutants carrying an alanine or lysine at this position remained sensitive to PMA (Fig.
11G, Table 1). Also the Kir4.1-Kir5.1T174D mutant also failed to respond to 15% CO2.
Single channel analysis showed that the T174D mutant has an increased Popen (Fig. 11D).
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Taken together we concluded that the T174 position is not a PKC phosphorylation site.
The double mutants were created by comparing the PMA effect of the single mutants and
selecting those that had a slightly lower PMA sensitivity. When tested, the double
mutants also showed a PMA sensitivity similar to the wild-type. Therefore, the PKC
phosphorylation sites remain to be demonstrated.
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Fig III-11. A. T174 as a potential phosphorylation site. Using TEVC whole-cell currents were
recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1T174D mutant. With 90 mM
K+ in the extracellular solution inward rectifying currents were recorded at baseline. Membrane
potential (Vm) was held at 0 mV. A series of command pulse potentials from –160 mV to 140 mV
with a 20-mV increment was applied to the cell. Exposure to 15 nM PMA failed to inhibit the
T174D currents. B. The same experiment was carried out using 1µM PMA. Exposure to 1µM
PMA also failed to inhibit the Kir4.1-Kir5.1T174D channel. C. Unlike the wild-type Kir4.1Kir5.1 channel that is strongly inhibited by 15% CO2, the T174D currents were unaffected by
such an exposure. D, E. Single channel recordings and analyses shows that the T174D mutant has
a higher basal Popen than the wild-type Kir4.1-Kir5.1 although the conductances are the very
similar (n≥5). F. Shows the I-V curve relationships for the experiments carried out in A, B and
C. G. Bargraph showing the effects of 15nM PMA on the T174 mutants. Note that the T174D
mutant had a much larger basal current and failed to be inhibited by PMA in comparison to the
wild-type and the other T174 mutants (n≥5).
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IIIb-8. Direct Phosphorylation of Kir4.1 and Kir5.1
The failure to demonstrate PKC phosphorylation sites raises a question as the
whether the channel proteins are indeed phosphorylated by PKC. Thus, we performed invitro phosphorylation experiments. Since most of the predicted PKC sites are located in
the C-terminus of Kir4.1 and Kir5.1, MBP fusion peptides with the Kir4.1-C-terminus
and Kir5.1C-terminus were produced as described in the Materials and Methods. After
extraction and purification, the fusion peptides were incubated with

32

P-γ-ATP in the

presence of the catalytically active subunit of PKC (20 ng). Such a treatment led to
positive phosphorylation of these peptides suggesting that both Kir4.1 and Kir5.1 are
directly phosphorylated by PKC (Fig. 12; Fig. 13).
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Fig III-12. Phosphorylation of MBP fusion proteins. A. 10% SDS-PAGE gel showing the
presence of the Kir4.1-C-terminus-MBP (~65 kDa) (lane 2), Kir5.1-C-terminus-MBP (~70 kDa)
(Lane 3), MBP alone (~42 kDa) (Lane 4) and Histone III-S (Lane 5). The size is indicated by the
ladder (Lane 1) (precision plus protein standards) (Biorad). B. Autoradiograph after 12 hours
showing phosphorylation of Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-MBP, MBP, and
Histone III-S. The proteins were incubated in the presence of 32P-γ-ATP and the catalytically
active PKC subunit.
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Fig III-13. Schematic for the inhibition of Kir4.1-Kir5.1 channels by PKC. The inhibition of the
Kir4.1-Kir5.1 channel is through the activation of PKC by way of DAG activation. The channel
appears to be inhibited by PKC directly (phosphorylation) and not by a reduction of PIP2.
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IIIc. DISCUSSION
Protein phosphorylation is an important process in regulating cellular functions.
Several inward rectifying K+ channels have been shown to be regulated by protein kinase
phosphorylation (Beguin et al., 1999; Fakler et al., 1994; Henry et al., 1996; Light et al.,
2000; Lin et al., 2000; Mao et al., 2004; Stevens et al., 1999; Vorobiov et al., 1998;
Wischmeyer et al., 1996; Zhang et al., 2004; Zhu et al., 1999; Zitron et al., 2004). For
example, the heteromeric GIRK1/GIRK4 channel has previously been shown to be
phosphorylated by protein kinase C at specific serine residues in the channel protein
affecting channel gating (Mao et al., 2004). This phosphorylation underscored the effect
of substance-P on this channel allowing the channel to partake in the cellular response to
this neurotransmitter.
In the present study we have presented evidence for the inhibition of the
heteromeric Kir4.1-Kir5.1 channel by PKC. The Kir4.1-Kir5.1 channel is inhibited by
nanomolar concentrations of PMA in a dose-dependent manner. Several experiments
show that the effect of PMA is specific. Pre-incubation of the oocytes with specific PKC
blockers (chelerythrine and calphostin-C) abolishes the PMA effect. Exposure of oocytes
to 4α-PDD (an analogue of PMA incapable of activating PKC) fails to inhibit the Kir4.1Kir5.1 channel. On the other hand, two other PKC activators (OAG & thymeleatoxin)
strongly inhibit the channel. The biophysical mechanism for the inhibition of the Kir4.1Kir5.1 channel by PKC appears to be mediated by reducing the channel open state
probability without affecting the single channel conductance. The Kir4.1-Kir5.1 channel
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inhibition does not seem to be produced by PKA and tyrosine kinase as forskolin and
genistein have rather small effects.
The PKC induced inhibition of the Kir4.1-Kir5.1 channel is independent of PIP2
and does not seem to be mediated by endocytosis. Since PIP2 has been shown to regulate
many Kir channels it is possible that the PKC induced inhibition of the Kir4.1-Kir5.1 was
a result of PIP2 depletion. The above experiments show that PMA inhibits the Kir4.1Kir5.1 channel independent of PIP2 depletion. Similarly, mutant channels with increased
PIP2 binding remains to be inhibited by PMA exposure to the same degree as the wildtype. Also, pre-incubation of oocytes with worthmannin (a PI3K inhibitor that reduces
PIP2) fails to abolish the PMA induced inhibition of the channel, suggesting that the
channel inhibition is not a result of PIP2 depletion. Immunocytochemistry experiments
demonstrating surface expression in addition to experiments using a defective dynamin II
mutant show that the effect of PMA is not a result of endocytosis. Although there may be
other mechanisms involved, these results suggest that activation of PKC inhibits the
Kir4.1-Kir5.1 channel by changing the channel gating mechanism.
Our biochemical experiments suggest a direct phosphorylation of the channel
protein as both C-termini of Kir4.1 and Kir5.1 can be phosphorylated by PKC. To find
the PKC phosphorylation sites, we screened more than 30 serine / threonine residues
(some identified as phosphorylation sites by prediction software programs) by mutation
to a non-phosphorylatable amino acid. None of the single mutations led to identification
of the phosphorylation site, as all single mutants tested except for Kir5.1T174D remained
highly sensitive to PMA. The Kir5.1T174 is not a PKC phosphorylation site either, as the
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Kir5.1T174A and Kir5.1T174K mutants are strongly inhibited by PMA. The effect of the
T174D mutation suggests that this residue or its surrounding area may play a role in the
channel gating mechanism and/or regulation by other intracellular factors. This mutant
channel lost the sensitivity to both CO2 and PKC. Since this area contains several charged
residues it is possible that a change in electrostatic charge in this area by the T174D
affects the process of channel gating. Several double mutations based on single sites
shown by phosphorylation prediction programs were also tested. None of these double
mutations affects the PMA sensitivity. Therefore, we believe that the heteromeric
combination of the Kir4.1-Kir5.1 channel may introduce multiple phosphorylation sites
whose phosphorylation collectively may result in a change in channel activity. Removal
of one or two of the phosphorylation sites may not be adequate to abolish the channel
inhibition by PKC. This is further supported by the in vitro phosphorylation experiments
that shows both Kir4.1 and Kir5.1 C-termini are directly phosphorylated by PKC. The
Kir4.1 channel can express as a homomeric channel in several tissues (Ishii et al., 2003;
Hibino et al., 1999; Hibino et al., 2004; Higashi et al., 2001; Ito et al., 1996; Kusaka et
al., 1999). However, this channel has low pH sensitivity (Xu et al., 2000a; Xu et al.,
2000b; Xu et al., 2000c) and is insensitive to phosphorylation by PKC according to our
current studies.
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IIId. SUMMARY AND CONCLUSION
The Kir4.1-Kir5.1 channel expressed using a tandem dimer construct was
inhibited by the PKC activator PMA in a dose-dependent manner. The channel inhibition
was produced via reduction of the Popen. The effect of PMA was abolished by specific
PKC inhibitors. In contrast, exposure of oocytes to forskolin (a PKA activator) had no
significant effect on Kir4.1-Kir5.1 currents. The channel inhibition appeared to be
independent of PIP2 depletion and PKC-dependent internalization. Several consensus
sequences of potential PKC phosphorylation sites were identified in the Kir4.1 and Kir5.1
subunits by sequence scan. Although the C terminal peptides of both Kir4.1 and Kir5.1
were phosphorylated in vitro, site-directed mutagenesis of individual residues failed to
reveal the PKC phosphorylation sites suggesting that the channel may have multiple
phosphorylation sites. Taken together, these results suggest that the Kir4.1-Kir5.1 but not
the homomeric Kir4.1 channel is strongly inhibited by PKC activation.
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Table III-1.

Effect of 15 nM PMA on wild-type Kir4.1, Kir4.1-Kir5.1 and mutant
channels

Kir4.1-Kir5.1 (Dim)
Kir4.1+Kir5.1 (Co-inj)
Kir4.1(homomer)
Kir4.1K67M-Kir5.1
Kir4.1T178A-Kir5.1
Kir4.1S206A-Kir5.1
Kir4.1T214A-Kir5.1
Kir4.1T262A-Kir5.1
Kir4.1T262S-Kir5.1
Kir4.1S263A-Kir5.1
Kir4.1S299A-Kir5.1
Kir4.1S320A-Kir5.1
Kir4.1T346A-Kir5.1
Kir4.1S360A-Kir5.1
Kir4.1S373A-Kir5.1
Kir4.1-Kir5.1T68A
Kir4.1-Kir5.1T174A
Kir4.1-Kir5.1T174D
Kir4.1-Kir5.1T174K
Kir4.1-Kir5.1R178Q
Kir4.1-Kir5.1T181A
Kir4.1-Kir5.1S185A
Kir4.1-Kir5.1T215A
Kir4.1-Kir5.1T232A
Kir4.1-Kir5.1S298A
Kir4.1-Kir5.1T370A
Kir4.1T32A-S299A-Kir5.1
Kir4.1K67M-Kir5.1T68A
Kir4.1T262A-Kir5.1T68A
Kir4.1-Kir5.1V211L
Kir4.1L208V
Kir4.1L208I
Kir4.1L208V-Kir5.1
Kir4.1L208I-Kir5.1

Baseline (µA)

PMA (µA)

% effect

N

6.5±0.6
8.9±2.1
15.3±2.3
20.53±3.0
3.4±0.7
6.0±1.3
3.3±0.2
16.96±1.5
14.1±0.7
9.7±1.0
8.8±1.6
4.7±0.6
4.8±0.4
4.0±0.4
4.1±0.4
11.9±0.8
3.1±0.3
16.5±3.9
5.1±1.1
6.2±0.5
3.8±0.3
10.1±0.6
3.6±0.2
4.0±0.5
10.2±0.4
3.6±0.4
22.5±3.3
8.5±3.3
11.04±0.6
4.5±0.6
10.4±2.0
n.f.
7.8±1.46
n.f.

3.8±0.43
5.2±1.2
15.23±2.2
12.3±2
2.22±0.43
3.8±0.84
2.1±0.2
11.1±1.3
9.7±0.6
6.2±1.0
5.4±1.0
3.0±0.6
2.75±0.48
2.3±0.23
2.46±0.23
8.2±0.5
1.9±0.27
15.38±3.3
2.94±0.61
3.88±0.54
2.08±0.31
6.28±0.64
2.08±0.17
2.3±0.27
6.12±0.82
2.26±0.25
14.8±3.17
5.95±2.6
7.1±0.27
2.6±0.4
9.45±1.9
n.f.
4.77±0.8
n.f.

-41.4±1.9
-40.7±1.9
-0.04±2.2
-41.35±3.23
-33.1±2.9
-36.7±3.7
-37.2±4.6
-34.9±3.5
-31.4±2.9
-36.2±3.9
-38.6±2.9
-39.0±5.0
-44.1±7.1
-40.3±5.8
-38.1±7.3
-30.5±1.5
-38.1±4.1
-0.9±7.2
-40.1±9.6
-37.8±4.0
-45.8±4.7
-37.8±5.1
-40.8±7.2
-41.4±5.6
-39.4±8.5
-36.6±5.2
-36.4±5.8
-35.8±5.2
-35.3±3.4
-41.2±5.7
-10.1±4.7

13
6
6
6
6
13
11
5
5
4
7
7
6
4
7
7
5
8
7
7
5
4
5
4
4
7
6
4
5
10
7

-37.8±2.9

6

Abbreviations: n, number of observation; n.f., nonfunctional
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IV.

GATING OF THE ATP-SENSITIVE K+ CHANNEL BY A PORE-LINING
PHENYLALANINE RESIDUE*

These results have been published:
Asheebo Rojas, Jianping Wu, Runping Wang, and Chun Jiang. Gating of the ATPsensitive K+ Channel by a Pore-lining Phenylalanine Residue. BBA-Biomembranes.
(2007) 1768 (1):39-51.
*In this part, Dr. Jianping Wu did 80 % of the single channel patch clamp recordings for
me. Ms. Runping Wang created 20 % of the mutations on the Kir6.2. Their help is
greatly appreciated.

144

IVa. INTRODUCTION
The KATP channels are heteromeric consisting of four subunits of Kir6 and four
subunits of sulphonylurea receptor (SUR). The Kir6, that forms the ion-conduction
pathway with two transmembrane domains, possesses the essential machineries for
channel opening and closure controls (Tucker et al., 1997).

A central question in

understanding the KATP channel function is how the channel opening and closure is
produced following ligand binding, a process that is known as channel gating.
Experimental evidence suggests that transmembrane domains, especially the pore-lining
membrane helices, play an important role in the channel gating (Bichet, et al., 2003;
Doyle, 2004; Yellen, 2002). The Ca++-dependent gating of the bacterial MthK channel
occurs through lateral movements of the inner transmembrane helices (TM2) while the
outer transmembrane domain (TM1) remains relatively rigid and stable (Jiang et al.,
2002). Such TM2 helical movements during channel gating have also been implied in the
KirBac1.1 and mammalian GIRK channels based on crystal structures (Jin et al., 2002;
Kuo et al., 2003). In the latter two Kir channels, a phenylalanine located at the narrowest
region of the inner vestibule appears to play a critical role in the channel gating (Jin et al.,
2002; Kuo et al., 2003). In Kir1.1 a leucine homologous to this phenylalanine was found
to be essential for pH gating (Sackin et al., 2005). Such a phenylalanine residue (Phe168)
is also found at the cytosolic end of the TM2 of the Kir6.2 subunit, which faces the ionconduction pathway when its amino acid (AA) sequence is aligned with the KirBac1.1.
Phenylalanine is hydrophobic with an aromatic side group. Recent studies on crystal
structures of the bacterial mechanosensitive MscL channel, nicotinic acetylcholine
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receptor and the KirBac1.1 channel have indicated that nonpolar residues may form a
gate through their hydrophobic interaction (Kuo et al., 2003; Sukharev et al., 2001;
Unwin, 1995; Unwin, 2003). It is necessary to demonstrate that such a gate is not only a
structural existence but also a functional entity. The functional role of Phe168 in Kir6.2
gating was investigated by replacing this residue with amino acids having side chains of
different size and hydrophobicity. Our results suggest that the aromatic group of
phenylalanine may occlude the ion conduction pathway in the closed state (Jin et al.,
2002; Kuo et al., 2003). However, other residues with bulky or hydrophobic side chains
at this location can also gate Kir6.2 in a similar manner. In addition to blockade of the ion
pathway during the closed state, the Phe168 appears to lower the energy barrier necessary
for the gating transition. Thus this phenylalanine may act as a hinderer and a facilitator in
the Kir6.2 channel gating.

IVb. RESULTS
IVb-1. Phenylalanine 168 at the narrowest region of the ion conduction pathway
AA sequence of several mammalian Kir channels were aligned with sequences of
the bacterial KirBac1.1 and KcsA channels in a region from the selectivity filter to the
proximal C-terminus. Based on the crystallographic structures of KcsA and KirBac1.1, a
phenylalanine is found at the narrowest region of the inner vestibule of the ionconduction pathway in the Kir6 and Kir3 subfamilies (Fig. 1A, also see Sackin et al.,
2005). These Kir channels have rather low basal channel activity. A hydrophobic residue
with an intermediate size side group (Leucine, methionine) is also seen in other Kir
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channels, most of which show high baseline Po. Based on the crystal structure of the
KirBac1.1 and KcsA channels (Doyle et al., 1998; Kuo et al., 2003), the phenylalanine
residue faces the pore with its side chain projecting into the ion pathway (Fig. 1B).
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Kir6.2 Human
Kir6.2 Mouse
Kir6.1 Mouse
Kir3.4 Mouse
Kir3.1 Mouse
Kir2.3 Human
Kir2.1 Rat
Kir5.1 Rat
Kir4.2 Mouse
Kir4.1 Mouse
Kir1.1 Mouse
Kirbac1.1
KcsA

Filter

M2

Phe168

C-Terminus

FMKTA-QAHRRAETL
GFGGRMVTEECPLAILILIVQNIVGLMINAIMLGCIFMKTA-QAHRRAETL
GFGGRMMTEECPLAITVLILQNIVGLIINAVMLGCIFMKTA-QAHRRAETL
GYGFRVITEKCPEGIILLLVQAILGSIVNAFMVGCMFIKIS-QPKKRAETL
GYGYR-YSDKCPEGIILFLFQSILGSIVDAFLIGCMFIKMS-QPKKRAESL
GYGFRCVTEECPLAVIAVVVQSIVGCVIDSFMIGTIMAKMA-RPKKRAQTL
GYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMA-KPKKRNETL
GYGYRCVTEECSVAVLTVILQSILSCIINTFIIGAALAKMA-TARKRAQTI
GYGVRSITEECPHAIFLLVAQLVITTLIEIFITGTFLAKIA-RPKKRAETI
GYGFRYISEECPLAIVLLIAQLVLTTILEIFITGTFLAKIA-RPKKRAETI
GYGFRFVTEQCATAIFLLIFQSILGVIINSFMCGAILAKIS-RPKKRAKTI
GYGD--MHPQTVYAHAIATLEIFVGMSGIALSTGLVFARFA-RPRAK---I
GYGD--LYPVTLWGRLVAVVVMVAGITSFGLVTAALATWFVGREQERRGHF
GFGGRMVTEECPLAILILIVQNIVGLMINAIMLGCI

B

Fig. IV-1. A. Phe168 is located in the narrowest sector of the ion conductive pore. Alignment of
the Kir6.2 with other K+ channels in a region from the selectivity filter to the proximal Cterminus. B. Phe168 is located in the narrowest sector of the inner pore when aligned with the
KcsA sequence and viewed using RasMol modeling (Capener et al., 2000).
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IVb-2. ATP- and H+-dependent channel gating with different residue mass and
hydrophobicity at position 168
Site-specific mutations of the Phe168 to small amino acids (alanine, glycine or
serine) allowed expression of functional inward rectifying currents. However, these
mutations severely disrupted the channel gating by intracellular ATP. The mutant
channels barely responded to 3mM ATP, whereas the wild-type Kir6.2∆C36 channel was
strongly inhibited by micromolar concentrations of ATP (Figs. 2C-E, F). In contrast to
these mutations, the ATP-dependent channel gating was well maintained when the
Phe168 was mutated to a bulky tryptophan (Fig. 2A). The F168W mutant showed a
similar ATP sensitivity as the wild-type channel (Figs. 2F, 3F), suggesting that a bulky
amino acid is necessary for the ATP-dependent channel gating. Slightly smaller than
phenylalanine, histidine is a hydrophilic amino acid with a bulky side chain. The F168H
mutation produced a channel that was poorly gated by intracellular ATP (Fig. 2F),
suggesting that the residue mass is not the only player in the Kir6.2 channel gating, and
hydrophobicity is also important. Further supporting this idea was that mutant channels
carrying a hydrophilic amino acid (i.e., glutamine, asparagine, glutamate) at residue 168
were also poorly gated by ATP (Fig. 2F, Table 1). Mutations to other massive and
hydrophilic residues (tyrosine, arginine) did not yield functional channels. A similar
phenomenon was observed in the presence of the sulphonylurea receptor 1 subunit
(SUR1). In the presence of SUR1 the 168 position showed a size dependent effect similar
to the Kir6.2∆C36. The presence of the SUR1 increased the channel sensitivity to ATP
without affecting the gating mechanism (Fig. 3, Table 1).
149

Fig. IV-2. ATP sensitivity of the Kir6.2 channel and its mutants. A. Currents were recorded from
an inside-out patch obtained from a cell expressing the Kir6.2∆C36 F168W. With ramp potentials
from –150 to 150mV applied to the patch membrane inward rectifying currents were recorded.
Exposures to ATP produced a dose-dependent inhibition of these currents with the ATP
concentration for 50% current inhibition (IC50) ~300µM. B. The Kir6.2∆C36 F168Q mutant was
only modestly inhibited by 1mM ATP. Note that eight superimposed traces are shown in each
panel. C-E. The F168S, F168A, and F168G mutants of Kir6.2∆C36 barely responded to 3mM
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ATP. F. The dose-response curves were produced using the Hill equation (see Methods). All
mutants were obtained from Kir6.2∆C36. Data are presented as means ± s.e with IC50 shown in
Table 1.
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Fig. IV-3. ATP sensitivity of Kir6.2 channel and its mutants expressed with SUR1. Currents were
recorded from an inside-out patch obtained from a cell expressing the Kir6.2-F168W+SUR1.
With ramp potentials from –150 to 150mV applied to the patch membrane inward rectifying
currents were recorded. Exposures to ATP produced a dose-dependent inhibition of the currents
with the ATP concentration for 50% current inhibition (IC50) ~10µM. The Kir6.2-F168G+SUR1
mutant barely responded to 3mM ATP. The dose-response curves were produced using the Hill
equation (see methods).
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The same gating pattern was observed for the proton-dependent gating of the Kir6.2. The
F168A and F168G mutations greatly diminished or completely eliminated the channel
gating by pH (Fig. 4D-F). The pH sensitivity was well maintained when the Phe168 was
mutated to a bulky tryptophan (Fig. 4B). Mutation to an AA with a medium side-chain
(glutamine, asparagine) had an intermediate effect (Figs. 4C, F), while mutation to
glutamate or histidine reversed the pH response (Table 1).
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When the ATP and pH sensitivities were plotted against the residue mass, we
found that the effect of ATP and pH on channel activity was a function of the residue
mass (Fig. 4F). With a residue of 165 Daltons or larger, the channels were fully
functional. They were strongly activated by protons and inhibited by ATP, whereas
mutations to a residue smaller than glutamine (146 Daltons) disrupted the channel gating
by both ATP and pH. The transition occurs between 146 and 165 Daltons (Fig. 4F),
suggesting that residue mass at this location is critical for the Kir6.2 channel gating.
To understand whether the hydrophobic nature of phenylalanine is adequate for
the channel gating, we also studied mutant channels with several other nonpolar amino
acids such as valine, leucine, isoleucine and methionine at residue 168. None of these
mutants produced detectable K+ currents (Table 1).
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Fig. IV-4. A. Activation of Kir6.2∆C36 by hypercapnic acidosis. Whole-cell currents were
studied in an oocyte injected with the Kir6.2∆C36 3 days earlier. With 90mM K+ in the
extracellular solution inward rectifying currents were recorded at baseline. The currents were
reversibly activated with a 5min exposure to 15% CO2 that acidifies the cytosol to pH 6.6. B.
Mutation of Phe168 to tryptophan resulted in current activation similar to the Kir6.2∆C36. C. The
channel was moderately activated when the Phe168 was mutated to glutamine. D,E. Mutation to
alanine or glycine yielded channels that were insensitivity to CO2. F. The effects of ATP and CO2
on single-channel and whole-cell currents were plotted against the residue mass (Kyte and
Doolittle, 1982) at the Phe168 location. A marked reduction in the pH and ATP sensitivities
occurred with residues smaller than glutamine (146 Daltons). In contrast, the channels showed
fair ATP and pH sensitivities with residue mass greater than 165 Daltons. When both plots
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combined, the critical mass of this residue is shown to be >155 Daltons for the full ATP and pH
sensitivities. Note that the channel response to acidic pH is inversely plotted. IC50=

concentration for 50% inhibition. I= current. The open triangle represents the IC50 and the
closed circles represent the % current change with CO2. G. The relationship of baseline Po
with residue mass. The Po remained low no matter what AA the Phe168 was substituted with
(open triangle). In higher magnification (solid triangle), the baseline Po was significantly higher
with small residues than with large ones with the transition between 145-165 Daltons. H. The
open-time constant (τo) and the long period of closed-time constant (τc3) obtained by fitting the
dwell-time histogram as illustrated in Fig. 4 show a clear residue-mass dependence. Note that for
comparison purpose, the open time was fitted with a single exponential for all channels. I. Similar
mass-dependence was observed with the mean open time (MTo) and mean closed time (MTc).

156

IVb-3. Effects of residue mass and hydrophobicity on the single channel properties
Consistent with previous reports (Tucker et al., 1997; Wu et al., 2002), singlechannel Kir6.2∆C36 currents showed short periods of openings with low baseline Po (Fig.
5, Table 2). The F168W-mutant channel showed similar single-channel activity with
moderate bursting activity (Fig. 7). It is worth noting that the F168W channel did not
show rapid rundown. With a small residue at this position, the F168G channel had much
longer openings and closures than the Kir6.2∆C36 (Figs. 5, 8), leading to a marked
decrease in the closure-opening frequency. These mutant channels ran down rather fast in
contrast to the F168W, especially when the patches were exposed to acidic pH that
causes rundown in wild-type Kir6.2 as well, though to a lesser degree (Xu et al., 2001;
Wu et al., 2002).
Although the baseline Po of all mutant channels remained low (Table 1),
significant differences in the baseline Po was observed between large and small residues.
The baseline Po of the F168G was almost twice as high as the Kir6.2∆C36 (P<0.01),
despite the fact that its rapid rundown may have led to an under-estimation of the Po
value. When the residue mass was plotted against Po, a clear transition of Po levels was
also seen at the residue mass of 146-165 Daltons (Fig. 4G). We also examined the
channel open- and closed-time properties and when plotted, the residue-mass dependence
was observed in these open and closed time properties with a transition at 146-165
Daltons (Fig. 4H, I).
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Fig. IV-5. Single-channel analysis of the open and closed times of the Kir6.2∆C36 and its
representative mutants. A-D. The Kir6.2∆C36 and F168W show brief openings and closures,
while the openings and closures are much longer in F168G and F168Q. Labels on the right
indicate the opening (o) and closure levels (c).
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IVb-4. Mutations at position 168 in Kir6.2 also affect single-channel kinetics
Channel open-time and closed-time properties were studied on the F168W,
F168Q and F168G mutants that represent residues of different size and hydrophobicity
(Figs. 7, 8, 9). The open time constant (τo) and the mean open time (MTo) of the F168W
were comparable to those of Kir6.2∆C36 (Table 2, Table 4), although its bursting activity
caused a reduction in long periods of closures leading to a modest decrease in the closedtime constants (τc) and the mean closed time (TMc) (Table 2). The F168G and F168Q
channels all showed much longer openings and closures (Table 2). They also had longer
τo and τc as well as longer MTo and MTc (Table 2, Table 4). Thus the mutant channels
without a bulky and hydrophobic residue at the 168 position tend to stay in long periods
of openings and closures (Fig. 5C, D), strongly suggesting that the Phe168 is not only
involved in blocking the ion pathway by its bulky side-group, but also facilitates the
transition between channel openings and closures.
Like Kir6.2∆C36 (Fig. 6), the F168W channel was fairly sensitive to ATP. The
inhibition by ATP was produced by selective augmentation of the long closures with little
or no effect on the openings (Fig. 7D, E). This led to an increase in the MTc with little
effect on the MTo (Table 2). The F168G mutant was unaffected by ATP up to 3mM ATP.
As a result, there were no evident changes in its single-channel kinetics with 1mM ATP
(Fig. 8, Table 4). The F168Q was modestly inhibited by ATP. Such a small effect was
also mediated by changes in the closed time constants (Fig. 9). Taken together, these
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results suggest that the mechanism for ATP inhibition remains similar in the F168W and
F168Q mutants although the magnitude of the inhibition is different.
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Fig. IV-6. Single-channel kinetics analysis of Kir6.2ΔC36 channel. Data were obtained from an
inside-out patch with each histogram constructed using >1min recording. A. Single-channel
current recorded from the patch was studied with different levels of ATP. Channel activity (Po,
shown on the right) decreased in the presence of 100μM ATP (lower trace). Labels on the left
indicate the opening (o) and closure levels (c). The total number of events (TE) used to compute
the histogram is also in the caption. B,C. Baseline open-time and closed-time histograms at pH
7.4 in the absence of ATP. B. The open-time histogram was fitted with one exponential with τo =
0.7 ms. C. The closed time was fitted with two exponentials with τc1 = 0.3 ms and τc2 = 28.8 ms.
D, E. In the presence of 100μM ATP (pH 7.4), a third closure event appeared and was very long.
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The time constant for the second closure was slightly changed, but the third closure was
prolonged (τc2 = 33.7 ms, τc3 = 110.9 ms), while the other time constants were barely affected.
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Fig. IV-7. Single-channel kinetics analysis of F168W. Data were obtained from an inside-out
patch with each histogram constructed using two stretches of 20 s recording in B, C, F and G and
one stretch in D and E. A. Single-channel current recorded from the patch was studied with
different levels of ATP. Channel activity (Po, shown on the right) decreased in the presence of
100μM ATP (lower trace). Labels on the left indicate the opening (o) and closure levels (c). The
total number of events (TE) used to compute the histogram is also in the caption. B, C. Baseline
open and closed time histograms at pH 7.4 in the absence of ATP. B. The open time histogram
was fitted with one exponential with τo = 1.0 ms. C. The closed time was fitted with two
exponentials with τc1 = 0.8 ms and τc2 = 13.1 ms. D, E. In the presence of 100μM ATP (pH
7.4), time constants for the second closure changed a little and a third closures became apparent
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and was prolonged (τc2 = 15.4 ms, τc3 = 60.3 ms), while the other time constants were barely
affected.
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Fig. IV-8. Single-channel kinetics analysis of F168G. Data were obtained from an inside-out
patch with each histogram constructed using ≥1min recordings. A. Single-channel current
recorded from the patch was studied with different levels of ATP. Channel activity (Po, shown on
the right) decreased in the presence of 1mM ATP (lower trace). Labels on the left indicate the
opening (o) and closure levels (c). The total number of events (TE) used to compute the
histogram is also in the caption. B,C. Baseline open and closed time histograms at pH 7.4 in the
absence of ATP. B. The open time histogram was fitted with one exponential with τo1 = 5.14 ms.
C. The closed time was fitted with three exponentials with τc1 = 0.6 ms, τc2 = 9.6 ms, τc3 =
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437.9 ms. D, E. ATP (1mM, pH 7.4) had no effect on the time constants (τc1 = 0.5 ms, τc2 = 7.9
ms, τc3 = 407.9 ms).
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Fig. IV-9. Single-channel kinetics analysis of F168Q. Data were obtained from an inside-out
patch with each histogram constructed using ≥1min recordings. A. Single-channel current
recorded from the patch was studied with different levels of ATP. Channel activity (Po, shown on
the right) decreased in the presence of 1mM ATP (lower trace). Labels on the left indicate the
opening (o) and closure levels (c). The total number of events (TE) used to compute the
histogram is also in the caption. B,C. Baseline open and closed time histograms at pH 7.4 in the
absence of ATP. B. The open time histogram was fitted with one exponential with τo1 = 6.6 ms.
C. The closed time was fitted with three exponentials with τc1 = 0.2 ms, τc2 = 3.0 ms, τc3 =
563.6 ms. D, E. In the presence of 1mM ATP (pH 7.4), time constants for the second and third
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closures were slightly prolonged (τc1 = 0.2 ms, τc2 = 5.0 ms, τc3 = 640.0 ms), while the other
time constants were barely affected.
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IVb-5. Kinetics modeling
The rate constant kinetics was determined for the Kir6.2∆C36 in the basal
condition as well as in the presence of ATP (Colquhoun & Hawkes, 1995; Trapp et al.,
1998). We adopted a simple kinetic scheme used previously for the KATP channel (Trapp
et al., 1998). In an ATP-free condition, the Kir6.2∆C36 channel has a single O with C1,
and C2. The C1 is the short-lived closed state that can be seen in bursts of openings, and
C2 is the long-lived closed state that determines the duration between bursts. During
baseline levels the Kir6.2∆C36 channel exhibits bursting that is reflective in the rate time
kinetics (Table 1). This channel tends to have alternating fast and slow kinetics between
open and closed states. The scheme is supported by the rate constant kinetics calculated
based on the equations described in the methods section. The kinetic model suggests that
the Kir6.2∆C36 channel spends very little time in either the closed or open states. The
transitions between the states are very rapid. During channel opening there is a fast
transition to the short-lived closed state. In the absence of ATP the kinetics favor a very
fast transition from the short-lived closure to the open state and also a very fast transition
from the open state to the long-lived closed state. This explains why in the basal
condition this channel exhibits bursting or flickering activity. When ATP is present, a
second long-lived closed state (C3) appears in the Kir6.2∆C36 (Scheme 1). The kinetics
favors a very fast transition towards C3 in the presence of ATP as indicated by the bold
arrow. As a result the C2 is shortened by ATP. Therefore, ATP inhibits the channel by
extending the long-lived closed state.
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To determine whether the Phe168 is critical for this gating transition, we
calculated the rate constant kinetics for the F168G mutant that causes severe disruption of
channel gating, and compared them with the rate constant kinetics of the Kir6.2∆C36.
The data for the F168G was fitted with the kinetic scheme 2. When the kinetics was
entered into the scheme it supported the idea that the F168G mutation has an increased
barrier of energy necessary for the gating transitions. The rate constant kinetics for this
mutant favors the transition towards openings from both C1 and C2 allowing the channel
to stay in the open state (Table 3). The transition from open to C1 is lessened as noted by
the dashed arrow (Table 3). Furthermore, the kinetics also favors the transition from C2
to C3 stabilizing at the long-lived close state (Table 3). Therefore, the F168G mutant
unlike the Kir6.2∆C36 has long periods of closures followed by long periods of openings.
This results in the slow transition between channel opening and closure, a completely
opposite effect to the bursting activity seen in the Kir6.2∆C36.
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IVc. DISCUSSION
Our results have shown that a bulky and hydrophobic AA is required at residue
168 for the Kir6.2 channel gating. With a small residue at this site, the mutant channels
remain conducting inward rectifying K+ currents, but fail to be gated by ATP and
protons. The requirement of a bulky residue on the ion-conduction pathway for channel
gating therefore suggests a steric hindrance effect. In addition to the residue-mass
dependence, hydrophobicity of residue 168 is important for the Kir6.2 channel gating.
The size of the residue at position 168 cannot completely account for full channel gating.
Various side chain characteristics may contribute to the gating properties. This is
apparent in channels carrying charges at the 168 position such as F168E and F168H.
These two channels show disrupted pH gating which may attribute to the charge carried
by these amino acids. The Kir6.2 channel is well gated with a hydrophobic but not a
hydrophilic residue. These results are consistent to what has been reported for the pH
gating of Kir1.1 (Sackin et al., 2005).
Based on crystal structures of the bacterial mechanosensitive MscL channel,
nicotinic acetylcholine receptor and the KirBac1.1 channel, a hydrophobic residue is
often found at the narrowest region of the ion-conduction pathways (Kuo et al., 2003;
Sukharev et al., 2001; Unwin, 1995; Unwin, 2003), leading to the “hydrophobic gate”
hypothesis: Gating of these channels involves movements of the pore-lining helices with
the pore widened during channel opening, while constriction of these pore-lining helices
during channel closure brings the nonpolar residues in each subunit of a multimeric
channel in contact with each other, thereby sealing the ion-conduction pathway (Doyle,
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2004). Our studies have evaluated this hypothesis by looking at functional consequences
of different amino acid properties at residue 168. Our results have shown that a
hydrophobic residue is necessary for the Kir6.2 channel gating. The channel gating is
severely compromised when the Phe168 is mutated to a hydrophilic amino acid including
histidine that has almost the same residue mass as phenylalanine. Thus, these results
provide functional evidence supporting the hydrophobic gate hypothesis.

Fig. IV-10. A. A structural representation of the residues in the lower TM2 domain. The Kir6.2
was aligned with the KirBac1.1 and displayed based on the KirBac1.1 X-ray crystallographic
structure [Kuo et al., 2003]. Shown are two of the channel subunits in a cis configuration. The
Phe168 is labeled in black. Also labeled by color are other hydrophobic residues located in the
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TM2 domain that may possibly interact with each other in the absence of the Phe168. B. When
the Phe168 is aligned with the KscA model [Doyle et al., 1998], the Phe168 is located at the
narrowest part of the ion-conduction pathway of the inner vestibule, and points its side chain
toward the pore.
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Phenylalanine has an aromatic side group. According to the KirBac1.1 model
(Kuo et al., 2003), the Phe168 faces the pore and may block the ion-conduction pathway
by the bulky side group (Fig. 10). The involvement of such a phenylalanine residue in
channel gating has been suggested in KirBac1.1 and GIRK channels. In the GIRK4
channel, Phe187 is located at the narrowest part of the ion-conduction pathway. The
channel gating requires flexibility of the TM2 helix above the Phe187, while introduction
of flexibility at the helical turn below the Phe187 renders the TM2 helix unable to
transduce the force exerted at its end by the channel-G-protein interaction and fails to
produce functional channels (Jin et al., 2002). In the KirBac1.1 channel, a phenylalanine
(Phe146) is identified at the corresponding site to the Phe187 in GIRK4 and Phe168 in
Kir6.2. Side chains of the Phe146 have been shown to form structural obstacles in the
ion-conduction pathway in the closed state (Kuo et al., 2003). Similarly, leucine residues
at a homologous position on Kir1.1 occlude the permeation path of Kir1.1 in the closed
state (Sackin et al., 2005). According to the White-Wimley hydropathy scale (Wimley &
White, 1996; White & Wimley, 1999), leucine is more hydrophobic than its counterpart
isoleucine and valine, suggesting that this leucine residue in the Kir1.1 channel may act
similarly as Phe168 in the Kir6.2 channel.
In Kir6.2, the baseline channel openings are maintained by the intrinsic
conformation of the channel protein, phosphorylation and other KATP channel regulators
such as phospholipids, ADP and protons (Baukrowitz et al., 1998; Light et al., 2000; Lin
et al., 2000; Shyng & Nichols,1998; Wu et al., 2002; Xu et al., 2001). ATP binding to
intracellular protein domains (Tanabe et al., 1999; Tsubo et al., 2004) may produce a
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conformational change of the inner helices. When the phenylalanine from each subunit
are close enough, they can interact with each other through hydrophobic forces and close
the ion pathway (Fig. 10), as indicated in the KirBac1.1 crystallographic structure (Kuo et
al., 2003). Substitution of this Phe168 residue with a smaller amino acid eliminates the
gating ring, and disrupts the channel gating. The pore blockade may be removed during
channel opening, as it is known that the inner helix bundle-crossing moves and the inner
pore is widened with channel opening (Armstrong, 1966; Davies, 1990;

Flynn &

Zagotta, 2001; Jiang et al., 2002; Johnson & Zagotta, 2001; Perozo et al., 1999; Phillips
et al., 2003; Shin et al., 2001), suggesting that the Phe168 also acts on the channel gating
by the steric hindrance effect.
A kinetic model is helpful to understand how this phenylalanine can have this
steric hindrance effect. We thus used the simplest kinetic scheme to explain our data for
the Kir6.2∆C36 and the F168G mutant channels. In the basal condition, the Kir6.2∆C36
channel contains two close states (C1, C2) and one open state (O). A third long-lived
closed state appears when ATP is present in the solution. In contrast to the Kir6.2∆C36,
the F168G mutant contains one open state and three closed states (C1, C2, C3) in the
absence of ATP. The C1 and C2 are similar to those in the Kir6.2∆C36, while the C3 is a
long-lived closed state independent of ATP. Kinetic analysis shows that the F168G
mutant tends to be stabilized in the open and long-lived closed states. Under such a
condition, higher free energy is needed to fulfill the gating transitions. This is consistent
with the observation that this mutant channel is no longer sensitive to ATP concentrations
that strongly inhibit the Kir6.2∆C36. The mere presence of a phenylalanine at position
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168 in the Kir6.2∆C36 appears sufficient to lower the barrier of energy necessary for the
gating transitions. In this respect, phenyalanine is likely to act as a facilitator of the
channel gating. Thus, a bulky and hydrophobic residue like phenylalanine and tryptophan
may block the ion-conduction pathway in the closed state and facilitate the closureopening transition in channel gating. Apparently this is a consequence of evolutionary
optimization of protein function. This phenylalanine is not seen in several other Kir
channels including Kir1.1, Kir2.1 and Kir4.1. Instead, a leucine or methionine is found in
those channels. It is known that some of these hydrophobic residues with an intermediate
side chain also serve as a gate as in the Kir1.1 channel (Sackin, 2005). Under such a
condition, a reduced hydrophobicity of the pore-lining residues may be necessary for
preventing pore collapse or channel rundown.
IVd. SUMMARY AND CONCLUSION
ATP-sensitive K+ (KATP) channels are gated by intracellular ATP, proton and
phospholipids. The pore-forming Kir6.2 subunit has all essential machineries for channel
gating by these ligands. It is known that channel gating involves the inner helix bundle of
crossing in which a phenylalanine residue (Phe168) is found in the TM2 at the narrowest
region of the ion-conduction pathway in the Kir6.2. Here we present evidence that
Phe168-Kir6.2 functions as an ATP- and proton-activated gate via steric hindrance and
hydrophobic interactions. Site-specific mutations of Phe168 to a small amino acid
resulted in losses of the ATP- and proton-dependent gating, whereas the channel gating
was well maintained after mutation to a bulky tryptophan, supporting the steric hindrance
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effect. The steric hindrance effect, though necessary, was insufficient for the gating, as
mutating Phe168 to a bulky hydrophilic residue severely compromised the channel
gating. Single-channel kinetics of the F168W mutant resembled the wild-type channel.
Small residues increased Popen, and displayed long-lasting closures and long-lasting
openings. Kinetic modeling showed that these resulted from stabilization of the channel
to open and long-lived closed states, suggesting that a bulky and hydrophobic residue
may lower the energy barrier for the switch between channel openings and closures.
Thus, it is likely that the Phe168 acts as not only a steric hindrance gate but also
potentially a facilitator of gating transitions in the Kir6.2 channel.
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Table IV-1. WT and mutant channels tested and their pH and ATP sensitivities
MW Hydropathy1 Hydropathy2

IC50 ATP

% CO2 Effect

Baseline Po

F168G

>9,000 (4)

4.5 ± 3.8 (8)

0.052 ± 0.004 (6)

75

−0.4

0.01

F168A

>9,000 (4)

6.7 ± 2.6 (9)

0.053 ± 0.004 (6)

89

1.8

0.17

F168S

8,061 ± 1,254 (6)

11.9 ± 2.2 (7)

0.055 ± 0.003 (4)

105

−0.8

0.13

F168V

NF

NF

NF

117

4.2

0.07

F168C

NF

NF

NF

121

2.5

-0.24

F168I

NF

NF

NF

131

4.5

-0.31

F168L

NF

NF

NF

131

3.8

-0.56

F168N

6,562 ± 797 (5)

15.8 ± 4.0 (5)

0.050 ± 0.005 (6)

132

-3.5

0.42

F168Q

6,274 ± 656 (4)

23.1 ± 2.9 (10)

0.056 ± 0.006 (13) 146

−3.5

0.58

F168K

NF

NF

NF

146

−3.9

0.99

F168E

5,989 ± 1,441 (6)

−7.5 ± 4.6 (6)

0.036 ± 0.005 (4)

147

−3.5

2.02

F168M

NF

NF

NF

149

1.9

-0.23

F168H

4,198 ± 375 (4)

−24.6 ± 3.4 (6)

0.046 ± 0.005 (4)

155

−3.2

0.96

109 ± 17 (14)

130.3 ± 12.2 (9)

0.029 ± 0.005 (7)
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2.8

-1.13

F168R

NF

± NF

NF

174

−4.5

0.81

F168Y

NF

NF

NF

181

−1.3

-0.94

F168W

195 ± 24 (6)

150 ± 16.6 (10)

0.039 ± 0.003 (13) 204

-0.9

-1.85

Kir6.2ΔC36

>9,000 (6)

0.070 ± 0.004 (5)

*Kir6.2 Sur1

7 ± 0.6 (11)

0.169 ± 0.014 (4)

*Kir6.2F168W

13 ± 2.6 (5)

0.243 ± 0.016 (11)

*Kir6.2F168G
+

The ATP sensitivity was studied in excised patches and is expressed by fitting the data
using the Hill equation. Hill coefficients are 1.0−1.2 (not shown). All mutants were created on
Kir6.2ΔC36. Abbreviations: MW, molecular weight; NF, nonfunctional. Data are presented as
means ± s.e with n (in the parentheses) = number of patches. Hydropathy was used to indicate
whole-residue hydrophobicity according to the interface scale (Kyte & Doolittle, 1982; Wimley
& White, 1996; White & Wimley, 1999). Hydropathy1 refers to the Kyte-Doolittle hydropathy
scale and hydropathy2 refers to the White-Wimley scale. Asterisk indicates the channel expressed
with SUR1.
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Table IV-2. Single channel data of wild-type and representative mutant channels

pH7.4, no ATP
Po
MTo
MTc
pH7.4, 100μM ATP
Po
MTo
MTc
pH7.4, 1mM ATP
Po
MTo
MTc

F168G

F168Q

Kir6.2ΔC36 F168

F168W

0.049 ± 0.003 (17)
2.1 ± 0.1 ms (11)
48.4 ± 7.0 ms (11)

0.056 ± 0.007 (14)
2.3 ± 0.5 ms (14)
36.4 ± 3.6 ms (14)

0.029 ± 0.004 (7)
0.7 ± 0.1 ms (6)
18.1 ± 2.6 ms (6)

0.039 ± 0.004 (9)
0.6 ± 0.1 ms (9)
15.3 ± 1.3 ms (9)

−
−
−

−
−
−

0.008 ± 0.002 (4)
0.8 ± 0.0 ms (4)
67.1 ± 4.3 ms (4)

0.021 ± 0.002 (4)
0.6 ± 0.0 ms (4)
22.4 ± 2.7 ms (5)

0.047 ± 0.008 (7)
2.6 ± 0.3 ms (7)
60.2 ± 7.6 ms (7)

0.040 ± 0.007 (6)
2.7 ± 0.5 ms (6)
64.0 ± 7.5 ms (6)

−
−
−

−
−
−

The open-state probability (Po), mean open time (MTo), and mean closed time (MTc) were studied
in patches with a single active channel. Excised inside-out patches were exposed to 100μM ATP
or 1mM ATP as dependent upon the IC50 of the mutant and compared to controls with no ATP.
All mutants were based on the Kir6.2∆C36. Data are presented as means ± s.e. with n shown in
parentheses and represents the number of patches.
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Table IV-3. Rate constants used for kinetic modeling
Kir6.2ΔC36

τo1
τc1
τc2
τc3
τc2'
τc3'
k1
k-1
k2
k-2
k3
k-3
k'3
k'-3

Kir6.2ΔC36-F168G

0.6
0.2
38.0
−
27.4
197.3

4.2
0.3
2.5
255.6
−
−

720.2
4,545.4
1,065.5
26.3
−
−
102,230.0
5.1

162.1
4,000.0
76.0
257.5
138.5
3.9
−
−

The average rate constants were calculated at -80mV. The τc2', τc3', k’3 and k’-3 were obtained in
the presence of 100μM ATP.
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Table IV-4. Open and closed time constants for wild-type and mutant channels
Kir6.2ΔC36

Kir6.2ΔC36F168W

Kir6.2ΔC36F168Q

Kir6.2ΔC36F168G

τo1
τc1
τc2
τc3

0.56±0.04 (5)
0.22±0.02 (5)
38.02±11.18 (5)
-

0.5±0.06 (5)
0.3±0.0 (5)
17.86±2.72 (5)
-

3.5±1.0 (5)
0.3±0.1 (5)
10±2.4 (5)
162.2±74.2 (5)

4.2±0.55 (4)
0.3±0.03 (4)
2.5±0.74 (4)
255.55±79.65 (4)

∗τo1
∗τc1
∗τc2
∗τc3

0.68±0.066 (5)
0.3±0.05 (5)
27.38±12.83 (5)
197.26±84.55 (5)

0.95±0.1 (4)
0.65±0.06 (4)
14.13±2.76 (4)
94.53±25.16 (4)

4.0±0.7 (5)
0.4±0.0 (5)
13.8±2.1 (5)
240.5±64.4 (5)

4.2±0.6 (4)
0.3±0 (4)
2.9±0.8 (4)
254.9±78.7 (4)

The open time constant (τo1) and the closed time constants (τc1, τc2, τc3) were studied in
patches with a single active channel. Excised inside-out patches were exposed to 100μM ATP or
1mM ATP as dependent upon the IC50 of the mutant and compared to controls with no ATP. All
mutants were based on the Kir6.2∆C36. Data are presented as means ± s.e. with n shown in
parentheses and represents the number of patches. Asterisk represent data obtained in the
presence of ATP.
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K. GENERAL DISCUSSION
K-1. Central CO2 chemoreception
The process by which the body senses CO2 is finely tuned, covering a wide range
of CO2 changes. The basal level of CO2 in the body is ~5% CO2. This is a partial
pressure of CO2 (pCO2) ~ 38 mmHg. In humans the range of pCO2 detected is from 38
mmHg to ~80 mmHg. pCO2 levels above 80 mmHg is considered a patho-physiological
condition that rapidly results in the stoppage of breathing. Even with such a broad range
of pCO2 levels being detected the central CO2 chemoreception system remains highly
sensitive to changes in CO2. A change in pCO2 as low as 1 mmHg results in a significant
change in ventilation (Nattie, 1999; Putnam et al., 2004). This minute change in the
partial pressure of CO2 results in only a minuscule change in blood pH (~0.001%). This
creates a paradox that is: how can the CO2 sensing mechanism in the brainstem maintain
such a high sensitivity to CO2 and at the same time cover a wide range of changes in the
pCO2? Researchers have been trying to address this question for many years.
K-2. Neuromodulation and central chemoreception
In some cases instead of changing the frequency of action potentials,
neurotransmitters may change the pattern of the firing. For example, neurons that are
normally tonic bursters may become phasic burster following the neurotransmitter
binding and vice versa. The response of the neuron to these neurotransmitters depends
on several factors such as the receptor subtype, the intracellular cascades activated,
receptor number, target molecule number and distribution, as well as the amount of
neurotransmitter released. Some neurotransmitters such as serotonin have many receptor
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subtypes. These different receptors although share a commonality in binding serotonin
may all lead to the activation of different intracellular cascades and molecules leading to
different neuromodulations. In this way it becomes extremely important in identifying
which receptor subtype is present in these chemosensitive neurons and what intracellular
cascades are activated following ligand binding. With such specificity the
neuromodulation may be confined to a specific cell type. In this way neuromodulation
may affect the cellular response to CO2 that may also explain how the CO2 signal may be
amplified leading to a highly sensitive detection system. In this thesis I have performed
experiments to test the hypothesis that blockade of synaptic transmission results in a
lower sensitivity to CO2 in cultured brainstem neurons. Brainstem neurons were
dissociated and cultured on MEA dishes. The response to CO2 was determined for
individual units. Following the blockade of synaptic transmission by the application of
specific neurotransmitter blockers to the bath solution the CO2 sensitivity of identified
units were determined to be lower than that prior to the application of the
neurotransmitter blocker. I was able to demonstrate that blockade of synaptic
transmission involving substance P, serotonin, and glutamate resulted in a lower response
to acidification, suggesting that cultured brainstem neurons have adopted synaptic
transmission as a means of amplifying the response to changes in CO2.
The high pH sensitivity of the Kir4.1-Kir5.1 channel in the physiological range
suggests that this channel may be a good candidate CO2 chemoreceptor molecule. To
strengthen the candidacy of this channel as a chemoreceptor molecule we found it
necessary to demonstrate how the neurotransmitters and CO2 affect the channel activity.
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We hypothesized that the neurotransmitters and CO2 inhibits the channel activity via
different mechanisms. Therefore, we performed experiments to test this hypothesis. We
found that although both CO2 and the neurotransmitters (SP, 5-HT, and TRH) can inhibit
the channel, the inhibition appeared to be though different and independent mechanisms.
This is an important finding as this suggests that both modulators combined may have a
greater effect on the channel than either modulator alone. This potentially implies that
the presence of the neurotransmitters may increase the channel’s sensitivity to CO2. This
is significant as we know that the have to be amplification of the signal during central
CO2 chemoreception (discussed earlier). This potentially may be one mechanism for
amplifying the signal the signal in central CO2 chemoreception.
K-3. Inward rectifier potassium channels as chemoreceptor molecules
A previous study performed by Wu et al., in 2004 demonstrated the presence of
mRNA for both Kir4.1 and Kir5.1 in the same brainstem chemosensitive neurons. This
study used in situ hybridization to identify mRNA of Kir4.1 and Kir5.1 in CO2
chemosensitive sites. Although mRNA for the Kir4.1 and Kir5.1 positively identified in
the same chemosensitive brainstem neurons suggested that the heteromeric Kir4.1-Kir5.1
is expressed, the weakness of this study is that mRNA is only suggestive. The presence
of mRNA is not indicative of the protein expression. The presence of mRNA does not
necessarily confer that the Kir4.1 and Kir5.1 proteins are present. Therefore, in this
dissertation I wanted to solidify the expression of the heteromeric Kir4.1-Kir.1 channel in
chemosensitive brainstem neurons. It was very imperative that we demonstrate
expression of the Kir4.1 and Kir5.1 proteins in neurons as both Kir4.1 and Kir5.1
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subunits are suggested to express only in glial cells where they function in potassium
recycling. Although we agree that the Kir4.1 and Kir5.1 subunits are expressed in glial
cells we also believe that they are expressed in neurons as well where they may form the
heteromeric Kir4.1-Kir5.1 channel that would have a different function than potassium
recycling. Using DAB immunocytochemistry and immunofluorescence I have presented
evidence in this thesis for the expression of the Kir4.1-Kir5.1 channel in chemosensitive
neurons. This neuronal expression suggests that this channel may have a different
function than potassium recycling in neurons compared to the homomeric counterparts
expressed in glial cells. In addition to demonstrating neuronal expression I also have
demonstrated expression of the Kir4.1-Kir5.1 channel in chemosensitive neurons. I
showed that the channel is expressed in primary sensory neurons such as LC neurons as
well as in chemosensitive motor neurons such as the hypoglossal motor neurons. The
demonstration of the presence of this Kir4.1-Kir5.1 channel in these chemosensitive
brainstem nuclei strengthens the candidacy of this channel as a central CO2
chemoreceptor molecule.
In this thesis I have also demonstrated another important regulation of the Kir4.1Kir5.1 channel critical for central chemoreception that is the modulation by
neurotransmitters critical for respiratory control. Recall that one of the requirements of a
central CO2 chemoreceptor molecule is that it should be subject to modulation by
neurotransmitters critical for respiratory control. The neurotransmitters 5-HT, SP, and
TRH are all critical for respiratory control. Therefore, I hypothesized that the Kir4.1Kir5.1 channel is regulated by these neurotransmitters as the immunocytochemistry
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experiments show co-expression of the Kir4.1-Kir5.1 channel with the NK1R. Xenopus
laevis oocytes co-expressing the natural receptors for these neurotransmitters and the
Kir4.1-Kir5.1 channel were exposed to the neurotransmitters. Bath application of all
three neurotransmitters inhibited Kir4.1-Kir5.1 currents and reduced the channel activity.
The effects of the neurotransmitters were dose dependent and specific. More
importantly, the effects of the neurotransmitters required co-expression of the Kir5.1 as
the homomeric Kir4.1 channel expressed with the neurotransmitters failed to be regulated
by the neurotransmitters. This important finding may prove to be a useful tool for future
experiments with the heteromeric channel in vivo. The activation of PKC has been
demonstrated to underscore the inhibition of G-protein gated inward rectifier potassium
channels (GIRK) by SP (Mao et al., 2004). Therefore we wanted to know whether
protein kinase C was involved in the inhibition of the Kir4.1-Kir5.1 by the
neurotransmitters 5-HT, SP, and TRH. Indeed, similar to GIRK channels we showed that
PKC activation was involved in the inhibition of the channel by the neurotransmitters.
Since the channel modulation by neurotransmitters depended upon protein kinase
C activation, we hypothesized that the Kir4.1-Kir5.1 channel may be phosphorylated by
PKC. Indeed, several other Kir channels have been shown to be phosphorylated by PKC
and PKC phosphorylation sites have been identified (Fakler et al., 1994; Henry et al.,
1996; Light et al., 2000; Lin et al., 2000; Mao et al., 2004; Stevens et al., 1999; Vorobiov
et al., 1998; Zhang et al., 2004; Zhu et al., 1999; Zitron et al., 2004). Both the Kir4.1 and
Kir5.1 channels were screened to identify potential PKC phosphorylation sites. Both
subunits contained numerous putative PKC phosphorylation sites in the C-termini,
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suggesting that PKC may phosphorylate the Kir4.1-Kir5.1 channel at residues in the Ctermini. In this thesis I showed that Kir4.1-Kir5.1 is inhibited by PKC activation and that
PKC could directly phosphorylate the C-termini of both Kir4.1 and Kir5.1.
Unfortunately, I was unable to identify the PKC phosphorylation site(s) as I think that the
channel contains multiple phosphorylation sites. In this way, single mutation of potential
phosphorylation sites may not lead to an identification of the phosphorylation site.
Indeed, the biochemistry experiments demonstrated that both Kir4.1 and Kir5.1 C-termini
can be directly phosphorylated by PKC which supports the idea that the heteromeric
interaction introduces additional potential phosphorylation sites. Although the Kir4.1 Cterminus was shown to contain phosphorylation sites that could be phosphorylated
directly by PKC the Kir4.1 channel expressed in xenopus oocytes failed to be regulated
by PKC activation suggesting that the presence of Kir5.1 allows for the regulation by
PKC. This is another regulatory function displayed by the Kir4.1-Kir5.1 channel that is
absent in the Kir4.1 homomeric channel. This may be proven to be a useful tool for
characterizing the heteromeric channel function in the future.
K-4. Kir channel gating
Ligand modulated ion channels have four properties that are: ion selectivity;
ion permeation, ligand binding, and gating. Of all these properties channel gating is the
least understood. Gating refers to the opening and closure of ion channels. Ion channels
can adopt at least two conformations; an open conformation and a closed conformation.
This suggests that ion channels can switch between these two conformations at any
giving time (gating). In ligand modulated channels, ligand binding results in a change in
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the channel gating mechanism. With the discovery that CO2 and the neurotransmitters
affect the Kir4.1-Kir5.1 channel via different mechanisms, I then tried to identify the
exact mechanism for the channel inhibition by these modulators. I hypothesized that Kir
channels have common gate that can be modulated by CO2. Since the protonation site in
the Kir4.1-Kir5.1 channel has not been clearly identified I decided to examine the gating
mechanism by CO2 using the Kir6.2+SUR1 channel. The Kir6.2+SUR1 channels have
several advantages over the Kir4.1-Kir5.1 channel for studying gating. The
Kir6.2+SUR1 channel’s CO2 sensitivity have been well documented. This channel in
addition to being pH sensitive is also ATP sensitive. And the channel has clearly
demonstrated ligand binding sites as well as gating sites.
I noticed that in the Kir6.2+SUR1 there was only one bulky hydrophobic residue
in the TMD2 domain (Phenylalanine 168). Therefore, I hypothesized that the bulky
hydrophobic phenylalanine 168 in the Kir6.2 was involved in channel gating by exposing
its bulky side chain to block the channel pore. I tested this hypothesis using site directed
mutagenesis and found that Phe168 acts as a gate in the Kir6.2+SUR1 channel. I found
that Phe168 not only hinders ion flow, but also facilitates it. How can one residue hinder
and facilitate ion flow? During basal conditions the bulky side chain of Phe168 clogs the
channel pore and hinders the flow of ions though the ion conducting pathway. Upon
ligand binding the TMD2 undergoes elaborate conformational changes that results in the
moving away of the bulky phenylalanine side chain from the pore. I showed that when
the 168 position is mutated to small amino acids the mutant channels tend to lose their
sensitivity to ATP and pH. Single channel analysis demonstrated that this is a result of
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the channels staying in long periods of openings and closures with more closures than
openings. However, the presence of a bulky hydrophobic residue at the 168 position
allows the channels to gate more readily. I demonstrated that the presence of
phenylalanine 168 lowers the energy barrier necessary for the transition from open to
close; thus being a facilitator of channel gating. I found that both ATP and proton
binding regulated the channel gating at this position, suggesting that the gate is shared by
multiple ligands. This is the first demonstration of a functional gate in the Kir6.2+SUR1
channel.

As mentioned before, all Kir channels have a bulky hydrophobic residue

located around the narrowest region of the ion conductive pathway. It now becomes
necessary to demonstrate the importance of this gate during ligand modulation in other
Kir channels. For the Kir6.2+SUR1 and the Kir4.1-Kir5.1 channel, the demonstration of
a functional pH modulation gate is critical for understand the role these channels may
play in central CO2 chemoreception.
The Kir6.2+SUR1 channel is a strong chemoreceptor molecule. We now know
that this channel is expressed in brainstem inspiratory neurons, the channel is sensitive to
pH within a physiological range, it can change the membrane excitability of neurons, and
it is gated by protons. The presence of the Kir6.2+SUR1 channel in inspiratory neurons
suggests that the channel functions in these cells (Haller et al., 2001). Since the
Kir6.2+SUR1 channel is stimulated by intracellular acidification, then channel may be
involved in the inhibition of these expiratory neurons during acidosis that is necessary.
The activation of this potassium channel would lead to release of potassium to the
extracellular space resulting in hyper polarization of these expiratory neurons. This
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hyper polarization would inhibit these neurons leading to a decrease in their firing
frequency and thus a decrease in their information relay to the respiratory muscles. This
is important physiologically as we know that the brain contains inspiratory and expiratory
neurons. During inspiration the respiratory neurons are inhibited where as during
expiration the inspiratory neurons are inhibited. Therefore, during inspiration activation
the Kir6.2+SUR1 channel is a mechanism that can potentially lead to the inhibition of
expiratory neurons. Recordings from brainstem expiratory neurons containing the
Kir6.2+SUR1 channels demonstrating the importance of this channel in these neurons
now becomes necessary for solidifying the role of this channel in central CO2
chemoreception.
The Kir4.1-Kir5.1 is also a strong central CO2 chemoreceptor candidate molecule.
We now know that this channel is expressed in the brainstem, it has high pH sensitivity
within the physiological range, it can detect both alkaline and acidic pH levels, it can
change the cellular excitability, it is subject to neuromodulation by neurotransmitters
critical for respiratory control, it is gated by protons. Similar to the Kir6.2+SUR1 the
presence of the Kir4.1-Kir5.1 channel in chemosensitive brainstem neurons suggest that
the channel may play an important role in these cells. The Kir4.1-Kir5.1 channel unlike
the Kir6.2+SUR1 is inhibited by intracellular acidosis. The heteromeric Kir4.1-Kir5.1
channel unlike the Kir6.2+SUR1 channel is inhibited by intracellular acidification. As
discussed earlier the inhibition appears to occur via protonation of lysine residues. Since
the Kir4.1-Kir5.1 channel is inhibited by intracellular acidosis its role in primary sensory
chemosensitive neurons may be to augment the firing activity of these neurons. The
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inhibition of the Kir4.1-Kir5.1 channel by CO2 would result in the cease of flow of
potassium out of the neurons resulting in the depolarization of the neurons.
Depolarization would lead to an increase in the firing frequency of these brainstem
neurons that would be relayed to the respiratory muscle leading to an increase in
ventilation. In addition to being inhibited by CO2 the Kir4.1-Kir5.1 channel may also be
inhibited by neurotransmitters critical for respiratory control thereby increasing the CO2
stimulus and the response during the relay to the respiratory muscles. The demonstration
of the modulation of the Kir4.1-Kir5.1 channel by neurotransmitters critical for
respiratory control is important physiologically as this suggests that the channel may play
in role in the control of respiration. This also suggests that the Kir4.1-Kir5.1 channel has
an additional function that the homomeric channels do not have.
The two channels studied and discussed in this dissertation are just two of the
potential chemoreceptor candidates. There are other candidates that were not studied as
they are weak candidates failing to satisfy the requirements for a central CO2
chemoreceptor molecule. For many years researchers have searched for the central CO2
chemoreceptor molecule. What we are proposing in this dissertation is that there may be
multiple CO2 chemoreceptor molecules. This idea can explain how central CO2
chemoreception can maintain a high sensitivity while spanning a broad range of changes
in pCO2. The potential CO2 receptor molecules may all be able to detect CO2/pH in
different levels such that collectively they would allow for the detection of a broad range
of changes in pCO2. Indeed, this is what is found for temperature sensing in the body.
Transient receptor potential channels are non selective cation channels. This channel
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super family contains many members that detect temperatures at different levels in such a
way that together they span a broad range of temperatures from cold to hot. We propose
that CO2 sensing has adopted a similar mechanism for detecting such a broad range of
pCO2. In this way both the heteromeric Kir4.1-Kir5.1 and the Kir6.2+SUR1 proposed in
the beginning of this dissertation may be central CO2 chemoreceptor molecules.
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L. GENERAL CONCLUSION
The experiments performed in this dissertation using heterologous expression
systems demonstrate the modulation of Kir channels. The results shown here strengthen
the candidacy of these channels as central CO2 chemoreceptors. In addition to the
findings of other researchers my studies demonstrate the ligand regulation of Kir
channels. I have presented additional evidence for the expression of the Kir4.1-Kir5.1
channel in the brainstem, modulation of the channel by neurotransmitters critical for
respiratory control and CO2, identification of the molecular mechanism underlying this
modulation, as well as identifying a functional pH regulated gate in the Kir6.2+SUR1
channel that appears to be shared by other Kir channels. These properties are critical to
the function of these channels as central CO2 chemoreceptor molecules that can couple
CO2 sensing to cellular excitability and thus an appropriate response by the respiratory
system. Therefore, the information obtained and presented in this dissertation about the
molecular mechanisms underlying the regulation of Kir channels by neurotransmitters
and CO2 constitutes a significant step towards the understanding of the role that may be
played by these channel as CO2 sensing molecules, and may have an impact on the
understanding of respiratory control diseases and on the formation of therapeutic
modalities by the manipulation of these channels.
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